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Abstract
The biological activity of azasugars has largely been attributed to their ability to mimic
the oxocarbenium ion-like transition state formed during reactions with carbohydrate-
processing enzymes and, for this reason, functional and stereochemical modifications
of the azasugar scaffold have led to the development of specific and potent glycosidase
inhibitors. Given the potential of azasugars as glycosidase inhibitors, we were interested
in developing efficient methodology for their synthesis.
This thesis highlights synthetic methodology developed to produce amino-imino-
hexitols as azasugar scaffolds. Key in the synthesis of the amino-imino-hexitols
was the application of a stereoselective Strecker reaction, without the need for chiral
Lewis acids or catalysts, and an extension of an I2-mediated carbamate annulation to
cyclise functionalised and protected alkenylamines. Sixteen amino-imino-hexitols were
synthesized, including ten previously undisclosed substrates with the D-galacto, D-talo,
and L-altro configurations. The novel amino-imino-hexitols were then tested for their
ability to act as glycosidase inhibitors and substrates of the D-talo configuration showed
promising inhibitory effects.
Mechanistic considerations of the I2-mediated carbamate annulation are discussed and
although the exact annulation mechanism has yet to be determined, experimental studies
have revealed that an aziridine is not an intermediate in the reaction. Factors influencing
the diastereoselectivity of the carbamate annulation are also explored. Furthermore, an
in depth analysis of the high cis-selectivity of the carbamate annulation is investigated
using density functional theory to calculate the transition states of iodocyclisations
en route to the formation of carbamates. Taken as a whole, the applicability of the
i
carbamate annulation to a variety of alkenylamines and an understanding of the factors
controlling the diastereoselectivity of the reaction should make this methodology a
valuable addition to the synthetic chemist’s toolbox.
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Chapter 1
Introduction
1.1 General Introduction
Azasugars, or iminosugars, are structural analogues of native carbohydrates in which
the ring oxygen has been replaced by a nitrogen. These sugar mimics are a valuable
class of compounds that play an important role in drug development, primarily due to
their ability to mimic the charge density in the transition state of glycosidic hydrolase
enzymes.1–3 Other biological activities of azasugars have also been noted, such as their
ability to act as molecular chaperones,4–7 as immunomodulators,8 or as inhibitors of
other enzymes and proteins.9,10
Azasugars sparked scientific interest in the early 1960’s with the almost simultaneous
reports of the syntheses of “piperidinoses”, sugar derivatives containing a nitrogen atom
in the ring, by the groups of Jones,11,12 Paulsen,13 and Hanessian.14 Shortly thereafter,
the first azasugar, nojirimycin (1), was isolated from Streptomyces reseochromogenes
1
and found to possess anti-microbial activity.15 Its 1-deoxy analogue deoxynojirimycin
(DNJ, 2), initially prepared by Paulsen et al.,16 was later isolated from Mulberry trees17
and shown to be a potent α-glycosidase inhibitor.18 The D-gluco chiral scaffold of the
nojirimycin family has subsequently played an important role in the development of
clinical drugs, such as Glysetr for non-insulin dependent diabetes (3),19 and Zavescar
(4, Fig. 1.3), for the control of Gaucher disease. 1-Deoxygalactonojirimycin (DGJ,
5), currently in clinical trials, has shown great promise in the treatment of Fabry’s
disease.20 These nojirimycin carbohydrate mimics represent just one of the many types
of azasugar that have been isolated, synthesised, and their biological activity explored in
an effort to find therapeutic activities.21–28 In addition to the aforementioned nojirimycin
derivatives (1-5), which belong to the piperidine (6-membered ring) class of azasugars,
other structural classes of azasugars include the pyrrolidines (5-membered) [e.g. 2,5-
dihydroxymethyl-3,4-dihydroxypyrrolidine 6, (DMDP, R = H)],8,29,30 the pyrrolizidines
(1,2-fused 5-5-membered bicyclic rings), [e.g. casuarine (7)],31 the indolizidines (1,2-
fused 5-6-membered bicyclic rings) [e.g. swainsonine (8)],32 and the nortropanes (2,6-
bridged 5-6-membered bicyclic rings) [e.g. calystegine A3 (9)].33
2
NOH
HO OH
HO R
1
, R = H, R1 = OH, Nojirimycin
, R = H, R1 = H, DNJ
, R = (CH2)2OH, R1 = H, Glyset
, R = (CH2)3CH3, R1 = H, Zavesca
H
N
OH
HO OH
HO
, DGJ
H
N
OHHO
, DMDP
N
HO H OH
HO OH
HO
, Casuarine
N OH
OHHHO
, Swainsonine
NH
HO
HO
HO
, Calystegine A3
HO OHR
1
2
3
4
5 6
7 8 9
Fig. 1.1 Classes of azasugars
Glycosidases are carbohydrate processing enzymes that catalyse the degradation of
glycosidic linkages to break down carbohydrate chains into smaller sugar units. There
are two general mechanisms by which glycosidases hydrolyse a glycosidic bond, with
either inversion or net retention of anomeric configuration.34,35 An inverting glycosidase
follows a one step mechanism ((a), Fig. 1.2) in which both a water molecule and
the substrate are bound by the enzyme. In the active site of the glycosidase, acid
and base residues catalyse a nucleophilic substitution by water via the generation
of an oxocarbenium ion-like transition state to produce the inverted hemiacetal. A
retaining glycosidase follows a double displacement mechanism (b) catalysed by both
nucleophilic and acid/base residues in the active site. Here, the substrate is attacked
by a nucleophilic residue to displace the leaving group via the generation of an
oxocarbenium ion-like transition state, which leads to formation of a covalent glycosyl-
enzyme intermediate.
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Fig. 1.2 Prototypical glycosidase mechanisms for hydrolysis, (a) inversion of
configuration, (b) retention of configuration, (c) protonated piperidines and pyrrolidines
can act as transition state inhibitors
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Nucleophilic attack by water at the anomeric carbon of the bound substrate then
displaces the glycoside via a second oxocarbenium ion-like transition state, leading to
retention of configuration. The ability of azasugars to inhibit glycosidases is illustrated
with both a piperidine and pyrrolidine (c). Here, the nitrogen atom of the azasugar is
protonated at physiological pH and it is this charged species that mimics the developing
charge density of the transition state during glycosidic hydrolysis.36 The adoption of
a chair conformation by the piperidine and envelope conformation by the pyrrolidine
allow both classes of azasugar to resemble the structure and electronics of the glycosyl
cation formed during the reaction.23
1.1.1 Evaluation of Glycosidase Inhibition
There are many classes of glycosidase enzymes37 and the inhibition of each specific class
can have potential in the treatment of different diseases.35 For example, the inhibition of
α-mannosidases has potential for the treatment of cancer,38 the inhibition of α-amylases
can be a treatment for type II diabetes,19 and the inhibition of α-galactosidases has the
potential to treat lysosomal storage disorders.39 Two types of measurements are used
predominantly to determine the glycosidase inhibitory activity of azasugars.40 For both
measurements, assays comprise a source of purified enzyme and its native substrate,
along with the inhibitor being evaluated. The inhibition constant, Ki, denotes the
equilibrium constant of the dissociation of the inhibitor-bound glycosidase complex. A
second measurement, the IC50 value, quantifies the concentration of inhibitor necessary
to halve the reaction rate of a glycosidase-catalysed reaction observed under specific
assay conditions. For both the IC50 and Ki, a smaller value denotes stronger inhibition.
Typically IC50 values are reported as they are less time consuming to measure and
5
require only one concentration of substrate over a range of inhibitor concentrations.
The IC50 value, however, is relative to the concentration of native substrate used and
can therefore vary across different assays. In comparison, determining the Ki involves
measuring the rates of the glycosidase-catalysed reactions while independently varying
the concentration of substrate and the concentration of inhibitor. These assays require
more experiments and are more time consuming to perform, however, the Ki measured
is a constant value for any given inhibitor with a particular glycosidase.40
1.2 Amino-imino-hexitols as Glycosidase Inhibitors
The focus of this thesis concerns the synthesis of amino-imino-hexitols and their ability
to act as glycosidase inhibitors. Of particular note is the pioneering work of Wong et al.
who observed that derivatisation of the naturally occurring 2,5-dihydroxymethyl-3,4-
dihydroxy-pyrrolidine (DMDP, 6, Fig. 1.1) to the 1-amino-1-deoxy-DMDP analogue
10 (Fig. 1.3) resulted in the generation of a compound with pronounced inhibitory
activity against N-acetyl-β-D-glucosaminidase.41 The subsequent synthesis of a library
of N-functionalised DMDP analogues42–44 then led to the identification of potential
drug candidates for osteoarthritis45,46 and bacterial infection.47 Moreover, the N-methyl
amino-hexitol 11 was found to be the most promising drug candidate with the strongest
inhibitory activity against hexosaminidase (Ki = 24 nm).46
The groups of Stu¨tz and Wrodnigg have also developed a series of functionalised
amino-imino-hexitols. Here, the Amadori rearrangement formed a key part of their
synthetic strategy.48–53 Stu¨tz and Wrodnigg found that the one-step N-derivatisation
of amine-derivative (12) led to the generation of powerful β-glycosidase inhibitors,
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while amino imino-hexitol 12 itself was a moderate β-glucosidase inhibitor.48,49,52 More
recently, Ramesh and co-workers prepared several selective glycosidase inhibitors based
on modifications to the L-ido azasugar 13.54 While the parent compound showed no
glycosidase inhibitory activity, N-tosyl, N-methyl, and N-ethyl derivatives all exhibited
good, and often selective, activity against the glycosidases tested. An N-acyl derivative
of imino-D-glucitol 14 was also found to exhibit potent and selective activity against
β-glucosidase while the parent compound was inactive.55
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Fig. 1.3 Representative amino-imino-hexitols
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1.2.1 Synthetic Routes to Amino-imino-hexitols
A number of routes have been developed for the synthesis of amino-imino-hexitols.
These utilise a variety of key synthetic transformations including dihydroxylation,56
reductive aminations,41,48,56 substitution reactions,54,56–58 enzymatic synthesis,41 nucleo-
philic additions,42,57,58 and rearrangements.48,49 A few synthetic routes are summarised
below.
Substitution Reaction
In 2004, Vogel and co-workers56 developed a synthesis of amino-imino-hexitols based
on the use of a lactam scaffold derived from (S)-pyroglutamic acid. The synthesis of
one such derivative, the L-allo configured hexitol (15), is illustrated (Scheme 1.1). Key
steps in the synthesis included a nucleophilic substitution to form the imino-hexitol ring,
and reductive amination to install the second amine. Following the procedure reported
by Ikota and co-workers,59 lactam derivative 16 was converted into the allylic alcohol
17, obtained as a mixture of inseparable diastereomers. Mesylation of the secondary
alcohol 17 followed by treatment with tBuOK induced cyclisation to give pyrrolidine
18. Subsequent ozonolysis and reduction of the corresponding aldehyde then provided
key imino-hexitol intermediates, 19 and 20, in moderate yields. The major pyrrolidine
isomer 20 was subjected to a Swern oxidation, and subsequent reductive amination
with benzylamine to generate protected amine 21. Global deprotection then afforded
amino-imino-hexitol 15 produced in 16 steps and 5% overall yield. While the route to
L-allo imino-hexitol 15 was not high yielding, Vogel was able to synthesise six amino-
imino-hexitol derivatives with the D- and L-allo and D-altro configurations, by extending
8
the route with either pyrrolidine isomer (19 or 20) and altering the protection strategy.
The synthesised amino-hexitols were tested against a panel of glycosidases for their
inhibition activity. A D-altro derivative was found to be a good broad ranging inhibitor
against five classes of glycosidases assayed, whereas amino-hexitol 15 was found to be
a selective moderate β-glucosidase inhibitor.
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Scheme 1.1 Synthesis of amino-imino-hexitols from an (S)-pyroglutamic acid
derivative
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Enzymatic Synthesis
In 1993, Wong and co-workers41 utilised an enzyme catalysed aldol condensation
as a key step for the synthesis of N-acetyl amino-imino-hexitol 22 (Scheme 1.2).
Here, azido alkene 23 underwent ozonolysis to produce aldehyde 24. Condensation
of acetamido propanal 24 with dihydroxyacetone phosphate 25 in the presence of
fructose 1,6-diphosphate aldolase (FDP-aldolase), followed by removal of the phosphate
ester by phosphatase produced aldol product 26 in excellent (84%) yield. Subsequent
hydrogenation of azido hydroxyketone 26 allowed cyclisation upon reductive amination
to give D-manno acetamide 22, which was found to be a potent inhibitor of N-acetyl-β-
D-glucosaminidase (Jack beans, Ki = 1.9 µM).
H
N
OHHO
HO NHAc
AcHN Ph
N3 O3
AcHN O
N3
HO OPO3
O
AcHN
N3
OH
OOH
OH
1) FDP Aldolase
2) Phosphatase
84%
Pd/C, H2
80%
23 24 25
2622
Scheme 1.2 Enzyme catalysed aldol condensation key in the synthesis of an amino-
imino-hexitol
Nucleophilic additions
Another approach to the synthesis of amino-imino-hexitols was reported in 2009 by
Cheng and co-workers.58 Here, the nucleophilic addition of cyanide to a cyclic nitrone
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intermediate formed a key step in the synthesis. A representative synthesis of the D-
altro amino-imino-hexitol 27 is illustrated (Scheme 1.3). In this strategy, D-lyxose
was converted to tri-O-benzyl derivative 28 via the methyl furanoside followed by
per-benzylation and hydrolysis. Tri-O-benzyl derivative 28 was then treated with
hydroxylamine hydrochloride and the resultant oxime subsequently protected with
TBDPSCl to provide a mixture of E/Z-oximes 29. Iodination of 29 followed by
intramolecular nucleophilic displacement in the presence of anhydrous TBAF provided
the key intermediate nitrone 30 in 71% yield from lactol 28. Nitrone 30 then underwent
a stereoselective cyanation to produce nitrile 31 in a diastereomeric ratio of 19:1. The
nitrile in 31 was reduced using Raney Ni/H2 in the presence of Boc2O to give the bis-N-
Boc protected diamine 32. Subsequent hydrogenolysis and Boc removal of 32 afforded
the desired D-altro amino-imino-hexitol 27, in 11 steps from D-lyxose and 27% overall
yield. D-Altro hexitol 27 proved to be a moderately selective α-mannosidase inhibitor
(Jack beans, IC50 = 32 µM). This synthetic route was also applied to the synthesis
of amino-imino-hexitols with the L-allo, D-manno and L-gulo, L-manno, and D-allo,
configurations, which was achieved by starting from D-ribose, D-arabinose, D-xylose
and D-lyxose, respectively.
11
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Scheme 1.3 Cyclic nitrones key in the synthesis of amino-imino-hexitols
McCort and Dure´alt reported55 the nucleophilic ring opening of a bis-aziridine as a
key step in the synthesis of D-gluco amino-imino-hexitol 14 (Scheme 1.4). Here D-
mannitol derived bis-aziridine 33 underwent nucleophilic ring opening with acetic acid,
followed by subsequent aminocyclisation via ring opening of the remaining aziridine
to produce a mixture of pyrrolidine 34 and piperidine 35 (2:1, 87%). Deprotection of
pyrrolidine 34 under Birch conditions and subsequent acid hydrolysis produced D-gluco
configured amino-hexitol 14, which displayed no inhibition towards five glycosidases
it was evaluated against. However, 1-acetamido-1,2,5-trideoxy-2,5-imino-D-glucitol
12
derived from pyrrolidine 34 was found to be a good inhibitor of β-glucosidase (Ki =
10 µM).
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82%
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14
Scheme 1.4 Synthetic route to an amino-imino-hexitol via the ring opening of an
aziridine
Rearrangement
In 1997, Wrodnigg and co-workers48 were the first to report the syntheses of the D-
manno and D-gluco amino-imino-hexitol scaffolds. They devised an elegant route to
the novel scaffolds utilising the Amadori rearrangement. As illustrated (Scheme 1.5),
readily available 5-azido-5-deoxy-glucofuranose 3660 was reacted with dibenzylamine
in the presence of acetic acid to produce D-fructopyranose 37 with introduction of the
C-1 amino group. Subsequent cyclisation with reductive amination and removal of the
N-benzyl groups upon treatment with Pd(OH)2/C and H2, provided D-manno hexitol 12
in good (75%) yield from azido-furanose 36. In subsequent work, elaboration of the D-
manno scaffold 12, via the one-step selective coupling with a variety of lipophilic side
13
chains, provided a library of 1-N-acyl or -N-sulfonylated derivatives, some of which
proved to be potent glycosidase inhibitors.49,50,52,53 For example, coumarin derivative 38
was produced in good (80%) yield via the HBTU mediated coupling of hexitol 12 with
acid 39, and proved to be a powerful β-glucosidase inhibitor (Agrobacterium sp.) with
a Ki of 1.2 nM.
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Scheme 1.5 Synthesis of the D-manno scaffold using an Amadori rearrangement with
further 1-N-derivatisation
1.3 The Synthesis of Amino-imino-hexitols
Given the potential of amino-imino-hexitols as glycosidase inhibitors, we were inter-
ested in developing an efficient methodology for their synthesis. To this end, we
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envisioned using cyclic carbamates II as key intermediates, which could be readily
hydrolysed to give the target amino-imino-hexitols I (Scheme 1.6). Azasugar scaffolds
I could be derivatised further as 1-N-functionalisation has been shown to produce
potent glycosidase inhibitors.42–44,49,50,52–55 The key intermediate carbamates should be
accessible from α-aminonitriles III via the I2-mediated carbamate annulation reaction
recently developed in our group.61–64 Application of this annulation methodology
to protected and functionalised alkenylamines, such as III, would greatly enhance
the scope of the reaction. The nitrile functionalised alkenylamines III could in turn
be prepared via a Strecker reaction65 of the intermediate aldehydes generated from
the Vasella reaction66,67 of readily available methyl iodoglycosides IV. Here, the
inherent chirality of the carbohydrate-derived aldehyde would be used to control the
diastereoselectivity of the Strecker reaction.68–70
H
N
HO OH
N
PO OP
O
O
O
PO OP OP
OP
NH2
CN
NH2HO
CN
OMe
I
Hydrogenation
Hydrolysis
Carbamate
annulation
Vasella
Strecker
I II
IIIIV P = Protecting group or H
1
2
34
5
6
Scheme 1.6 Proposed retrosynthesis for the formation of amino-imino-hexitols
utilising the I2-mediated carbamate annulation
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1.3.1 Vasella Reaction
In 1979, Bernet and Vasella reported the preparation of aldehydes via a Zn-mediated
reductive elimination of haloglycosides (Scheme 1.7).66,67 Here, activated zinc and
acetic acid were added to a solution of methyl bromoglucoside 40 in ethanol and
the solution was stirred at reflux to give aldehyde 41. The Vasella reaction proceeds
via oxidative insertion of zinc into the carbon-bromide bond, this is followed by
reductive elimination with the loss of methoxide to give the aldehyde product. Thus,
in our proposed methodology for the preparation of amino-imino-hexitols we anticipate
the application of Vasella conditions to methyl iodoglycosides (IV, Scheme 2.1) will
produce the corresponding aldehydes.
O
OMeBnO
BnO
BnO
Br
O
OMe
BnO
BnO
BnO
ZnBr
BnO
OBn
OBn
OZn, AcOH
EtOH
TMP340 41
Scheme 1.7 Vasella reaction
1.3.2 Strecker Reaction
One of the key aspects of our proposed methodology for the synthesis of amino-
imino-hexitols is the Strecker reaction, which provides a convenient means to prepare
α-aminonitriles from aldehydes. The Strecker reaction was one of the earliest one-
pot, multi-component reactions discovered71 and has found wide application since
the pioneering synthesis of α-amino acids by Strecker in 1850.65 Since this time,
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the development of modified and asymmetric Strecker reactions have received much
attention.71–75
The Strecker reaction to produce α-aminonitriles follows a general mechanism, whereby
an aldehyde 42 reacts with an amine to form an imine 43, which undergoes subsequent
nucleophilic attack by a cyanide to produce the desired α-aminonitrile 44 (Scheme 1.8).
α-Aminonitriles 44 are useful synthetic precursors and, for example, can be transformed
into amino acids via acid hydrolysis76 (45), or reduced with LiAlH4 to give primary
amines (46).77,78
R
O
H R
N
H
R1
H+
R
HN
CN
R1 R
HN
O
OH
R1
R
HN
NH2
R1
R1
H2N
-H2O
CN
HCl aq
LiAlH4
42 43 44
45
46
Scheme 1.8 General mechanism of the Strecker reaction with examples of the
synthetic usage of the α-aminonitrile formed
In Strecker’s original conditions hydrogen cyanide was used as the source of nitrile
nucleophile, however, due to the highly toxic nature of HCN, modifications to the
Strecker reaction have since involved the addition of alternative sources of nitrile.
Alkaline cyanide salts such as KCN or NaCN have been utilised,79 however, these salts
are not very soluble in organic solvents and can lead to low yields of α-aminonitriles
and tedious reaction work-ups. Improved cyanide solubility in organic solvents has
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been obtained by the use of nitrile sources such as diethyl phosphorocyanidate80 and
TMSCN,81 resulting in the efficient preparation of α-aminonitriles under mild reaction
conditions.
There are a number of synthetic methodologies that can be used to achieve a stereo-
selective Strecker reaction. These include the use of a chiral Lewis acid,82,83 or the
generation of a chiral imine (auxiliary).84–87 A recent example of auxiliary use was
reported by Wang and Resnick,88 who utilised a chiral Strecker reaction via Davis’
sulfinimine protocol85,89 as a key step in the synthesis of a novel γ-sectretase inhibitor
(Scheme 1.9). Here, condensation of (S)-(+)-toluenesulfinamide with aldehyde 48
provided sulfinimine 49, which was subjected to a Strecker reaction with Et(i-OPr)AlCN
to give aminonitrile 50 with good (7:1) diastereoselectivity. Subsequent crystallisation
enhanced the diastereomeric ratio (100:1). Aminonitrile 50 was then hydrolysed to give
the unnatural α-amino acid 26 in excellent (99%) yield.
OF3C H2N
S
O
Ti(OEt)4, DCM
65%
F3C N
S
O
Et(iPrO)AlCN
THF, 63%
F3C NH
S
OCNconc HCl
~99%F3C NH2
OHO
48 49
5026
Scheme 1.9 Sulfinimine auxillary mediated asymmetric Strecker reaction
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Another strategy to achieve an asymmetric Strecker reaction is via the catalytic
enantioselective cyanation of achiral imines, of which there have been many examples
over the past decade.75 For example, Jacobsen and co-workers90 recently reported
a robust asymmetric catalytic method to provide non-natural amino acids with high
enantioselectivities via the use of aqueous cyanide salts (Scheme 1.10). Here, cyanation
of imine 51 with KCN in the presence of a catalytic amount of amido-thiourea derivative
52 produced aminonitrile 53 with good enantioselectivity (90% ee). Subsequent acid-
mediated hydrolysis followed by treatment of the resulting aqueous amino acid solution
with di-tert-butyl dicarbonate then provided amino acid 54 on the multi-gram scale and
with improved enantiomeric excess upon recrystallisation.
t-Bu
N CHPh2
N
O
Ph
Ph
N
H
N
H
S
CF3
CF3
Me t-Bu
KCN, AcOH, H2O, toluene, 0 oC, 4 h
t-Bu
HN CHPh2
CN
90% ee
t-Bu
NH2
CO2H
Boc2O, dioxane
65% from
(0.5 mol %)
t-Bu
NHBoc
CO2H
99% ee
H2SO4, HCl
51
51
52
53
54
Scheme 1.10 Catalytic asymmetric Strecker synthesis of an unnatural α-amino acid
Strecker reactions in which the chiral matrix is the carbonyl or imine reagent, however,
have many advantages as they avoid additional steps and the added complexities
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associated with the use of an auxiliary or a catalyst. Some recent examples in this
field include a highly diastereoselective Strecker reaction reported by Seki et al.68,69
used as a key step in the synthesis of (+)-biotin (Scheme 1.11). Here, α-amino-
aldehyde 55, derived from L-cysteine, was first treated with benzylamine and then
TMSCN to provide the protected α-aminonitrile 56 in excellent (96%) yield and high
syn-diastereoselectivity (28:1, syn/anti).
HS CO2H
NH2 .HCl
L-Cysteine
S
NO
CHO
Bn
S
NO
Bn
NHBn
CN
S
NHHN
O
CO2H
4
(+)-Biotin
1) BnNH2
2) TMSCN
96%
syn/anti  = 28:1
55 56
Scheme 1.11 Stereoselective Strecker reaction key in the synthesis of (+)-biotin
Furthermore, Ga´lvez, Dı´az-de-Villegas and co-workers reported the synthesis of syn-
thetic precursors for the preparation of β-hydroxy-α-amino acids that utilised a stereo-
selective Strecker reaction as a key step (Scheme 1.12).70 Here, protected D-glycer-
aldehyde 57, was reacted with benzylamine to form imine 58, which upon reaction
with TMSCN afforded the corresponding α-aminonitriles in 75% yield and good
diastereoselectivity (6:1, 59:60).
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Scheme 1.12 Stereoselective Strecker reaction with a glyceraldehyde derivative
Ga´lvez and Dı´az-de-Villegas then explained the observed diastereoselectivity of their
Strecker reaction by the glyceraldehyde derived imine 58 adopting an anti-Felkin-Anh91
conformation in which the α-OBn group is situated perpendicular to the imine nitrogen
such that the cyanide can preferentially attack from the Re-face to produce the major
syn-product (Fig. 1.4). Based on the stereochemical outcomes of the Strecker reactions
with both glyceraldyde 57 and α-amino-aldehyde 55 we could expect to observe similar
syn-diastereoselectivity in the formation of our α-aminonitriles III (Scheme 1.6, pg. 15).
BnO
HN
H
SiMe3Bn
:CN
OTBS
Fig. 1.4 Anti-Felkin-Anh model to explain observed syn-diastereoselectivity
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1.3.3 Organic Carbamate Synthesis
Organic carbamates have found wide application in chemistry with their use as
pharmaceuticals and pharmaceutical intermediates, as agrochemicals, as linkers in
combinatorial chemistry, and as protecting-groups during peptide couplings.92 Indeed,
in our own retrosynthesis for the preparation of amino-imino-hexitols, an organic
carbamate forms a key intermediate (Scheme 1.6). A number of strategies have been
developed for the synthesis of carbamates and these include the reaction of amines with
phosgene (or derivatives), carbon dioxide (gaseous, electrochemical, and supercritical),
carbonate esters and salts, or the use of amides in, for example, Hoffmann, Curtius and
Lossen rearrangements.92
Phosgene (61) is a potentially useful building block for the addition of a carbonyl
equivalent to bind amines (62) and alcohols (63) in the synthesis of carbamates (64)
(Scheme 1.13).92 However, as phosgene (61) is extremely toxic, safer derivatives have
also been utilised for the synthesis of carbamates 64, such as di-phosgene 65 or tri-
phosgene 66.92
Cl Cl
O
Cl OCCl3
O
Cl3CO OCCl3
O
RNH2
X X
O
R1OH N
H
OR1
O(either      or       or      )
R
62 63
61
61
65
65
66
66
64
Scheme 1.13 The use of phosgene and derivatives for the synthesis of carbamates
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The synthesis of carbamates with CO2 has also been well utilised.92 Kojima and co-
workers have reported the formation of carbamates 67 from addition of CO2 to amines 68
(Scheme 1.14).93 Here, CO2 was trapped by an aluminium porphyrin and thus activated
to react with secondary amines 68 in the presence of epoxides 69 to produce hydroxy
carbamates 67.
O
R3R2
RR1NH
CO2
Aluminium porphyrin OH
R3
O
R2
N
O
R
R1
68 69 67
Scheme 1.14 The use of carbon dioxide for the synthesis of carbamates
Huang and Keillor have reported94 a modified Hoffman rearrangement for the synthesis
of carbamates (Scheme 1.15). Here, a series of aliphatic and aromatic amides 70
were treated with NBS and NaOMe and, via rearrangement to the isocyanate with
addition of methanol, produced the corresponding carbamates 71 in excellent (85%-
100%) yields.
R NH2
O NBS, NaOMe
MeOH, reflux, 10 min.
85-100%
N
H
OMe
O
R
70 71
Scheme 1.15 A modfied Hoffman rearrangement for the preparation of carbamates
Curtius and Lossen rearrangements have also produced carbamates from azides and
hydroxamic acids via isocyanate intermediates (Scheme 1.16).92 The Curtius rearrange-
ment involves heating acyl azides 72 to give isocyanates with the loss of N2. The
Lossen rearrangement generally involves the reaction of hydroxamic acids with an acyl
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or sulfonyl chloride, which under basic conditions rearranges to form an isocyanate. For
both rearrangements, subsequent reaction of the intermediate isocyanates with alcohols
provides carbamates 64.
R N3
O
N
H
OR2
O
RN C O
R R2OH
∆, -N2
R N
H
O
Lossen
OH
R1COCl
 NaOH
Curtius72
73
64
Scheme 1.16 Carbamates prepared via a Curtius or Lossen rearrangement
Other recent examples of organic carbamate synthesis include the use of alkyl chloro-
formates, as illustrated by Kim and Jung95 who reported on the simple and efficient
conversion of a series of amines to their carbamate derivatives via indium metal
catalysis (Scheme 1.17). Here, amine 74 reacted with an equimolar amount of methyl
chloroformate in the presence of indium to produce carbamate 75 in excellent (92%)
yield. This general route to carbamates was then further exemplified by starting with a
wide variety of aliphatic and aromatic amine precursors.
NH2
Cl OMe
O
N
H
OMe
O
In, (0.1 equiv.)
MeCN, 3 h, reflux
92%74 75
Scheme 1.17 Indium catalysed formation of carbamates
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A stereoselective synthesis of cyclic carbamates from linear amino alcohol precursors
was reported by Dinsmore and Mercer in 200496 (Scheme 1.18). Here, carboxylation
of amino alcohols 76 followed by a Mitsunobu reaction provided either carbamate 77
with retention of configuration or 78 with inversion (Scheme 1.18). Using this method
a series of cyclic carbamates were produced in good yields from a variety of amino
alcohols. Unexpectedly, the stereochemical outcome of the Mitsunobu reaction was
dependent on whether the carbamic acid intermediate was N-substituted with hydrogen
(retention) or carbon (inversion).
HNHO
MePh
R
NHO
MePh
R
HO
O
O NH
O
MePh
O N
O
MePh
Mea R = Hb R = Me
CO2, DBU, MeCN
n-Bu3P, DBAD
(84%)
(73%)
76
76
77
78
Scheme 1.18 Formation of cyclic carbamates from amino alcohols
1.3.4 I2-mediated Carbamate Annulation
More recently, Stocker, Timmer and co-workers developed a highly stereoselective I2-
mediated carbamate annulation as a key step in the protecting-group-free synthesis of
azasugars.61–64 This methodology was inspired by seminal work of Hassner and Burke97
and Inesi et al.98 who prepared cyclic carbamates, in modest yield, from the reaction of
acyclic amines equipped with a halogen leaving group and either sodium carbonate or
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tetraethylammonium bicarbonate. Stocker and Timmer thus envisioned a retrosynthetic
strategy for the preparation of azasugars V whereby the target compounds could
be readily prepared from the precursor carbamates VI via base-mediated hydrolysis
(Scheme 1.19). Carbamates VI, in turn, could be formed via the I2-mediated annulation,
with the required alkenylamines VII being prepared from the parent sugars VIII via
a Vasella reductive amination.66,67,99 In this manner, both five-membered (n = 1) or
six-membered (n = 2) azasugars, without an ‘anomeric’ substituent, could be readily
prepared. As this thesis concerns the synthesis of pyrrolidines, our attention will thus
focus on the scope and limitations of the I2-mediated annulation for this ring size.
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N
OHHO
n
N
OHHO
n
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O
NH2
OH
OH
n O
OHHO
n
OMe
HO I
V VII VIIIVI
Carbamate Annulation
Scheme 1.19 Retrosynthesis for the protecting-group-free preparation of azasugars
Stocker and Timmer’s general synthetic approach was applied to the protecting-group-
free synthesis of pyrrolidines (Scheme 1.20)61–63 In their seminal work, the parent
pentose 79 was readily converted into the corresponding alkenylamine 80 via a Vasella
reaction followed by a protecting-group-free reductive amination.99 Subjection of
alkenylamine 80 to a solution of I2 and excess NaHCO3 in H2O then formed carbamate
81 in one step and in excellent yield and diastereoselectivity.61 The carbamate annulation
favours the formation of 3,4-cis pyrrolidines (dr >20:1), with the stereochemistry
at the 3-position exerting stereocontrol on the cyclisation.100–103 Carbamate 81 was
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subsequently treated with NaOH in EtOH to provide the 1,4-dideoxy-1,4-imino-L-
lyxitol 82 in excellent (99%) yield. Using this strategy, 1,4-dideoxy-1,4-imino-D-lyxitol
83 ,63 1,4-dideoxy-1,4-imino-D-xylitol 84,61 1,4-dideoxy-1,4-imino-L-xylitol 85,63 and
1,2,4-trideoxy-1,4-imino-L-xylitol 86 (Fig. 1.5),62 were prepared in excellent (48%-
57%) overall yields.
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Scheme 1.20 Carbamate annulation used in the synthesis of pyrrolidines
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Fig. 1.5 Application of the carbamate annulation to a series of pyrrolidines
To explain the mechanism of the annulation, Stocker and Timmer proposed a reaction
involving the initial formation of a haloamine followed by in situ carbonylation, similar
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to that described for the addition of CO2 to 1,2-hydroxyhalides104 (cf. 87 → 88,
Scheme 1.21) To support this idea the role of the base in the reaction was investigated61
and it was observed that subjection of alkenylamine 80 to N-iodosuccinimide (NIS),
or iodine in the presence of DBU or NaOH gave an inseparable mixture of five- and
six-membered iodoazasugars 89 and 90 (Scheme 1.21) presumably formed from 80 via
aziridine formation and subsequent opening of the three-membered ring by nucleophilic
iodide.105 Moreover, in all experiments, there was no evidence for the formation of the
corresponding carbamate, suggesting that the CO2 required for the reaction is generated
via the dissolution of NaHCO3 in water. Attempts were also made to determine
if the unprotected iodoamine 87 was indeed an intermediate in the reaction though
unfortunately iodoamine 87 was unable to be isolated despite numerous attempts.61
NaHCO3 (excess)
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Scheme 1.21 Proposed iodoamine intermediate in the carbamate annulation
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1.3.5 Diastereoselectivity in the I2-mediated Carbamate Annulation
The high diastereoselectivity observed in the I2-mediated carbamate annulation of
alkenylamines without an α-amine substituent62 was explained by adapting a transition
state model originally proposed by Chamberlin et al.,100–102 and in line with more recent
theoretical studies by Gouverneur and co-workers.103 Here it was proposed that during
electrophilic cyclisations, the stereo directing hydroxyl could be positioned either in
the plane of the double bond (A, O-in-plane), or almost perpendicular to that plane (B,
H-in-plane) (Fig. 1.6). Of these two transition states, A had minimal overlap between
the electron-withdrawing σ*C-O and reacting piC=C orbitals, thereby forming the lowest
energy transition state. The H-in-plane conformation (B) had overlapping hydroxyl
σ*C-O and double bond piC=C orbitals, which destabilised the I2–pi complex and was
hence disfavoured.
HO
I I
HRNu
H
II
HO R Nu
pi
σ∗ σ∗
pi
A O-in-plane B H-in-plane
Favoured Disfavoured
Fig. 1.6 O-in-plane vs H-in-plane
Accordingly, during the protecting-group-free carbamate annulation, attack of the
amine on the I2–olefin complex was envisioned to take place via a 5-membered ring
transition structure, in which the ring nitrogen approached the double bond in an NE
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(envelope) conformation and followed a Bu¨rgi-Dunitz-like trajectory106 (Scheme 1.22).
Applying the transition state model, it is apparent that the favoured O-in-plane (A)
conformation leads to the observed 3,4-cis-product 91 and the less favoured H-in-plane
(B) conformation leads to the unobserved 3,4-trans-product 92.
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Scheme 1.22 Stocker and Timmer’s proposed transtion state for the protecting-group-
free I2-mediated carbamate annulation
Based on the stereochemical outcomes of carbamate annulations with alkenylamines
without an α-amine substituent, we could expect to observe similar high cis-diastereo-
selectivity in the production of carbamates II from α-aminonitriles III (Scheme 1.6,
pg. 15). However, the nitrile substituent at the α-amine position may play a role in the
transition states of our carbamate annulation.
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1.4 Thesis Outline
The work in this thesis focuses on the synthesis of amino-imino-hexitols as glycosidase
inhibitors via an I2-mediated carbamate annulation and includes investigations into
the mechanism and diastereoselectivity of the carbamate annulation. Chapter 2
describes novel methodology for the synthesis of 1-amino-1,2,5-trideoxy-2,5-imino-L-
iditol 13 starting from D-arabinose (Scheme 1.23). Key in the synthesis is a modified
Strecker reaction with aldehyde 93 to produce α-aminonitrile syn-94 in excellent
diastereoselectivity and the annulation of alkenylamine syn-94 to give carbamate 95 as
the only observed diastereomer. Iodoamine 96 is identified as an intermediate formed
during the carbamate annulation.
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OBn
BnO
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N CN
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O
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Carbamate
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NH2 2 steps HN CN
BnO OBn
I
93 94
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Scheme 1.23 Novel methodology to synthesise an amino-imino-hexitol
Chapter 3 reports on the application of the methodology presented in Chapter 2
to prepare five more amino-imino-hexitol scaffolds with the D-gluco, D-manno, and
previously undisclosed D-galacto, D-talo and L-altro configurations (Scheme 1.24).
Here, the variety of azasugar scaffolds are accessed via carbamate annulations of
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alkenylamines derived from D-arabinose and D-ribose.
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Scheme 1.24 Preparation of amino-imino-hexitols
Chapter 4 focuses on evaluation of the glycosidase inhibitory activity of a number
of amino-imino-hexitols, along with N-acylation of the compounds with novel con-
figurations. In Chapter 5, mechanistic considerations of the I2-mediated carbamate
annulation are presented along with a discussion of the diastereoselectivity of the
reaction and proposed transition state models for the initial iodocyclisation (e.g. syn-
94→ 96, Scheme 1.25).
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Scheme 1.25 Proposed transition state in the iodocyclisation of α-aminonitrile syn-94
The work in Chapter 6 comprises a computational investigation of the diastereoselec-
tivity of the carbamate annulation using density functional theory to find transition
states of the initial iodocyclisation step. Calculations starting with several alkenylamine
precursors with and without an α-amine substituent are presented. Chapter 7 focuses
on future prospects.
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Each Chapter in this thesis has been written in a self contained format and thus has its
own compound numbering, experimental details and reference list.
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Chapter 2
Development of Stereoselective
Strecker and I2-mediated Carbamate
Annulation for the Synthesis of an
Amino-imino-hexitol
2.1 Introduction
Azasugars, or iminosugars, are a valuable class of compounds that play an important
role in drug discovery, primarily due to their ability to mimic oxocarbenium ion-like
transition states of glycosidase reactions (Chapter 1).1,2 In particular, the therapeutic
potential of amino-imino-hexitols as glycosidase inhibitors has led to a number of past
syntheses of these azasugars and their N-acyl derivatives.3–6 We sought to develop
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amino-imino-hexitols as scaffolds for drug development and therefore devise a synthetic
strategy that would enable access to the various stereoisomers. We aimed to do this by
taking advantage of the I2-mediated carbamate annulation recently developed within the
Stocker and Timmer research group.7–10
The focus of the work in this chapter is the development of methodology that allowed
for the efficient and stereoselective synthesis of amino-imino-hexitols (I, Scheme 2.1).11
Key to achieving this goal was the extension of the I2-mediated carbamate annulation
to functionalised alkenylamines (III to II), and the application of a diastereoselective
Strecker12 reaction (IV to III). At the start of this project we chose to synthesise the
previously undisclosed L-ido configured amino-imino-hexitol (1, Fig. 2.1) as a ‘proof-
of-concept’ for the synthesis of a variety of amino-imino-hexitols. However, during the
course of the research the synthesis of L-ido-hexitol (1) was published by Ramesh and
co-workers.13
H
N
HO OH
N
PO OP
O
O
O
PO OPOP
OP
NH2
CNNH2HO
CN
OMe
I
I II III IV
P = Protecting group or H
Scheme 2.1 Retrosynthetic analysis of amino-imino-hexitols
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N
HO OH
NH2HO
1
Fig. 2.1 L-Ido configured amino-imino-hexitol (1)
2.2 Development of a Stereoselective Strecker Reaction
With our synthetic plan in place, we set out to prepare the D-arabinose derived α-
aminonitriles syn-2 and anti-3 (Scheme 2.3). Previously, work was carried out by
Dangerfield,11 within the Stocker and Timmer research group, to attempt the Strecker
reaction without the use of protecting-groups, as this would provide a shorter synthetic
route if successful (Scheme 2.2). To this end, methyl iodoglycoside 4, readily prepared
from D-arabinose in 64% yield (2 steps),9,14 was subjected to Vasella15,16 conditions.
Though a lower running spot was observed via TLC, isolation of the corresponding
aldehyde proved futile with product degradation being observed. A two-step one pot
Vasella/Strecker reaction was then attempted by first treating glycoside 4 with activated
zinc in EtOH at reflux, followed by cooling and treatment with amine (either Ph2CHNH2
or NH4Cl) and nitrile (either KCN or TMSCN). Unfortunately, under these conditions,
significant product degradation was observed. At best only a minor amount (ca. 5%)
of the desired α-aminonitrile 5 could be obtained when Ph2CHNH2 was used as the
nucleophile.
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NHCHPh2
OH
OH
CN
Zn,  NH2CHPh2, KCN 
EtOH, reflux 18 h
5%
O OMe
HO OH
ref. 10
I
D-Arabinose
4 5
Scheme 2.2 Attempts to produce nitrile-functionalised alkenylamines via a protecting-
group-free protocol
In light of the issues in preparing and isolating the α-aminonitriles without protecting
groups, we decided to develop the Strecker reaction with the use of protecting groups
(Scheme 2.3). Here, D-arabinose was converted into the benzyl-protected methyl
iodoglycoside 6 in 5 steps and 62% overall yield following literature procedures.9,17,18
Subsequent treatment of iodide 6 with a solution of activated zinc in EtOH, according to
the conditions of Vasella, gave the corresponding aldehyde 7 in an excellent 97% yield.
Given the chirality of 7, we then envisioned that a diastereoselective Strecker reaction
could be developed to favour the selective formation of one α-aminonitrile, either syn-2
or anti-3, representing the D-lyxo and D-xylo configurations, respectively.
O OMe
BnO OBn
Zn, AcOH, EtOH
reflux, 2 h, 97%
O
OBn
BnO
OBn
BnO
syn-    & anti-      R = H
CN
NHR
Table 2.1
I
D-Arabinose
ref. 
17,18
syn-    & anti-      R = CHPh2
6 7
2 3
8 9
Scheme 2.3 Preparation of nitrile-functionalised alkenylamines
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Aldehyde 7 was first treated with KCN in the presence of NH4Cl in acetonitrile (entry
1, Table 2.1). Unfortunately, the poor solubility of NH4Cl in acetonitrile resulted
in formation of the corresponding cyanohydrin, as observed by 1H NMR (illustrated
by the downfield shift of the α-protons to 4.53 and 4.45 ppm from 3.89 and 3.70
ppm, respectively), and the desired α-aminonitrile was not observed. Studies of the
Strecker reaction by Taillades and Commeyra demonstrated that cyanohydrin formation
is kinetically favoured;19 it is interesting to note that in this case none of the desired α-
aminonitriles syn-2 or anti-3 were observed, even after prolonged reaction times (24
h). To prevent formation of the cyanohydrin and other impurities, the much more
soluble and nucleophilic Ph2CHNH2 has been utilised,20,21 which, with increased steric
bulk, could also lead to enhanced diastereoselectivity. Aldehyde 7 was thus treated
with Ph2CHNH2, KCN, as the nitrile source, and Al2O3 (entry 2, Table 1). The
reaction was sluggish, and a reaction time of two weeks was required for the complete
disappearance of aldehyde 7 starting material. Although the yield of aminonitriles syn-
8 and anti-9 was poor (ca. 30%), the diastereoselectivity was excellent, being 11:1 in
favour of the S diastereomer syn-8, and both isomers could be separated via column
chromatography. Next, in an attempt to improve the yield and decrease the reaction
time, sonication22 was employed (entry 3). This improved the reaction yield (78%),
though the diastereoselectivity was reduced (7:1, syn:anti).
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Table 2.1 Optimisation of the Strecker reaction
O
OBn
BnO Conditions
RNH2 OBn
BnO
syn-    R = H
syn-    R = CHPh2
CN
NHR
OBn
BnO
anti-    R = H
anti-    R = CHPh2
CN
NHR
+
7 2 3
8 9
Entry R-NH2 (equiv.) Nitrile (equiv.) Conditions Ratioa b syn:anti Yield (%)
1 NH4Cl (2.1) KCN (2) MeCN, sonication, 50 ◦C, 18 h - 0c
2 Ph2CHNH2 (2) KCN (2) Al2O3, MeCN, r.t., 14 d 11:1 33
3 Ph2CHNH2 (2) KCN (2) Al2O3, MeCN, sonication, 50 ◦C, 2 d 7:1 78
4 Ph2CHNH2 (2) (EtO)2P(O)CN (1.2) MeCN, r.t., 2 h 7:1 52
5 Ph2CHNH2 (2) (EtO)2P(O)CN (1.2) THF, r.t., 6 h 2:1 72
6 Ph2CHNH2 (2) KCN (2) TMSCl, MeCN, r.t., 2 d 8.5:1 49
7 Ph2CHNH2 (2) TMSCN (1.2) MeCN, r.t., 16 h 12.5 :1 85
8 NH4OAc (10) TMSCN (1.2) MeCN, r.t., 24 h 5.5:1 80
9 NH4OAc (10) TMSCN (1.2) THF/H2O, r.t., 18 h - 0c
10 NH4OAc (10) TMSCN (1.2) EtOH, r.t., 18 h 8:1 82
11 NH4OAc (10) TMSCN (2) EtOH, r.t., 18 h 9:1 88
aAs determined from analysis of the crude reaction mixture by 1H NMR spectroscopy.
bThe configurations of syn-2 and anti-3 were determined after cyclisation by 1H NMR NOE correlations and comparison of the optical rotation
values with those of known products. The configuration of anti-3 was further confirmed through X-ray crystallography. For syn-8 and anti-9, the
diphenylmethyl group was removed by treatment with TFA and the resulting 1H NMR spectrum was compared to that of syn-2 and anti-3.
cOnly the cyanohydrin was observed.
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We then explored nitrile sources with improved solubility in organic solvents. When
diethyl phosphorocyanidate23 was added to a solution of aldehyde 7 and Ph2CHNH2 in
acetonitrile (entry 4), the diastereoselectivity (7:1, syn:anti) was similar to that observed
using KCN and sonication (entry 3), however the yield was only 52%. Changing the
solvent to THF (entry 5) improved the overall yield, but led to a dramatic decrease in
diastereoselectivity (2:1). The use of TMSCN as a nitrile source was then investigated.
First, TMSCN was generated in situ via the addition of KCN to a solution of TMSCl,
this was then added to a solution of the aldehyde in acetonitrile (entry 6). This
reaction proved to be slow, taking 2 days to go to completion, and although the
diastereoselectivity was good (8.5:1, syn:anti), the overall yield was modest (49%).
Unreacted imine was observed by 1H NMR analysis of the crude reaction mixture.
A change to TMSCN,24 however, led to a rapid improvement in yield (85%) and
diastereoselectivity (12.5:1, syn:anti, entry 7), providing the conditions of choice for
the Strecker reaction with Ph2CHNH2 as the amine source.
Although the initial experiments with NH4Cl and KCN (entry 1) failed to give
the desired aminonitriles, we were keen to explore whether the optimised Strecker
conditions, using Ph2CHNH2 as the nucleophile, were also applicable when using an
ammonium salt. This would allow us to pursue our initial goal of using an unprotected
amine source and remove one step from the reaction sequence. To this end, the more
soluble NH4OAc was used in combination with TMSCN as the nitrile source, and to
our delight, this resulted in a respectable 80% yield for the two diastereomers and
good diastereoselectivity (5.5:1, syn/anti), (entry 8). The stereochemistry of syn-2
was determined via subsequent NOE correlations and comparison with known optical
rotation values following cyclisation (vide infra), while a crystal structure of anti-
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3 was obtained (Fig. 2.2), proving the stereochemistry unambiguously. To further
explore the effects of solvent on reaction yield and diastereoselectivity, the reaction
was repeated, this time using a solution of THF/H2O (1:1) to dissolve both aldehyde
7 and the ammonium salt (entry 9). Unfortunately, these conditions yielded only the
cyanohydrin. A change to EtOH, however, led to both an improvement in yield (82%)
and diastereoselectivity (8:1, syn/anti) (entry 10), with only a minor amount of the
cyanohydrin formed. A further improvement was observed with the addition of 2
equivalents of TMSCN (entry 11), which gave the desired α-aminonitrile in excellent
(88%) yield and diastereoselectivity (9:1, syn/anti). This result was remarkable in
that both the yield and diastereoselectivity were excellent, and moreover, that the
diastereomers were readily separable via flash chromatography [syn-2, Rf = 0.47; anti-3,
Rf = 0.38 (hexanes/EtOAc; 1:1)].
Fig. 2.2 Crystal structure of anti-325
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The stereochemical outcome of the reaction can be explained by considering the
approach of the cyanide nucleophile through a Cram-model of a chelation controlled
transition state (Fig. 2.3). Here chelation occurs via the iminium proton and the α-
benzyloxy group to give a five-membered ring. The cyanide then attacks from the least
hindered Si face of the ring.
R
OBn
H
N
H
HH
NC:
Fig. 2.3 Cram chelate model for the Strecker reaction to give α-aminonitrile syn-10
2.3 Extension of the I2-mediated Carbamate Annulation
With the desired α-aminonitriles in hand, an iodine mediated carbamate annulation was
investigated. Previous work from our research group illustrated that iodine-mediated
cyclisations of hydroxy-functionalised alkenylamines led to the rapid formation of
pyrrolidine-derived cyclic carbamates with excellent diastereoselectivity in favour of
the 4,5-cis product.7 These cyclisations were performed in saturated aqueous NaHCO3,
and were in contrast to previous scientific dogma whereby iodine-mediated cyclisations
of alkenes containing an internal nucleophile (oxygen or nitrogen) were reported to
give a halide-functionalised product.26 Given the limited solubility of benzyl-protected
α-aminonitrile syn-2 in H2O, the carbamate annulation would need to occur in a
mixed solvent system, and moreover, generation of a primary iodide was suggested
by the literature. To this end, a number of I2-mediated electrophilic cyclisations were
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performed.
First, we treated protected amine syn-8 with N-iodosuccinimide (NIS) as the source
of iodine, and unsurprisingly, in the absence of a ‘CO2’ source, generated the primary
iodide 10 in good (79%) yield (entry 1, Table 2.2). A similar result was observed when
NIS was used with unprotected amine syn-2 with the corresponding iodo azasugar 11
being prepared in 75% yield (entry 2). A change of base to NaHCO3 (1.5 equiv.) and
iodine source to I2 with the use of a mixed solvent system, THF/H2O (1:1) led to the
generation of only a minor amount of carbamate 12 (<10%) when the reaction was
stirred at room temperature for 4 h (entry 3). Here, the major product was the primary
iodide 11. Increasing the reaction time to 20 h, however, led to a dramatic increase
in the yield of 12 (ca. 50%) and suggests that iodo iminosugar 11 is an intermediate
en route to the formation of 12 (entry 4). Only the 4,5-cis diastereomer was formed for
both 12 and 11, as was predicted by our previous carbamate annulations to form dideoxy
pyrrolidines,7–9 and literature precedence for the iodocyclisation of substrates carrying
an alkoxy substituent in the allylic position.27–30
Given that the primary iodide appears to be a key intermediate during the carbamate
annulation (2 → [11] → 12), it is the formation of the iodide that determines the
diastereoselectivity of the reaction. Seminal work by Chamberlin et al.,31,32 and the
more recent theoretical studies by Gouverneur and coworkers33 highlight the effects of
the substitution pattern on I2-mediated electrophilic halocyclisations and the role that
the allylic group has on influencing the diastereoselectivity of the reaction. The attack
of the amine on the I2-alkene complex is thought to take place via a five-membered
ring transition state in which the internal nucleophile approaches the double bond in an
envelope conformation and follows a Bu¨rgi-Dunitz-like trajectory. In our studies, the
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benzyloxy substituent on the ring would be preferentially positioned in the plane of the
double bond, resulting in the 4,5-cis-product. The addition of ’CO2’ to 11 then provides
carbamate 12. A more detailed discussion on the mechanism and diastereoselectivity of
the I2-mediated carbamate annulation, will be provided in Chapters 5 and 6.
The number of equivalents of iodine and NaHCO3 were then increased to further
improve carbamate formation. The use of 2.5 equiv. of iodine and 15 equiv. of NaHCO3
led to the preferential formation of 12 (1:20, 11:12) after 20 h (entry 5). Finally, optimal
conditions for the formation of the carbamate 12 were found when 20 equiv. of NaHCO3
were added to a solution of iodine in THF/H2O (1/1) so that the final concentration of
NaHCO3 in H2O was approximately 6M (entry 6). Under these conditions there was
no trace of iodide 11, as evidenced by 1H NMR of the crude reaction mixture. Again,
conversion of iodide 11 to carbamate 12 was observed via TLC analysis (hexanes:ethyl
acetate, 2:1; Rf = 0.52 for iodide 11, Rf = 0.35 for α-aminonitrile syn-2; Rf = 0.24 for
carbamate 12). Here it is important to note that the ability to form carbamate 12, when
starting with a functionalised and protected alkenylamine, greatly expands the scope of
this annulation methodology.
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Table 2.2 Formation of cyclic carbamate 12
OBn
OBn
CN
NHR
N CN
BnO OBn
R = H
R = CHPh2
R
N CN
BnO OBn
O
O
+
Conditions
syn-   R = H
syn-   R = CHPh2
I
2
8
11
10
12
Entry R Conditions Ratioab 11/12 Yield (%)
1 CH2Ph2 NIS, (1.2 equiv.), DCM, r.t., 5 h 10 only 79
2 H NIS (1.2 equiv.), DCM, r.t., 5 h >20:1 75
3 H I2 (1.1 equiv.), NaHCO3 (1.5 equiv.), THF/H2O (1/1), r.t., 4 h 9:1 80
4 H I2 (1.1 equiv.), NaHCO3 (1.5 equiv.), THF/H2O (1/1), r.t., 20 h 1:1.5 76
5 H I2 (2.5 equiv.), NaHCO3 (15 equiv.), THF/H2O (1/1), r.t., 20 h 1:20 84
6 H I2 (2.5 equiv.), NaHCO3 (20 equiv.), THF/H2O (1/1), r.t., 20 h <1:20 85
aDetermined by integration of the relevant signals in the 1H NMR spectrum of the crude reaction mixture.
bConfiguration determined by NOE correlations and comparison of spectra with that of known aminoiminohexitols (vide infra)
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To complete the synthesis of target amino-imino-hexitol 1 (Scheme 2.4), carbamate 12
was treated with Pd(OH)2/C in the presence of 2M HCl and H2 (7 bar) to give amine 13
in 98% yield. This one pot reduction and deprotection strategy gave clean product as
evidenced by the 1H NMR (Fig. 2.4) and 13C NMR (Fig. 2.5) spectra of amino carbamate
13. Here, characteristic NMR resonances were observed at (1H δ) 4.64 (t) and 4.52 ppm
(dd) for the H-1 methylene protons, 1A and 1B, respectively, which had a long range
correlation according to HMBC, to the C-3 carbonyl peak (13C δ 164.9 ppm). Also the
CH2NH2 methylene protons at (1H δ) 3.30 (dd) and 3.21 ppm (dd) for CHANH2 and
CHBNH2, respectively, correlated by HSQC to the upfield CH2NH2 carbon resonance at
(13C δ) 39.3 ppm (full characterisation details can be found in the experimental section).
N CN
BnO OBn
O
O
N
HO OH
O
OH2, Pd(OH)2/C
2M HCl in Et2O
CHCl3:EtOH (3:5)
rt, 72 h, 98%
NH2 HN
HO OH
NH2HONaOH, EtOH
reflux, 2 h
 98%
.HCl
12 13 1
Scheme 2.4 Nitrile reduction and deprotection
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Fig. 2.4 1H NMR spectrum of amino carbamate 13, (500 MHz, HCl salt in D2O)
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Fig. 2.5 13C NMR spectrum of amino carbamate 13, (133 MHz, HCl salt in D2O)
55
NOE correlations between the methylene proton HB of the CH2NH2 group of 13, the
methine proton at C-7, the bridge proton at C-7a and the methine proton at C-6, and
between the methylene proton HA of the CH2NH2 and the methine proton at C-6
confirmed the stereochemistry of this product (Fig. 2.6). The carbamate in 13 was
then hydrolysed using a solution of NaOH in EtOH, followed by neutralisation with
DOWEX-H+ to complete the synthesis and generate the known L-ido amino-imino-
hexitol 1,13 in good (39%) overall yield from D-arabinose.
O
NO
NH2
H
H
H
H
HOH
H
HO
H
H
3
7
5
6
7a
1
A
B
B
A
13
Fig. 2.6 NOE of amine 13
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2.4 Conclusion
In summary, an efficient route for the preparation of the L-ido amino-imino-hexitol (1)
has been developed. This has been demonstrated via the preparation of amino-imino-
hexitol 1 in 10 steps from D-arabinose and a good 39% overall yield. During the course
of this work, the power of a highly diastereoselective Strecker reaction, without the
need for chiral Lewis acids or catalysts, has been demonstrated. The stereoselectivity
of the Strecker reaction can be explained by the Cram-chelation control model to
favour the syn-aminonitrile 2. Furthermore, an I2-mediated carbamate annulation
has been optimised for alkenylamine syn-2 to produce carbamate 12. A primary
iodoamine has also been identified as a key intermediate in the carbamate annulation
reaction. Moreover, the potential of our novel carbamate annulation for the cyclisation
of protected and functionalised alkenylamine precursors has greatly expanded the scope
of this reaction.
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2.5 Experimental
General Experimental
Unless otherwise stated all reactions were performed under air. THF was distilled from
LiAlH4 and DCM was distilled from P2O5 prior to use. All chemicals obtained from
commercial suppliers were used without further purification. Zn dust was activated by
the careful addition of conc. H2SO4, followed by decantation and washing with EtOH
(3 x) and hexanes (3 x), and storage under dry hexanes. All solvents were removed
by evaporation under reduced pressure. Reactions were monitored by TLC analysis
on silica gel coated plastic sheets (0.20 mm, Polygram SIL G/UV254) with detection
by coating with 20% H2SO4 in EtOH followed by charring at ca. 150 ◦C, by coating
with a solution of ninhydrin in EtOH followed by charring at ca. 150 ◦C, by coating
with Hanessian’s stain followed by charring at ca. 150 ◦C, or by coating with a solution
of 5% KMnO4 and 1% NaIO4 in H2O followed by heating. Column chromatography
was performed on silica gel (40-63 µm). Dowex Monosphere M-31 acidic resin
was used for ion exchange chromatography. Melting points [◦C] were obtained with
Gallenkamp apparatus and are uncorrected. High-resolution mass spectra were recorded
on a Waters Q-TOF PremierTM Tandem Mass Spectrometer using positive electro-spray
ionisation. Optical rotations were recorded using a Perkin-Elmer 241 or a Rudolf
Research Analytical Autopol II polarimeter at the sodium D-line. Infrared spectra were
recorded as thin films using a Bruker Tensor 27 FTIR spectrometer, equipped with
an Attenuated Total Reflectance (ATR) sampling accessory, and are reported in wave
numbers (cm-1). Nuclear magnetic resonance spectra were recorded using a Varian Inova
operating at 500 MHz for 1H and 125 MHz 13C or a Varian Direct Drive operating at
600 MHz and 133 MHz. 1H and 13C chemical shifts (δ) were internally referenced to
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the residual solvent peak, (CDCl3 = 7.26 ppm and 77.16 ppm, D2O = 4.79 ppm). NMR
peak assignments are based on 2D NMR experiments (COSY, HSQC, and HMBC).
O
OBn
BnO
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4
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(2S,3R)-2,3-Dibenzyloxypent-4-enal (7). To a solution of methyl iodo
arabinoside 69,17,18 (397 mg, 0.87 mmol) in EtOH/H2O/AcOH (40/2/1, v/v/v, 13 mL)
was added Zn (284 mg, 4.35 mmol). The mixture was stirred at reflux for 2 h, cooled to
room temperature and filtered through a celite plug with EtOAc. The resulting mixture
was further diluted with EtOAc and washed twice with sat. aq.˙ NaHCO3, then H2O
and brine, dried (MgSO4), filtered and concentrated in vacuo to provide aldehyde 7 as a
colourless oil (251 mg, 0.85 mmol, 97%), which was used without further purification.
Rf = 0.41 (hexanes/EtOAc, 3/1, v/v); [α]D22 = -48.5 (c = 0.73, CHCl3); IR (film) 3064,
3031, 1732, 1454, 1066, 735, 696 cm-1. 1H NMR: (500 MHz, CDCl3, 20 ◦C) δ 9.68 (d,
J1,2 = 1.6 Hz, 1H, H-1), 7.35–7.26 (m, 10H, H-Ar), 5.94 (ddd, J4,5 = 18.2, J4,5a = 10.5,
J3,4 = 7.8 Hz, 1H, H-4), 5.37 (ddd, J4,5a = 10.5, 2J5a,5b = 1.5, 4J3,5a = 1 Hz, 1H, H-5a),
5.35 (ddd, J4,5b = 18.2, 2J5a,5b = 1.5, 4J3,5b = 1 Hz, 1H, H-5b), 4.76 (d, 2Ja,b = 11.9 Hz,
1H, CHa 2-O-Bn), 4.64 (d, 2Ja,b = 12.2 Hz, 1H, CHa 3-O-Bn), 4.63 (d, 2Ja,b = 11.9 Hz,
1H, CHb 2-O-Bn), 4.36 (d, 2Ja,b = 12.2 Hz, 1H, CHb 3-O-Bn), 4.17 (ddt, J3,4 = 7.8,
2J2,3 = 4.2, 4J3,5a = 4J3,5b = 1 Hz, 1H, H-3), 3.83 (dd, J2,3 = 4.2, J1,2 = 1.6 Hz, 1H, H-2);
13C NMR: (125 MHz CDCl3, 20 ◦C) δ 202.7 (C-1), 137.6 (C-i 3-O-Bn), 137.2 (C-i 2-O-
Bn), 133.9 (C-4), 128.6 (C-Ar), 128.5 (C-Ar), 128.3 (C-Ar), 128.3 (C-Ar), 128.0 (C-Ar),
127.9 (C-Ar), 120.0 (C-5), 85.3 (C-2), 80.0 (C-3), 73.6 (CH2 2-O-Bn), 70.8 (CH2 3-O-
Bn); HRMS (ESI) m/z calcd. for [C19H20O3+Na]+: 319.1305, obsd.: 319.1311.
59
OBn
BnO
CN
NH2
6
1
2
3
4
5
and OBn
BnO
CN
NH2
6
1
2
3
4
5
(2S,3R,4R)-2-Amino-3,4-dibenzyloxy-hex-5-
enenitrile (syn-2) and (2R,3R,4R)-2-Amino-3,4-dibenzyloxy-hex-5-enenitrile
(anti-3). To a solution of aldehyde 7 (32.0 mg, 0.11 mmol) in EtOH (2.2 mL) was
added NH4OAc (83.2 mg, 1.07 mmol). The mixture was stirred at room temperature
for 15 min, at which point TMSCN (28.9 µL, 0.22 mmol) was added dropwise. The
clear colourless solution was stirred at room temperature for 18 h, then diluted with
EtOAc, washed with sat. aq. NaHCO3, H2O and brine, dried (MgSO4), filtered and
concentrated in vacuo. Purification of the α-amino nitriles using silica gel gradient
flash chromatography (hexanes/EtOAc, 10/1→ 1/1, v/v) first gave α-amino-nitrile syn-
2 as a pale yellow oil (27.5 mg, 0.09 mmol, 79%) and then α-amino-nitrile anti-3
as a pale yellow oil (3.06 mg, 0.01 mmol, 9%). Crystallisation of anti-3 (minimum
EtOAc/hexanes) yielded fine colourless needles, for which a single crystal X-ray
diffraction was obtained then solved and refined using Olex2.34 Syn-2: Rf = 0.47
(hexanes/EtOAc, 1/1, v/v); [α-]D22 = -1.08 (c = 0.90, CHCl3); IR (film) 3393, 3327,
3064, 3031, 2868, 2361, 1497, 1067, 738, 698 cm-1. 1H NMR: (500 MHz, CDCl3,
20 ◦C) δ 7.39–7.29 (m, 10H, H-Ar), 5.86 (ddd, J5,6a = 17.4, J5,6b = 10.4, J4,5 = 7.7 Hz,
1H, H-5), 5.44 (ddd, J5,6a = 17.4, 2J6a,6b = 1.5, 4J4,6a = 1 Hz, 1H, H-6a), 5.41 (ddd, J5,6b =
10.4, 2J6a,6b = 1.5, 4J4,6b = 0.7 Hz, 1H, H-6b), 4.91 (d, 2Ja,b = 11.0 Hz, 1H, CHa 3-O-Bn),
4.71 (d, 2Ja,b = 11.0 Hz, 1H, CHb 3-O-Bn), 4.64 (d, 2Ja,b = 11.7 Hz, 1H, CHa 4-O-Bn),
4.40 (d, 2Ja,b = 11.7 Hz, 1H, CHb 4-O-Bn), 4.16 (dd, J4,5 = 7.7, J3,4 = 6.8 Hz, 1H, H-4),
3.89 (d, J2,3 = 3.3 Hz, 1H, H-2), 3.70 (dd, J3,4 = 6.8, J2,3 = 3.3 Hz, 1H, H-3), 1.63 (br
s, 2H, NH2); 13C NMR: (125 MHz CDCl3, 20 ◦C) δ 138.0 (C-i 4-O-Bn), 137.7 (C-i
3-O-Bn), 134.6 (C-5), 128.6 (C-Ar), 128.6 (C-Ar), 128.5 (C-Ar), 128.2 (C-Ar), 128.1
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(C-Ar), 127.9 (C-Ar), 121.3 (C-1), 120.5 (C-6), 81.8 (C-3), 81.0 (C-4), 75.7 (CH2 3-O-
Bn), 71.1 (CH2 4-O-Bn), 44.7 (C-2); HRMS (ESI) m/z calcd. for [C20H22N2O2+Na]+:
345.1573, obsd.: 345.1572. Anti-3: Rf = 0.38 (hexanes/EtOAc, 1/1, v/v); MP = 64.5
– 64.7 ◦C; [α-]D23 = -15.5 (c = 1.0, CHCl3); IR (film) 3389, 3325, 3064, 3031, 2919,
2870, 2358, 1497, 1068, 737, 698 cm-1. 1H NMR: (500 MHz, CDCl3, 20 ◦C) δ 7.36–
7.30 (m, 10H, H-Ar), 5.83 (ddd, J5,6b = 17.5, J5,6a = 10.5, 2J4,5 = 7.9 Hz, 1H, H-5), 5.49
(dd, J5,6a = 17.5, 2J6a,6b = 1 Hz, 1H, H-6a), 5.44 (dd, J5,6b = 10.5, J6a,6b = 1 Hz, 1H,
H-6b), 4.96 (d, 2Ja,b = 11.4 Hz, 1H, CHa 3-O-Bn), 4.72 (d, 2Ja,b = 11.4 Hz, 1H, CHb
3-O-Bn), 4.64 (d, 2Ja,b = 11.6 Hz, 1H, CHa 4-O-Bn), 4.41 (d, 2Ja,b = 11.6 Hz, 1H, CHb
4-O-Bn), 4.13 (t, J4,5 = 7.9, J3,4 = 6.6 Hz, 1H, H-4), 3.80 (d, J2,3 = 4.4 Hz, 1H, H-2),
3.64 (dd, J3,4 = 6.6, J2,3 = 4.4 Hz, 1H, H-3), 1.68 (br s, 2H, NH2); 13C NMR: (125 MHz
CDCl3, 20 ◦C) δ 138.0 (C-i 4-O-Bn), 137.9 (C-i 3-O-Bn), 133.9 (C-5), 128.6 (C-Ar),
128.6 (C-Ar), 128.3 (C-Ar), 128.1 (C-Ar), 127.9 (C-Ar), 121.3 (C-1), 120.4 (C-6), 82.1
(C-3 and C-4), 75.5 (CH2 3-O-Bn), 71.0 (CH2 4-O-Bn), 45.3 (C-2); HRMS (ESI) m/z
calcd. for [C20H22N2O2+Na]+: 345.1573, obsd.: 345.1573.
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(2S,3R,4R,5R)-3,4-Bisbenzyloxy-5-iodomethylpyrrolidine-2-carbo-
nitrile (11). α-Aminonitrile syn-2 (30.0 mg, 0.09 mmol) was co- evaporated with
toluene and dissolved in DCM (450 µL) under a nitrogen atmosphere. N-Iodosuccinimide
(25.1 mg, 0.11 mmol) was added, and the pink solution was stirred at room temperature
for 5 h, over which time the solution became dark red in color. The solution was
quenched with sat. aq. Na2S2O3 and extracted with EtOAc, and the organic layer was
washed with H2O and brine, dried (MgSO4), filtered, and concentrated in vacuo. The
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residue was purified using silica gel gradient flash chromatography (hexanes/ EtOAc,
20/1→ 3/1) to give iodoazasugar 11 as a pale orange oil (31.3 mg, 0.07 mmol, 75%). Rf
= 0.52 (hexanes/EtOAc, 2/1). [α]D20.6 = -21.0 (c = 1.0, CHCl3). IR (film) 3336, 3062,
3030, 2922, 2867, 2245, 1496, 1454, 1354, 1207, 1091, 1027, 913, 736, 697 cm-1.
1H NMR: (500 MHz, CDCl3, 20 ◦C) δ 7.39–7.28 (m, 10 H, H-Ar), 4.66 (d, 2Ja,b = 11.8
Hz, 1H, CHa 3-O-Bn), 4.59 (d, 2Ja,b = 11.8 Hz, 1H, CHb 3-O-Bn), 4.54 (d, 2Ja,b = 11.6
Hz, 1H, CHa 4-O-Bn), 4.51 (d, 2Ja,b = 11.6 Hz, 1H, CHb 4-O-Bn), 4.27 (d, J4,5 = 5.4 Hz,
1H, H-2), 4.09 (dd, J2,3 = 5.4 Hz, J3,4 = 2.7 Hz, 1H, H-3), 4.03 (dd, J4,5 = 5.4 Hz, J3,4 =
2.7 Hz, 1H, H-4) 3.84 (td, J5,6a = J5,6b = 7.3 Hz, J4,5 = 5.4 Hz, 1H, H-5), 3.27 (dd, 2J6a,6b
= 9.6 Hz, J5,6a = 7.3 Hz, 1H, H-6a), 3.15 (dd, 2J6a,6b = 9.6 Hz, J5,6b = 7.3 Hz, 1H, H-6b),
2.32 (br. s, 1H, NH) ppm. 13C NMR: (125 MHz CDCl3, 20 ◦C) δ 137.3 (C-i 4-O-Bn),
136.8 (C-i 3-O-Bn), 128.8 (C-Ar), 128.7 (C-Ar), 128.5 (C-Ar), 128.3 (C-Ar), 128.3 (C-
Ar), 128.1 (C-Ar), 117.9 (CN), 82.4 (C-3), 81.8 (C-4), 73.1 (CH2 3,4-O-Bn), 61.5 (C-5),
51.4 (C-2), 4.1 (C-6); HRMS (ESI) m/z calcd. for [C20H21IN2O2+Na]+: 449.0720: found
449.0726.
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(5S,6R,7R,7aS)-6,7-Dibenzyloxy-3-oxo-tetrahydro-pyrrolo[1,2-c]-
oxaza-5-carbonitrile (12). To a solution of α-amino-nitrile syn-2 (34.0 mg, 0.11 mmol)
in THF (0.4 mL), was added I2 (66.9 mg, 0.26 mmol), H2O (0.4 mL) and NaHCO3
(177 mg, 2.11 mmol). The reaction mixture was stirred at room temperature for 20
h, quenched via the addition of sat. aq. Na2S2O3 and extracted with EtOAc. The
organic layer was washed with H2O and brine, dried (MgSO4), filtered and concentrated
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in vacuo. Purification of the residue using silica gel gradient flash chromatography
(hexanes/EtOAc, 10/1 → 1/1, v/v) provided carbamate 12 as a colourless viscous oil
(32.6 mg, 0.09 mmol, 85%). Rf = 0.24 (hexanes/EtOAc, 2/1, v/v); [α]D20 = +23.7 (c =
1.0, CHCl3); IR (film) 3064, 3032, 2925, 2872, 2254, 1755, 1469, 1316, 1216, 1093,
1051, 1001, 814, 736, 698 cm-1. 1H NMR: (500 MHz, CDCl3, 20 ◦C) δ 7.43–7.32 (m,
10H, H-Ar), 7.16 (m, 2H, H-Ar), 4.75 (d, 2Ja,b = 12 Hz, 1H, CHa 6-O-Bn), 4.76 (d, J2,3
= 5.2 Hz, 1H, H-5), 4.56 (d, 2Ja,b = 12 Hz, 1H, CHb 6-O-Bn), 4.50 (d, 2Ja,b = 12.6, Hz,
1H, CHa 7-O-Bn), 4.45 (t, 2J1a,1b = 8.7, J1a,7a = 8.2 Hz, 1H, H-1a), 4.38 (t, 2J1a,1b = 6.2,
J1b,7a = 3.0 Hz, 1H, H-1b), 4.35 (d, 2Ja,b = 12.6 Hz, 1H, CHb 7-O-Bn), 4.27 (dt, J1a,7a =
8.2, J1b,7a = J7,7a, = 3.0 Hz, 1H, H-7a), 4.23 (dd, J5,6 = 5.2, J6,7 = 1.0 Hz, 1H, H-6), 3.77
(dd, J7,7a = 3.0, J6,7 = 1.0 Hz, 1H, H-7); 13C NMR: (125 MHz CDCl3, 20 ◦C) δ 161.0
(C-3), 136.5 (C-i 7-O-Bn), 136.3 (C-i 6-O-Bn), 128.9 (C-Ar), 128.9 (C-Ar), 128.7 (C-
Ar), 128.6 (C-Ar), 128.3 (C-Ar), 127.9 (C-Ar), 115.4 (CN), 81.6 (C-6), 79.9 (C-7), 73.8
(CH2 6-O-Bn), 72.0 (CH2 7-O-Bn), 63.2 (C-1), 61.3 (C-7a), 53.2 (C-5); HRMS (ESI)
m/z calcd. for [C21H20N2O2+Na]+: 387.1315, obsd.: 387.1317.
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(5S,6R,7R,7aS)-5-Aminomethyl-6,7-dihydroxy-tetrahydro-pyrrolo
[1,2-c]oxazol-3-one hydrochloride (13). Carbamate 12 (100 mg, 0.27 mmol) was
dissolved in CHCl3 (4.5 mL) and transferred into a Fischer-Porter bottle, EtOH (7.5
mL), HCl in ether (1.4 mL 2M) and Pd(OH)2/C (230 mg) were then added and the
vessel was charged with H2 (7 bar). The reaction mixture was stirred vigorously at
room temperature for 3 d. After releasing the H2 pressure, the reaction mixture was
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filtered through a plug of celite, washing with EtOH and H2O, and concentrated in
vacuo to provide amine 13 as the HCl salt (50.1 mg, 0.26 mmol, 98%). Rf = 0.25
(DCM/MeOH/EtOH/30% aq. NH3, 5/2/2/1, v/v); [α]D19 = -50.0 (c = 0.1, H2O); IR
(film) 3928, 2925, 2854, 1727, 1642, 1404, 1243, 1083, 1014, 783 cm-1. 1H NMR:
(500 MHz, 2% DCl in D2O, 20 ◦C) δ 4.64 (t, 2J1a,1b = 9.2, J1a,7a = 8.9 Hz, 1H, H-1a),
4.52 (dd, 2J1a,1b = 9.2, J1b,7a = 3.3 Hz, 1H, H-1b), 4.49 (dd, J5,6 = 4.4, J6,7 = 0.5 Hz,
1H, H-6), 4.36 (dt, J1a,7a = 8.9, J1b,7a = 3.3, J7,7a ¡1 Hz, 1H, H-7a), 4.09 (br s, 1H,
H-7), 4.04 (dt, JCHbNH2,5 = 8.5, J5,6 = JCHaNH2,5 = 4.4 Hz, 1H, H-5), 3.30 (dd, 2Ja,b =
13.4, JCHaNH2,5 = 4.4 Hz, 1H, CHaNH2), 3.21 (dd, 2Ja,b = 13.4, JCHbNH2,5 = 8.5 Hz, 1H,
H-CHbNH2); 13C NMR: (125 MHz, 2% DCl in D2O, 20 ◦C) δ 164.9 (C-3), 77.7 (C-6),
75.1 (C-7), 64.4 (C-1), 61.8 (C-7a), 58.8 (C-5), 39.3 (CH2NH2); HRMS (ESI) m/z calcd.
for [C7H12N2O4+Na]+: 211.0689, obsd.: 211.0684.
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1-Amino-1,2,5-trideoxy-2,5-imino-L-iditol (1). A solution of NaOH
in EtOH (0.5 ml, 2M) was added to amino carbamate 13 (16.0 mg, 0.09 mmol) and
stirred at reflux for 2 h. The resulting reaction mixture was loaded directly onto
a Dowex-H+ ion-exchange resin column and washed with H2O to remove excess
salt. The hydrolysed amine was then eluted with 30% aq.˙ NH3 and concentrated
in vacuo to provide amino hexitol 1 (13.5 mg, 0.08 mmol, 98%). Rf = 0.01
(DCM/MeOH/EtOH/30% aq. NH3, 5/2/2/1, v/v); (HCl salt) [α]D26 = +6.0 (c = 1.0,
H2O); IR (film, free base) 3376, 2881, 2854, 1651, 1549, 1393, 1218, 1115, 1059, 946,
836 cm-1. 1H NMR: (500 MHz, 2% NaOD in D2O, 20 ◦C) δ 4.14 (d, J2,3 = 4.0, J3,4 <1
Hz, 1H, H-3), 4.09 (d, J4,5 = 4.0, J3,4 <1 Hz, 1H, H-4), 3.73 (dd, 2J6a,6b = 11.2, J5,6a = 6.5
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Hz, 1H, H-6a), 3.64 (dd, 2J6a,6b = 11.2, J5,6b = 6.5 Hz, 1H, H-6b), 3.35 (td, J5,6a = J5,6b
= 6.5, J4,5 = 4.0 Hz, 1H, H-5), 3.28 (td, J1a,2 = J1b,2 = 6.9, J2,3 = 4.0 Hz, 1H, H-2), 2.77
(dd, 2J1a,1b = 12.7, J1a,2 = 6.9 Hz, 1H, H-1a), 2.66 (dd, 2J1a,1b = 12.7, J1b,2 = 6.9 Hz, 1H,
H-1b); 13C NMR: (125 MHz, 2% NaOD in D2O, 20 ◦C) δ 77.3 (C-3), 77.0 (C-4), 61.1
(C-5), 60.4 (C-6), 59.9 (C-2), 40.1 (C-1); HRMS (ESI) m/z calcd. for [C6H14N2O3+H]+:
163.1077, obsd.: 163.1077. 1H NMR (500 MHz, D2O, 2HCl salt, 20 ◦C) δ 4.41 (dd,
J2,3 = 3.4, J3,4 = 1.7 Hz, 1H, H-3), 4.40 (dd, J4,5 = 3.6, J3,4 = 1.7 Hz, 1H, H-4), 4.17 (td,
J1a,2 = J1b,2 = 6.8, J2,3 = 3.4 Hz, 1H, H-2), 4.07 (ddd, J5,6a = 8.8, J5,6b = 4.6, J4,5 = 3.6
Hz, 1H, H-5), 4.00 (dd, 2J6a,6b = 12.2, J5,6a = 4.6 Hz, 1H, H-6a), 3.91 (dd, 2J6a,6b = 12.2,
J5,6b = 8.8 Hz, 1H, H-6b), 3.58 (dd, 2J1a,1b = 13.7, J1a,2 = 6.8 Hz, 1H, H-1a), 3.49 (dd,
2J1a,1b = 13.7, J1b,2 = 6.8 Hz, 1H, H-1b); 13C NMR (125 MHz, D2O, 2HCl salt, 20 ◦C) δ
74.5 (C-3), 74.2 (C-4), 63.8 (C-5), 58.2 (C-2), 57.2 (C-6), 35.8 (C-1).
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Chapter 3
Application of I2-mediated Carbamate
Annulation to the Synthesis of
Amino-imino-hexitols
3.1 Introduction
Given the potential of pyrrolidines as glycosidase inhibitors, (see Sections 1.1 and 1.2
and references cited therein), we were interested in developing efficient methodology
for the preparation of amino-imino-hexitols. To this end, we demonstrated that the
combination of a diastereoselective Strecker reaction and the recently developed I2-
promoted carbamate annulation methodology1–3 allowed for the synthesis of the L-ido
derived amino-imino-hexitol 1 in 39% overall yield from D-arabinose (Scheme 3.1).4
Here, we illustrated that benzyl-protected aldehyde 2, readily prepared from D-
arabinose, underwent a highly diastereoselective Strecker5 reaction to give the syn-3
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and anti-4 alkenylamines (dr = 9:1), which were readily separated by flash column
chromatography. The major syn-isomer was subjected to I2 and excess NaHCO3 in
THF:H2O to give, by way of intermediate iodide 5, the 4,5-cis carbamate 6 in excellent
yield and diastereoselectivity (dr >95:5). Treatment of carbamate 6 with Pd(OH)2/C in
the presence of 2M HCl followed by hydrolysis then gave known L-ido amino-imino-
hexitol 1.4
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Scheme 3.1 Preparation of 1 from D-arabinose
To further explore this methodology, we herein report6 on the application of our
carbamate annulation to the synthesis of other amino-imino-hexitols including 1-
amino-1,2,5-trideoxy-2,5-imino-D-mannitol7 and 1-amino-1,2,5-trideoxy-2,5-imino-D-
glucitol,7 and the previously undisclosed stereoisomers with the D-galacto 7, D-talo 8,
and L-altro 9 configurations (Fig. 3.1). Factors influencing the diastereoselectivity of
the I2-mediated carbamate annulation will also be noted.
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Fig. 3.1 Novel amino-imino-hexitols
3.2 Synthesis of Amino-imino-hexitols
To gain access to the 3,4-cis-series of hydroxylated iminosugars, we required the 3,4-
anti-substituted α-aminonitrile precursors, and consequently, D-ribose as the starting
material (Scheme 3.2). Methyl iodoriboside 10 was conveniently prepared according
to literature precedent8 and subjected to a Vasella reaction9,10 to give aldehyde 11 in
excellent (97%) yield. Aldehyde 11 was then treated with NH4OAc and TMSCN to give
α-aminonitrile syn-12, the chelation-controlled Cram product, as the major diastereomer
(syn-12:anti-13, 8:1) and in excellent (92%) overall yield. It is interesting to note
that the syn-stereoselectivity of the Strecker reaction does not appear to be affected
by the relative configuration between C-2 and C-3 of the linear aldehyde, with similar
diastereoselectivities being obtained for both the arabinose (cf. Scheme 3.1)4 and ribose
derived aldehydes. The diastereomers, syn-12 and anti-13, were readily separated via
flash column chromatography (hexanes:EtOAc, 2:1; Rf = 0.27 for α-aminonitrile syn-
12, Rf = 0.16 for α-aminonitrile anti-13) and their relative configurations confirmed
following subsequent cyclisation (vide infra).
The major Strecker product syn-aminonitrile 12 was then subjected to a carbamate
annulation via treatment with NaHCO3 and I2 (Scheme 3.3). Surprisingly, in contrast
to the usual high selectivity of this reaction1–4 two diastereomeric carbamates 14 and
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Scheme 3.2 Preparation of α-aminonitriles commencing with D-ribose
15 (dr = 4:1) were formed. Here, the major carbamate was the 4,5-cis-isomer 14, as
confirmed by X-ray analysis (Fig. 3.2(a)). Cyclisation of the minor Strecker product,
anti-aminonitrile 13, however, gave only one diastereomer 16, in 53% yield. This
was also crystallised and a crystal structure obtained (Fig. 3.2(b)). Though the yield
of anti-aminonitrile 13 was modest, there was no evidence by 1H NMR of the other
carbamate diastereomer or the intermediate primary iodide. 1H NMR of the crude
reaction mixture, however, did indicate that retro-Strecker products (e.g. aldehydes)
were formed in addition to the desired product. It is also interesting that both ribose-
derived alkenylamines took longer to cyclise (6 days), when compared to the cyclisation
of arabinose-derived syn-3 (20 h). This suggests that the activation energies for the
formation of 14, 15 and 16 are higher than for the formation of 10, which could be
due to steric constraints encountered by the benzyloxy groups at C-3 and C-4 when
transforming from the linear (3,4-anti) to cyclised (3,4-cis) structures. In earlier studies
by Tamaru et al.,11 it was also observed that cyclisation of 1,2-alkoxy substituted
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pentenylic alcohols proceeded much more slowly when forming the 2,5-cis, as compared
to the 2,5-trans, products.
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Scheme 3.3 Carbamate annulations with D-ribose-derived α-aminonitriles
To further tease out the effects that the substituents have on the diastereoselectivity of
the annulation, the minor arabinose derived aminonitrile anti-17 was also subjected to
the carbamate annulation conditions (Scheme 3.4). Here, cyclisation resulted in the
generation of two carbamate products (18:19, dr = 6:1) following stirring at room
temperature for 48 h, with the configuration of each diastereomer being determined
at subsequent stages in the synthesis (vide infra). A full discussion of the observed
diastereoselectivities of the I2-mediated carbamate annulation will be provided in
chapters five and six.
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(a)
(b)
Fig. 3.2 Crystal structures of carbamates 14 (a) and 16 (b)
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Scheme 3.4 I2-mediated carbamate annulation using D-arabinose derived anti-17
Having noted the interesting diastereoselectivity of the carbamate annulation, we were
then interested in using the said carbamates as intermediates for the synthesis of amino-
imino-hexitols. To this end, carbamate 14 was first hydrogenated using Pd(OH)2/C
in the presence of 2M HCl with the objective of simultaneously removing the benzyl
groups and reducing the nitrile to the amine (Scheme 3.5). According to TLC analysis,
this reaction appeared to proceed smoothly and following silica gel chromatography
(DCM/EtOH/MeOH/30% aq. NH3, 5/2/2/1, v/v/v/v) only one product was observed.
HRMS also gave a molecular ion of 189.0869 [M+H]+ corresponding to the expected
[C7H12N2O4+H]+. Close analysis of the NMR spectral data, however, revealed the
presence of a carbonyl peak at δ 164.0 ppm in the 13C NMR spectra, which correlated
by HMBC to two methylene protons at δ 3.59 and 3.49 ppm (Fig. 3.3) instead of the
downfield methylene protons at δ 4.13 and 3.72 ppm. This HMBC correlation indicated
that the carbonyl was next to a CH2NH group rather than a CH2O group due to the
comparative upfield proton chemical shifts. Further analysis by 2D NMR (COSY,
HMBC, HSQC) revealed that, rather than the desired amino sugar, urea-derivative 20
was formed in 30% yield (unoptimised). We presume the urea was formed via the ring
closure of the intermediate amine on the carbamate in 21 due to the cis-relationship
across the ring nitrogen, which allowed the basic amino group close proximity to
the carbonyl for migration. After silica gel chromatography the product fractions
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required heating in vacuo to remove the aqueous solvents, this could have aided in the
transformation from carbamate 21 to urea 20.
Fig. 3.3 HMBC spectrum of urea 20, (500 MHz in D2O)
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Scheme 3.5 Deprotection of carbamate 14
An attempt was made to prevent urea formation by changing the deprotection order
through the hydrolysis of carbamate 14 with LiOH, however, this led to epimerisation of
the proton α to the nitrile and carbamate 16 was isolated in quantitative yield. Carbamate
16 was identified by analysis of the 1H and 13C NMR spectra. Features of note were a
change of chemical shift for the H-5 epimerised proton from δ (1H) 4.52 in 14 to 4.57
ppm and a shift of the carbonyl peak from δ (13C) 157.4 in 14 to 160.8 ppm. While not
effecting the desired transformation, this epimerisation to favour the thermodynamically
more stable trans relationship between the carbamate and the nitrile, provides a high
yielding route for the preparation of carbamate 16. Previously, carbamate 16 could
only be prepared from the minor ribose-derived Strecker product. The hydrogenation of
carbamate 14 using Pd(OH)2/C was then repeated, and during workup it was observed
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that if the amine remained protonated, by keeping the conditions acidic throughout,
the desired amine functionalised carbamate 21 could be obtained in excellent (99%)
yield and without the need for further purification. Attempts to hydrolyse carbamate 21
under acidic conditions then followed but surprisingly the use of 6M HCl gave chloro-
amino-imino-hexitol 22 as the major product and only minor amounts of the desired
D-galacto amino-imino-hexitol 7. Acidic conditions were needed to hydrolyse the
carbamate in 21 as using the previously used basic conditions would lead to formation
of the urea derivative 20. Urea 20 was very stable under the basic hydrolysis conditions
that were tried earlier. Though a potentially useful synthetic intermediate, chloride
22 decomposed upon purification by silica gel chromatography and thus could not be
isolated in sufficient purity for subsequent biological assessment. Subjecting carbamate
21 to 3M H2SO4 at reflux, however, followed by neutralisation with basic DOWEX
allowed for amino-imino-hexitol 7 to be obtained in quantitative yield as the free base.
Urea-derivative 20 could also be quantitatively converted to the desired amino-imino-
hexitol 7 as the hydrochloride salt following treatment with refluxing 6M HCl. Using the
optimised route (14→ 21→ 7), the target amino-imino-hexitol 7, can now be prepared
in 36% overall yield from D-ribose.
Armed with this knowledge, the remaining carbamates were then transformed into their
corresponding amino-imino-hexitols (Scheme 3.6). Treatment of carbamate 15 with
Pd(OH)2/C in the presence of 2M HCl led to the smooth conversion into amine 23
(98% yield). The carbamate in 23 was then hydrolysed using a solution of NaOH
in EtOH, followed by neutralisation with DOWEX-H+ to complete the synthesis and
generate novel D-talo amino-imino-hexitol 8. Here, it is important to note that when
there is a 2,5-trans relationship between the aminomethyl and carbamate moieties, the
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corresponding urea derivative is not formed and base-mediated hydrolysis can be used.
Amino-imino-hexitol 8 was characterised by a combination of NMR spectroscopic (1H,
13C, COSY, HSQC, HMBC) analysis and mass spectrometry (full characterisation can
be found in the experimental section). Analyses of the data revealed characteristic
NMR resonances at (1H δ) 2.77 (dd) and 2.62 ppm (dd) for the H-1 methylene protons,
1A and 1B, respectively (Fig. 3.4), which correlated in the HSQC to the upfield C-
1 chemical shift (13C δ 40.4 ppm, Fig. 3.5). Here, also the H-6 methylene proton
resonances were observed at (1H δ) 3.68 (dd) and 3.56 ppm (dd), for 6A and 6B,
respectively, and correlated in the HSQC to the C-6 methylene carbon at (13C δ) 62.4
ppm. HRMS also gave an exact m/z of 163.1084 [M+Na]+ corresponding to the
expected [C6H14N2O3+H]+.
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Fig. 3.4 1H NMR spectrum for amino-imino-hexitol 8, (500 MHz, 2% NaOD in D2O)
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Fig. 3.5 13C NMR spectrum for amino-imino-hexitol 8, (125 MHz, 2% NaOD in D2O)
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Carbamate 16 was then hydrogenated to give the corresponding amine 24 (99% yield),
and subsequent hydrolysis proceeded uneventfully to yield the novel L-altro derived
amino-imino-hexitol 9 in 37% overall yield from D-ribose. Though we had already
assigned the stereochemistry of 9 from the crystal structure of the precursor carbamate
24, the 1H NMR and 13C NMR data was consistent with that of the known D-
altro enantiomer and the optical rotation of similar magnitude but opposite sign.12,13
Carbamate 18, with the cis-relationship between the aminomethyl and carbamate
functionalities, was then hydrogenated and the ammonium salt 25 obtained in excellent
(99%) yield. The acid catalysed hydrolysis of 25 using 3M H2SO4 then gave the D-
glucitol derived amino-imino-hexitol 14, again in excellent yield. Spectral data for 14
matched that previously reported.7 Finally, carbamate 19, derived from D-arabinose,
was hydrogenated in 90% yield to generate the deprotected amine 26, which was
subsequently hydrolysed under basic conditions to give the known D-mannitol derived
amino-imino-hexitol 12.7,14
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Scheme 3.6 Amine reduction and carbamate hydrolysis
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3.3 Conclusion
In summary, an efficient route for the preparation of a number of amino-imino-hexitols
has been presented. In particular, the two novel amino-imino-hexitols 7 and 9 were
efficiently prepared in 36% and 37% overall yield from D-ribose, respectively. During
the course of this work, the power of a highly diastereoselective Strecker reaction
without the need for chiral Lewis acids or catalysts has been demonstrated. The
diastereoselectivity of the reaction can be explained by the Cram-chelation control
model for both D-arabinose and D-ribose derived aldehydes. Moreover, the potential
of our novel carbamate annulation for the cyclisation of protected and functionalised
alkenylamine precursors has been highlighted. The applicability of the carbamate
annulation to a variety of alkenylamines and an understanding of the factors controlling
the diastereoselectivity of the reaction should make this methodology a valuable addition
to the synthetic chemist’s toolbox.
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3.4 Experimental
General Experimental
Unless otherwise stated all reactions were performed under air. THF was distilled from
LiAlH4 prior to use. All chemicals obtained from commercial suppliers were used
without further purification. Zn dust was activated by the careful addition of conc.
H2SO4, followed by decantation and washing with EtOH (3 x) and hexanes (3 x), and
storage under dry hexanes. All solvents were removed by evaporation under reduced
pressure. Reactions were monitored by TLC analysis on silica gel coated plastic sheets
(0.20 mm, Polygram SIL G/UV254) with detection by coating with 20% H2SO4 in
EtOH followed by charring at ca. 150 ◦C, by coating with a solution of ninhydrin in
EtOH followed by charring at ca. 150 ◦C, by coating with Hanessian’s stain followed by
charring at ca. 150 ◦C, or by coating with a solution of 5% KMnO4 and 1% NaIO4
in H2O followed by heating. Column chromatography was performed on silica gel
(40-63 µm). Dowex Monosphere M-31 acidic resin and Dowex 1x4-50 basic resin
were used for ion exchange chromatography. Melting points [◦C] were obtained with a
Gallenkamp apparatus and are uncorrected. High-resolution mass spectra were recorded
on a Waters Q-TOF PremierTM Tandem Mass Spectrometer using positive electro-
spray ionisation. Optical rotations were recorded using a Perkin-Elmer 241 or Rudolf
Research Analytical Autopol II polarimeter at the sodium D-line. Infrared spectra were
recorded as thin films using a Bruker Tensor 27 FTIR spectrometer, equipped with
an Attenuated Total Reflectance (ATR) sampling accessory, and are reported in wave
numbers (cm-1). Nuclear magnetic resonance spectra were measured using a Varian
Inova operating at 500 MHz for 1H and 125 MHz for 13C or a Varian Direct Drive
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operating at 600 MHz and 133 MHz. 1H and 13C chemical shifts (δ) were internally
referenced to the residual solvent peak, (CDCl3 = 7.26 ppm and 77.16 ppm, D2O = 4.79
ppm). NMR peak assignments are based on 2D NMR experiments (COSY, HSQC, and
HMBC).
O
OBn
BnO
123
4
5
(2R,3R)-2,3-Dibenzyloxypent-4-enal (11). To a solution of methyl
iodoriboside 108 (1.63 g, 3.59 mmol) in EtOH/H2O/AcOH (40/2/1, v/v/v, 54 mL) was
added Zn (1.17 g, 18.0 mmol). The mixture was stirred at reflux for 3 h, cooled to
room temperature and filtered through a celite plug with EtOAc. The resulting mixture
was further diluted with EtOAc and washed twice with sat. aq.˙ NaHCO3, then H2O and
brine, dried (MgSO4), filtered and concentrated in vacuo to provide the aldehyde 11 as a
colourless oil (1.03 g, 3.48 mmol, 97%). Rf = 0.57 (hexanes/EtOAc, 2/1, v/v); [α]D17.6 =
-29 (c = 1.0, CHCl3); IR (film) 3064, 3031, 2925, 2868, 1729, 1455, 1207, 1069, 1027,
933, 735, 696 cm-1. 1H NMR: (500 MHz, CDCl3, 20 ◦C) δ 9.64 (d, J1,2 = 2.0 Hz, 1H,
H-1), 7.38–7.27 (m, 10H, H-Ar), 5.88 (ddd, J4,5b = 17.7, J4,5a = 10.4, J3,4 = 7.6 Hz, 1H,
H-4), 5.38 (dt, J4,5a = 10.4, 2J5a,5b = 4J3,5a = 1.2 Hz, 1H, H-5a), 5.35 (dt, J4,5b = 17.7,
2J5a,5b = 4J3,5b = 1.2 Hz, 1H, H-5b), 4.71 (d, 2Ja,b = 12.0 Hz, 1H, CHa 2-O-Bn), 4.66
(d, 2Ja,b = 12.0 Hz, 1H, CHb 2-O-Bn), 4.65 (d, 2Ja,b = 12.0 Hz, 1H, CHa 3-O-Bn), 4.42
(d, 2Ja,b = 12.0 Hz, 1H, CHb 3-O-Bn), 4.17 (ddt, J3,4 = 7.6, J2,3 = 4.7, 4J3,5 Hz, 1H,
H-3), 3.90 (dd, J2,3 = 4.7, J1,2 = 2Hz, 1H, H-2); 13C NMR: (125 MHz CDCl3, 20 ◦C) δ
201.8 (C-1), 137.9 (C-i 3-O-Bn), 137.3 (C-i 2-O-Bn), 134.2 (C-4), 128.6 (C-Ar), 128.5
(C-Ar), 128.2 (C-Ar), 128.2 (C-Ar), 127.9 (C-Ar), 128.8 (C-Ar), 120.2 (C-5), 85.0 (C-
2), 80.3 (C-3), 73.1 (CH2 2-O-Bn), 70.6 (CH2 3-O-Bn); HRMS (ESI) m/z calcd. for
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[C19H20O3+Na]+: 319.1305, obsd.: 319.1311.
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(2S,3S,4R)-2-Amino-3,4-dibenzyloxyhex-5-
enenitrile (syn-12) and (2S,3S,4R)-2-Amino-3,4-dibenzyloxyhex-5-enenitrile
(anti-13). To a solution of aldehyde 11 (166 mg, 0.56 mmol) in EtOH (11.2 mL) was
added NH4OAc (471 mg, 5.60 mmol). The mixture was stirred at room temperature for
15 mins, at which point TMSCN (147 µL, 1.12 mmol) was added dropwise. The clear
colourless solution was stirred at room temperature for 48 h. The resulting solution was
diluted with EtOAc, washed with sat. aq.˙ NaHCO3, H2O and brine, dried (MgSO4),
filtered and concentrated in vacuo. Purification of the α-aminonitriles using gradient
flash chromatography (hexanes/EtOAc, 10/1→ 1/1, v/v), gave first α-aminonitrile syn-
12 as a pale yellow oil (147 mg, 0.46 mmol, 82%) and then α-aminonitrile anti-13 as a
pale yellow oil (18.9 mg, 0.06 mmol, 10%), (dr = 8:1, syn-12:anti-13). syn-12: Rf = 0.27
(hexanes/EtOAc, 2/1, v/v); [α]D19 = -22.4 (c = 1.0, CHCl3); IR (film) 3397, 3327, 3088,
3064, 3032, 2871, 2372, 1710, 1497, 1455, 1392, 1214, 1088, 1072, 935, 741, 698 cm-1.
1H NMR: (500 MHz, CDCl3, 20 ◦C) δ 7.37–7.30 (m, 10H, H-Ar), 5.84 (ddd, J5,6a = 17.2,
J5,6b = 10.5, J4,5 = 7.9 Hz, 1H, H-5), 5.46 (ddd, J5,6a = 17.2, 2J6a,6b = 1.7, 4J4,6a = 0.7 Hz,
1H, H-6a), 5.45 (ddd, J5,6b = 10.5, 2J6a,6b = 1.7, 4J4,6b = 0.7 Hz, 1H, H-6b) 4.76 (d, 2Ja,b
= 10.8 Hz, 1H, CHa 3-O-Bn), 4.68 (d, 2Ja,b = 10.8 Hz, 1H, CHb 3-O-Bn), 4.62 (d, 2Ja,b
= 11.4 Hz, 1H, CHa 4-O-Bn), 4.36 (d, 2Ja,b = 11.4 Hz, 1H, CHb 4-O-Bn), 4.08 (d, J2,3 =
2.0 Hz, 1H, H-2), 4.06 (tt, J4,5 = J3,4 = 7.9, 4J4,6 = 0.7 Hz, 1H, H-4), 3.66 (dd, J3,4 = 7.9,
J2,3 = 2.0 Hz, 1H, H-3), 1.82 (br s, 2H, NH2); 13C NMR: (125 MHz CDCl3, 20 ◦C) δ
137.7 (C-i 4-O-Bn), 137.2 (C-i 3-O-Bn), 135.3 (C-5), 128.7 (C-Ar), 128.6 (C-Ar), 128.6
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(C-Ar), 128.5 (C-Ar), 128.5 (C-Ar), 128.4 (C-Ar), 128.2 (C-Ar), 128.2 (C-Ar), 128.0
(C-Ar), 121.3 (C-1), 120.8 (C-6), 81.5 (C-3), 79.0 (C-4), 74.8 (CH2 3-O-Bn), 70.8 (CH2
4-O-Bn), 44.4 (C-2); HRMS (ESI) m/z calcd. for [C20H22N2O2+H]+: 323.1754, obsd.:
323.1762. anti-13: Rf = 0.16 (hexanes/EtOAc, 2/1, v/v); [α]D19 = -2.8 (c = 1.0, CHCl3);
IR (film) 3388, 3325, 3088, 3065, 3031, 2869, 2231, 1643, 1497, 1455, 1392, 1210,
1086, 1070, 1028, 936, 738, 698 cm-1. 1H NMR: (500 MHz, CDCl3, 20 ◦C) δ 7.38–7.30
(m, 10H, H-Ar), 5.90 (ddd, J5,6a = 17.3, J5,6b = 10.3, J4,5 = 7.8 Hz, 1H, H-5), 5.51 (ddd,
J5,6a = 17.3, 2J6a,6b = 1.7, 4J4,6a = 1.0 Hz, 1H, H-6a), 5.47 (ddd, J5,6b = 10.3, 2J6a,6b =
1.7, 4J4,6a = 1.0 Hz, 1H, H-6b) 4.81 (d, 2Ja,b = 11.2 Hz, 1H, CHa 3-O-Bn), 4.64 (d,
2Ja,b = 11.3 Hz, 1H, CHa 4-O-Bn), 4.62 (d, 2Ja,b = 11.2 Hz, 1H, CHb 3-O-Bn), 4.39
(d, 2Ja,b = 11.3 Hz, 1H, CHb 4-O-Bn), 4.08 (d, J2,3 = 4.2 Hz, 1H, H-2), 4.05 (tt, J4,5 =
J3,4 = 7.8, 4J4,6 = 0.7 Hz, 1H, H-4), 3.64 (dd, J3,4 = 7.8, J2,3 = 4.2 Hz, 1H, H-3), 1.76
(br s, 2H, NH2); 13C NMR: (125 MHz CDCl3, 20 ◦C) δ 137.8 (C-i 4-O-Bn), 137.6 (C-i
3-O-Bn), 135.2 (C-5), 128.6 (C-Ar), 128.1 (C-Ar), 128.1 (C-Ar), 128.0 (C-Ar), 128.0
(C-Ar), 121.2 (C-1), 120.5 (C-6), 82.6 (C-3), 81.0 (C-4), 75.2 (CH2 3-O-Bn), 70.9 (CH2
4-O-Bn), 45.9 (C-2); HRMS (ESI) m/z calcd. for [C20H22N2O2+H]+: 323.1754, obsd.:
323.1763.
General Procedure for the Carbamate Annulation. To a solution of α-aminonitrile
(1 mmol) in THF (3.5 mL), were added I2 (634 mg, 2.5 mmol), H2O (3.5 mL) and
NaHCO3 (1.68 g, 20 mmol). The reaction mixture was stirred at room temperature for
varying lengths of time (20 h – 6 d), quenched with sat. aq.˙ Na2S2O3 and extracted with
EtOAc. The organic layer was washed with H2O and brine, dried (MgSO4), filtered and
concentrated in vacuo. Purification was achieved using gradient flash chromatography
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(hexanes/EtOAc, v/v) or (DCM/EtOAc, v/v).
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(5R,6S,7R,7aS)-6,7-Dibenzyloxy-3-oxotetrahydropyrrolo[1,2-c]oxazol-
5-carbonitrile (14). By subjecting α-aminonitrile syn-12 (492 mg, 1.53 mmol) to the
general procedure for the carbamate annulation for 6 d, carbamate 14 was obtained as a
white solid (378 mg, 1.04 mmol, 68%, dr = 4:1, 18:19). Crystallisation (DCM) yielded
fine white needles for which a single crystal X-ray diffraction was obtained then solved
and refined using Olex2.15 Rf = 0.19 (DCM/EtOAc, 50/1, v/v); MP = 198.9 – 199.9 ◦C;
[α]D20 = +34.5 (c = 1.0, CHCl3); IR (film) 3066, 3028, 2953, 2921, 2887, 2251, 1737,
1395, 1269, 1256, 1150, 1101, 1046, 1002, 702, 694 cm-1. 1H NMR: (500 MHz, CDCl3,
20 ◦C) δ 7.43–7.30 (m, 10H, H-Ar), 5.18 (d, 2Ja,b = 11.8 Hz, 1H, CHa 7-O-Bn), 4.78 (d,
2Ja,b = 11.9 Hz, 1H, CHa 6-O-Bn), 4.71 (d, 2Ja,b = 11.9 Hz, 1H, CHb 6-O-Bn) 4.68 (d,
2Ja,b = 11.8 Hz, 1H, CHb 7-O-Bn), 4.51 (dd, 2J1a,1b = 8.8, J1a,7a = 6.8, Hz, 1H, H-1a),
4.42 (d, J5,6 = 7.1 Hz, 1H, H-5), 4.35 (t, J1a,1b = J1b,7a = 8.8 Hz, 1H, H-1b), 4.37 (dd,
J5,6 = 7.1, J6,7 = 2.7 Hz, 1H, H-6), 4.09 (ddd, J1b,7a = 8.8, J1a,7a = 6.8, J7,7a = 2.7 Hz, 1H,
H-7a), 3.87 (t, J7,7a = J6,7 = 2.7 Hz, 1H, H-7); 13C NMR: (125 MHz CDCl3, 20 ◦C) δ
157.4 (C-3), 137.4 (C-i 7-O-Bn), 136.1 (C-i 6-O-Bn), 129.0 (C-Ar), 128.9 (C-Ar), 128.7
(C-Ar), 128.3 (C-Ar), 128.3 (C-Ar), 128.2 (C-Ar), 112.9 (CN), 83.7 (C-6), 74.5 (C-7),
73.8 (CH2 6-O-Bn), 73.6 (CH2 7-O-Bn), 64.1 (C-1), 58.8 (C-7a), 47.2 (C-5); HRMS
(ESI) m/z calcd. for [C21H20N2O4+Na]+: 387.1315, obsd.: 387.1321.
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(5R,6S,7R,7aR)-6,7-Dibenzyloxy-3-oxotetrahydropyrrolo[1,2-c]oxazol-
5-carbonitrile (15). By subjecting α-aminonitrile syn-12 (492 mg, 1.53 mmol) to the
general procedure for the carbamate annulation for 6 d, carbamate 15 was obtained as
a colourless oil (94.5 mg, 0.26 mmol, 17%, dr = 4:1, 18:19). Rf = 0.31 (DCM/EtOAc,
20/1, v/v); [α]D20 = +45.2 (c = 1.0, CHCl3); IR (film) 3064, 3032, 2919, 2872, 1761,
1455, 1393, 1306, 1214, 1136, 1027, 1010, 737, 699 cm-1. 1H NMR: (500 MHz, CDCl3,
20 ◦C) δ 7.45–7.27 (m, 10H, H-Ar), 4.96 (d, 2Ja,b = 11.5 Hz, 1H, CHa 6-O-Bn), 4.77 (d,
J2,3 = 5.0 Hz, 1H, H-5), 4.73 (d, 2Ja,b = 11.5 Hz, 1H, CHb 6-O-Bn), 4.64 (d, 2Ja,b = 11.9
Hz, 1H, CHa 7-O-Bn), 4.46 (dd, 2J1a,1b = 9.6, J1a,7a = 8.3 Hz, 1H, H-1a), 4.36 (d, 2Ja,b
= 11.9 Hz, 1H, CHb 7-O-Bn), 4.29 (t, J6,7 = J5,6 = 5.0 Hz, 1H, H-3), 4.23 (td, J1a,7a =
J7,7a = 8.3, J1b,7a = 2.7 Hz, H-7a), 4.08 (dd, 2J1a,1b = 9.6, J1b,7a = 2.7 Hz, 1H, H-1b), 3.56
(dd, J7,7a = 8.3, J6,7 = 5.0 Hz, 1H, H-7); 13C NMR: (125 MHz CDCl3, 20 ◦C) δ 160.2
(C-3), 136.6 (C-i 7-O-Bn), 136.5 (C-i 6-O-Bn), 129.0 (C-Ar), 128.8 (C-Ar), 128.8 (C-
Ar), 128.6 (C-Ar), 128.6 (C-Ar), 128.0 (C-Ar), 115.0 (CN), 80.7 (C-7), 77.1 (C-6), 74.5
(CH2 6-O-Bn), 73.2 (CH2 7-O-Bn), 66.3 (C-1), 60.0 (C-7a), 53.1 (C-5); HRMS (ESI)
m/z calcd. for [C21H20N2O4+Na]+: 387.1315, obsd.: 387.1328.
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(5S,6S,7R,7aS)-6,7-Dibenzyloxy-3-oxotetrahydropyrrolo[1,2-c]oxazol-
5-carbonitrile (16). By subjecting α-aminonitrile anti-13 (25.0 mg, 0.08 mmol) to the
general procedure for the carbamate annulation for 6 d, carbamate 16 was obtained as
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a white solid (14.9 mg, 0.04 mmol, 53%). Crystallisation (DCM) yielded colourless
plates for which a single crystal X-ray diffraction was obtained then solved and refined
using Olex2.15 Rf = 0.45 (DCM/EtOAc, 20/1, v/v); [α]D20 = +13.6 (c = 0.5, CHCl3);
MP = 97.4 – 97.6 ◦C; IR (film) 3034, 2953, 2923, 2852, 1757, 1456, 1395, 1207, 1141,
1075, 1005, 772, 735, 696 cm-1. 1H NMR: (500 MHz, CDCl3, 20 ◦C) δ 7.43–7.25 (m,
10H, H-Ar), 4.93 (d, 2Ja,b = 11.9 Hz, 1H, CHa 7-O-Bn), 4.79 (d, 2Ja,b = 11.9 Hz, 1H,
CHa 6-O-Bn), 4.69 (d, 2Ja,b = 11.9 Hz, 1H, CHb 6-O-Bn), 4.59 (d, 2Ja,b = 11.9 Hz, 1H,
CHb 7-O-Bn), 4.57 (d, J5,6 = 6.8 Hz, 1H, H-5), 4.46 (dd, J6,7 = 3.4, J5,6 = 6.8 Hz, 1H,
H-6), 4.40 (dd, 2J1a,1b = 8.6, J1a,7a = 3.7 Hz, 1H, H-1a), 4.34 (t, 2J1a,1b = J1a,7a = 8.6
Hz, 1H, H-1b), 4.03 (td, J1a,7a = J1b,7a = 8.6, J7,7a = 3.4 Hz, 1H, H-7a), 3.95 (t, J7,7a =
J6,7 = 3.4 Hz, 1H, H-7); 13C NMR: (125 MHz CDCl3, 20 ◦C) δ 160.8 (C-3), 137.2 (C-i
7-O-Bn), 136.1 (C-i 6-O-Bn), 129.0 (C-Ar), 128.8 (C-Ar), 128.8 (C-Ar), 128.4 (C-Ar),
128.1 (C-Ar), 128.0 (C-Ar), 117.9 (CN), 86.0 (C-6), 76.2 (C-7), 73.8 (CH2 7-O-Bn),
73.8 (CH2 6-O-Bn), 63.7 (C-1), 59.5 (C-7a), 50.9 (C-5); HRMS (ESI) m/z calcd. for
[C21H20N2O4+Na]+: 387.1315, obsd.: 387.1320.
Synthesis of 16 via Epimerisation. To a solution of carbamate 14 (11.0 mg, 0.03 mmol)
in THF (0.6 mL) was added LiOH aq. (2M, 0.3 mL). The reaction mixture was stirred at
room temperature for 4 h, then quenched with sat. aq.˙ NH4Cl and extracted with EtOAc.
The organic layer was washed with H2O and brine, dried (MgSO4) and concentrated in
vacuo to provide carbamate 16 as a colourless oil (11.0 mg, 0.03 mmol, quantitative).
Spectral data as above.
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(5R,6R,7R,7aS)-6,7-Dibenzyloxy-3-oxotetrahydropyrrolo[1,2-c]oxazol-
5-carbonitrile (18). By subjecting α-aminonitrile anti-174 (140 mg, 0.43 mmol) to the
general procedure for the carbamate annulation for 48 h, carbamate 18 was obtained as
a colourless oil (129 mg, 0.35 mmol, 81%, dr = 6:1, 21:22). Rf = 0.29 (hexanes/EtOAc,
1/1, v/v); [α]D24 = +25.7 (c = 1.0, CHCl3); IR (film) 3064, 3032, 2919, 2872, 2247,
1752, 1471, 1395, 1246, 1096, 1077, 1007, 740, 698 cm-1. 1H NMR: (500 MHz, CDCl3,
20 ◦C) δ 7.42–7.27 (m, 10H, H-Ar), 4.73 (d, 2Ja,b = 12 Hz, 1H, CHa 7-O-Bn), 4.60 (d,
2Ja,b = 11.9 Hz, 1H, CHa 6-O-Bn), 4.55 (s, 1H, H-6), 4.53 (d, 2Ja,b = 11.9 Hz, 1H, CHb
6-O-Bn), 4.46 (dd, 2J1a,1b = 8.6, J1a,7a = 5.6 Hz, 1H, H-1a), 4.44 (d, 2Ja,b = 12 Hz, 1H,
CHb 7-O-Bn), 4.42 (t, 2J1a,1b = J1b,7a = 8.6 Hz, 1H, H-1b), 4.36 (ddd, J1b,7a = 8.6, J1a,7a
= 5.6, J7,7a = 3.2 Hz, 1H, H-7a), 4.22 (d, J5,6 = 0.5 Hz, 1H, H-5), 3.79 (dd, J7,7a = 3.2,
J6,7 = 1.0 Hz, 1H, H-7); 13C NMR: (125 MHz CDCl3, 20 ◦C) δ 157.5 (C-3), 136.3 (C-i
7-O-Bn), 135.9 (C-i 6-O-Bn), 129.0 (C-Ar), 128.9 (C-Ar), 128.9 (C-Ar), 128.6 (C-Ar),
128.4 (C-Ar), 128.2 (C-Ar), 113.5 (CN), 87.0 (C-6), 78.2 (C-7), 73.2 (CH2 6-O-Bn),
71.9 (CH2 7-O-Bn), 62.6 (C-1), 62.0 (C-7a), 50.6 (C-5); HRMS (ESI) m/z calcd. for
[C21H20N2O4+Na]+: 387.1315, obsd.: 387.1324.
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(5R,6R,7R,7aR)-6,7-Dibenzyloxy-3-oxotetrahydropyrrolo[1,2-c]oxazol-
5-carbonitrile (19). By subjecting α-aminonitrile anti-174 (140 mg, 0.43 mmol) to the
general procedure for the carbamate annulation for 48 h, carbamate 19 was obtained as a
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colourless oil (21.4 mg, 0.06 mmol, 13.6%, dr = 6:1, 21:22). Rf = 0.50 (hexanes/EtOAc,
1/1, v/v); [α]D24 = +5.7 (c = 1.0, CHCl3); IR (film) 3064, 3032, 2919, 2872, 2250, 1762,
1455, 1391, 1211, 1099, 1072, 740, 698 cm-1. 1H NMR: (500 MHz, CDCl3, 20 ◦C) δ
7.41–7.28 (m, 10H, H-Ar), 4.80 (d, J5,6 = 2.1 Hz, 1H, H-5), 4.65 (d, 2Ja,b = 12.0 Hz,
1H, CHa 7-O-Bn), 4.63 (d, 2Ja,b = 11.5 Hz, 1H, CHa 6-O-Bn), 4.51 (ddd, J1a,7a = 8.7,
2J1a,1b = 7.5, 4J1a,7 = 4.0 Hz, 1H, H-1a), 4.50 (d, 2Ja,b = 12.0 Hz, 1H, CHb 7-O-Bn),
4.46 (d, 2Ja,b = 11.5 Hz, 1H, CHb 6-O-Bn), 4.37 (dd, J5,6 = 2.1, J6,7 = 2.7 Hz, 1H, H-6),
4.12 (dd, J1a,1b = 7.5, J1b,7a = 4.4 Hz, 1H, H-1b), 4.09 (ddd, J1a,7a = 8.7, J1b,7a = 4.4,
J7,7a = 0.5 Hz, 1H, H-7a), 3.87 (ddd, 4J1a,7 = 4.0, J6,7 = 2.7, J7,7a = 0.5 Hz, 1H, H-7);
13C NMR: (125 MHz CDCl3, 20 ◦C) δ 160.0 (C-3), 136.6 (C-i 7-O-Bn), 135.7 (C-i 6-
O-Bn), 129.1 (C-Ar), 129.0 (C-Ar), 128.9 (C-Ar), 128.8 (C-Ar), 128.7 (C-Ar), 128.6
(C-Ar), 128.3 (C-Ar), 128.1 (C-Ar), 115.9 (CN), 86.8 (C-7), 86.4 (C-6), 73.0 (CH2 7-
O-Bn), 72.8 (CH2 6-O-Bn), 67.4 (C-1), 62.7 (C-7a), 52.3 (C-5); HRMS(ESI) m/z calcd.
for [C21H20N2O4+Na]+: 387.1315, obsd.: 387.1321.
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(5S,6R,7S,7aR)-6,7-Dihydroxy-5-(hydroxymethyl)tetrahydro-1H-
pyrrolo[1,2-c]imidazol-3(2H)-one (20). Carbamate 14 (147 mg, 0.40 mmol) was
dissolved in CHCl3 (3.0 mL) and transferred into a Fischer-Porter bottle, EtOH (5.0
mL), HCl in ether (1.0 mL 2M) and Pd(OH2)/C (110 mg) were then added and the vessel
was charged with 7 bar pressure of H2. The reaction mixture was stirred vigorously at
room temperature for 3 d. After releasing H2 pressure the reaction mixture was filtered
through a plug of celite, washing with EtOH and DCM/MeOH/EtOH/30% aq. NH3,
93
(5/2/2/1, v/v/v/v) and concentrated in vacuo. Purification was achieved by dry-loading
using gradient flash chromatography (DCM/MeOH/EtOH/30% aq. NH3, 50/2/2/1 →
5/2/2/1, v/v/v/v) to provide the urea 20 as a colourless oil (23.0 mg, 0.12 mmol, 30%).
Rf = 0.48 (DCM/MeOH/EtOH/30% aq. NH3, 5/2/2/1, v/v/v/v); [α]D21 = -22.0 (c = 1.0,
H2O); IR (film) 3288, 2927, 1658, 1492, 1451, 1372, 1130, 1025, 978, 757, 700 cm-1.
1H NMR: (500 MHz, D2O, 20 ◦C) δ 4.61 (dd, J5,6 = 8.1, J6,7 = 4.0 Hz, 1H, H-6), 4.13
(dd, 2Ja,b = 12.0, J5,CHaOH = 3.2, Hz, 1H, H-CHaOH) 4.12 (ddd, J1b,7a = 9.5, J1a,7a =
8.1, J7,7a = 4.0 Hz, 1H, H-7a), 3.99 (t, J6,7 = J7,7a = 4.0 Hz, 1H, H-7), 3.76 (dt, J5,6 =
8.1, J5,CHaOH = J5,CHbOH = 3.2 Hz, 1H, H-5), 3.72 (dd, 2Ja,b = 12.0, J5,CHbOH = 3.2 Hz,
H-CHbOH) 3.59 (dd, 2J1a,1b = 9.5, J1a,7a = 8.1 Hz, 1H, H-1a), 3.49 (t, 2J1a,1b = J1b,7a =
9.5 Hz, 1H, H-1b); 13C NMR: (125 MHz D2O, 20 ◦C) δ 164.0 (C-3), 74.2 (C-6), 69.1
(C-7), 60.1 (C-7a), 58.5 (C-5), 55.3 (CH2OH), 38.7 (C-1); HRMS (ESI) m/z calcd. for
[C7H12N2O4+H]+: 189.0870, obsd.: 189.0869.
General Procedure for Hydrogenation of Carbamates. Protected carbamate (0.27
mmol) was dissolved in CHCl3 (4.5 mL) and transferred into a Fischer-Porter bottle,
EtOH (7.5 mL), HCl in ether (1.4 mL 2M) and Pd(OH)2/C (230 mg) were then added
and the vessel was charged with 7 bar pressure of H2. The reaction mixture was stirred
vigorously at room temperature for 3 d. After releasing H2 pressure the reaction mixture
was filtered through a plug of celite, washing with EtOH and H2O, and concentrated in
vacuo to provide the amino carbamate as the hydrochloride salt.
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(5R,6S,7R,7aS)-5-(Aminomethyl)-6,7-dihydroxytetrahydropyrrolo
[1,2-c]oxazol-3(1H)-one hydrochloride (21). By subjecting carbamate 14 (60 mg, 0.16
mmol) to the general procedure for the hydrogenation of carbamates, ammonium salt 21
was obtained as a white solid (30.8 mg, 0.16 mmol, 99%) and further crystallised from
MeOH. Rf = 0.29 (DCM/MeOH/EtOH/30% aq. NH3, 5/2/2/1, v/v/v/v); [α]D26.1 = +30.0
(c = 1.0, H2O); MP = 230.0 – 230.5 ◦C; IR (film) 3362, 2960, 2930, 1724, 1633, 1433,
1261, 1127, 1075, 949, 897 cm-1. 1H NMR: (500 MHz, D2O, 20 ◦C) δ 4.66 (dd, J5,6
= 7.6, J6,7 = 3.4 Hz, 1H, H-6), 4.56 (t, 2J1a,1b = J1a,7a = 9.3 Hz, 1H, H-1a), 4.49 (dd,
2J1a,1b = 9.3, J1a,7a = 7.1 Hz, 1H, H-1b), 4.25 (ddd, J1a,7a = 9.3, J1b,7a = 7.1, J7,7a = 3.4
Hz, 1H, H-7a), 4.13 (t, J7,7a = J6,7 = 3.4 Hz, 1H, H-7), 4.04 (td, J5,6 = J5,CHbNH2 = 7.6,
J5,CHaNH2 = 3.4 Hz, 1H, H-5), 3.59 (dd, 2Ja,b = 14.2, J5,CHaNH2 = 3.4 Hz, 1H, CHaNH2),
3.38 (dd, 2Ja,b = 14.2, J5,CHbNH2 = 7.6 Hz, 1H, CHbNH2); 13C NMR: (125 MHz D2O,
20 ◦C) δ 159.7 (C-3), 74.3 (C-6), 69.1 (C-7), 64.5 (C-1), 60.3 (C-7a), 55.0 (C-5), 36.7
(CH2NH2); HRMS (ESI) m/z calcd. for [C7H12N2O4+H]+: 189.0870, obsd.: 189.0869.
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(5R,6S,7R,7aR)-5-(Aminomethyl)-6,7-dihydroxytetrahydropyrrolo
[1,2-c]oxazol-3(1H)-one hydrochloride (23). By subjecting carbamate 15 (4 mg,
0.01 mmol) to the general procedure for the hydrogenation of carbamates, ammonium
salt 26 was obtained as a colourless oil (2.0 mg, 0.01 mmol, 98%). Rf = 0.25
(DCM/MeOH/EtOH/30% aq. NH3, 5/2/2/1, v/v/v/v); [α]D25.7 = -10.0 (c = 0.7, H2O);
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IR (film) 3382, 3284, 2927, 2855, 1735, 1630, 1402, 1243, 1221, 1114, 999, 768 cm-1.
1H NMR: (500 MHz, D2O, 20 ◦C) δ 4.59–4.56 (m, 1H, H-1a), 4.36–4.34 (m, 2H, H-6
and H-1b), 4.00–3.94 (m, 3H, H-5, H-7 and H-7a), 3.17 (dd, 2Ja,b = 13.2, J5,CHaNH2 = 3.6
Hz, 1H, CHaNH2), 3.12 (dd, 2Ja,b = 13.2, J5,CHbNH2 = 7.8 Hz, 1H, CHbNH2); 13C NMR:
(125 MHz D2O, 20 ◦C) δ 163.7 (C-3), 74.3 (C-6), 73.3 (C-7), 67.9 (C-1), 60.2 (C-7a),
58.7 (C-5), 39.6 (CH2NH2); HRMS (ESI) m/z calcd. for [C7H12N2O4+H]+: 189.0870,
obsd.: 189.0873.
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(5S,6S,7R,7aS)-5-(Aminomethyl)-6,7-dihydroxytetrahydropyrrolo
[1,2-c]oxazol-3(1H)-one hydrochloride (24). By subjecting carbamate 16 (104 mg,
0.29 mmol) to the general procedure for the hydrogenation of carbamates, ammonium
salt 24 was obtained as a colourless oil (53.0 mg, 0.28 mmol, 99%). Rf = 0.22
(DCM/MeOH/EtOH/30% aq. NH3, 5/2/2/1, v/v/v/v); [α]D25 = +14.8 (c = 1.0, H2O);
IR (film) 3233, 2978, 2903, 2837, 1736, 1622, 1506, 1403, 1236, 1089, 1013, 916, 823,
775 cm-1. 1H NMR: (500 MHz, D2O, 20 ◦C) δ 4.57 (t, 2J1a,1b = J1a,7a = 9.3 Hz, 1H,
H-1a), 4.54 (dd, 2J1a,1b = 9.3, J1b,7a = 3.7 Hz, 1H, H-1b), 4.24 (dd, J5,6 = 7.8, J6,7 = Hz,
1H, H-6), 4.21–4.20 (m, 1H, H-7a) 4.06 (br s, 1H, H-7), 3.62 (td, J5,6 = J5,CHbNH2 = 7.8,
J5,CHaNH2 = 3.4 Hz, 1H, H-5), 3.28 (dd, 2Ja,b = 13.2, J5,CHaNH2 = 3.4 Hz, 1H, CHaNH2),
3.01 (dd, 2Ja,b = 13.2, J5,CHbNH2 = 7.8 Hz, 1H, CHbNH2); 13C NMR: (125 MHz D2O,
20 ◦C) δ 164.4 (C-3), 76.6, (C-6), 71.4 (C-7), 64.6 (C-1), 60.7 (C-5), 60.4 (C-7a), 42.0
(CH2NH2); HRMS (ESI) m/z calcd. for [C7H12N2O4+H]+: 189.0870, obsd.: 189.0872.
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(5R,6R,7R,7aS)-5-(Aminomethyl)-6,7-dihydroxytetrahydropyrrolo
[1,2-c]oxazol-3(1H)-one hydrochloride (25). By subjecting carbamate 18 (100 mg,
0.27 mmol) to the general procedure for the hydrogenation of carbamates, ammonium
salt 25 was obtained as a white solid (51.4 mg, 0.27 mmol, 99%) and further crystallised
from EtOH. Rf = 0.62 (DCM/MeOH/EtOH/30% aq. NH3, 5/2/2/1, v/v/v/v); [α]D25.8 =
+60.2 (c = 0.83, H2O); MP = 183.3 – 184.0 ◦C; IR (film) 3356, 2961, 2929, 1716, 1633,
1428, 1262, 1143, 1094, 1063, 1007, 949, 893 cm-1. 1H NMR: (500 MHz, D2O, 20 ◦C)
δ 4.63–4.59 (m, 1H, H-1a), 4.52–4.47 (m, 2H, H-7a, and H-1b), 4.15 (t, J6,7 = J5,6 = 1.9
Hz, 1H, H-6), 4.01 (dd, J7,7a = 2.8, J6,7 = 1.9 Hz, 1H, H-7), 3.72 (ddd, J5,CHbNH2 = 10.0,
J5,CHaNH2 = 3.2, J5,6 = 1.9 Hz, 1H, H-5), 3.59 (dd, 2Ja,b = 13.9, J5,CHaNH2 = 3.2 Hz, 1H,
CHaNH2), 3.53 (dd, 2Ja,b = 13.9, J5,CHbNH2 = 10.0 Hz, 1H, CHbNH2); 13C NMR: (125
MHz D2O, 20 ◦C) δ 160.2 (C-3), 82.2 (C-6), 73.3 (C-7), 63.9 (C-1), 63.2 (C-7a), 62.5
(C-5), 39.3 (CH2NH2); HRMS (ESI) m/z calcd. for [C7H12N2O4+H]+: 189.0870, obsd.:
189.0871.
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(5R,6R,7R,7aR)-5-(Aminomethyl)-6,7-dihydroxytetrahydropyrrolo
[1,2-c]oxazol-3(1H)-one hydrochloride (26). By subjecting carbamate 19 (16 mg,
0.04 mmol) to the general procedure for the hydrogenation of carbamates, ammonium
salt 26 was obtained as a colourless oil (7.0 mg, 0.04 mmol, 90%). Rf = 0.41
(DCM/MeOH/EtOH/30% aq. NH3, 5/2/2/1, v/v/v/v); [α]D24.8 = +10.0 (c = 0.4, H2O); IR
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(film) 3330, 3247, 2924, 1731, 1641, 1404, 1235, 1084, 1012, 918, 773 cm-1. 1H NMR:
(500 MHz, D2O, 20 ◦C) δ 4.70 (dd, 2J1a,1b = 9.6, J1a,7a = 8.1 Hz, 1H, H-1a), 4.48 (dd,
2J1a,1b = 9.6, J1b,7a = 4 Hz, 1H, H-1b), 4.07–4.02 (m, 3H, H-6, H-7 and H-7a), 3.84 (ddd,
J5,CHbNH2 = 11, J5,6 = 4.9, J5,CHaNH2 = 3.3 Hz, 1H, H-5), 3.37 (dd, 2Ja,b = 13.1, J5,CHaNH2 =
3.3 Hz, 1H, CHaNH2), 3.19 (dd, 2Ja,b = 13.1, J5,CHbNH2 = 11, 1H, CHbNH2); 13C NMR:
(125 MHz D2O, 20 ◦C) δ 163.6 (C-3), 79.2 (C-6), 78.4 (C-7), 68.4 (C-1), 61.6 (C-5),
60.9 (C-7a), 40.8 (CH2NH2); HRMS (ESI) m/z calcd. for [C7H12N2O4+H]+: 189.0870,
obsd.: 189.0874.
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1-Amino-6-chloro-1,2,5,6-tetradeoxy-2,5-imino-D-galactitol dihy-
drochloride (22). Amino carbamate 21 (4 mg, 0.07 mmol) was dissolved in HCl
(1.2 mL, conc.). The solution was stirred at reflux for 3 h, then cooled and con-
centrated in vacuo. Purification was attempted using gradient flash chromatography
(DCM/MeOH/EtOH/30% aq. NH3, 15/2/2/1 → 5/2/2/1, v/v/v/v) to provide chloro-
imino-galactitol 22 as a white solid with an inseparable decomposition product also
observed. Rf = 0.37 (DCM/MeOH/EtOH/30% aq. NH3, 5/2/2/1, v/v/v/v); 1H NMR:
(500 MHz, 2% DCl in D2O, 20 ◦C) δ 4.65 (dd, J2,3 = 7.1, J3,4 = 4.4 Hz, 1H, H-3), 4.47
(t, J4,5 = J3,4 = 4.4 Hz, 1H, H-4), 4.08 (td, J2,3 = J1a,2 = 7.1, J1b,2 = 5.4 Hz, 1H, H-2), 4.02
(dd, 2J6a,6b = 13.2, J5,6a = 4.4 Hz, 1H, H-6a), 4.01 (td, J5,6b = 11.5, J5,6a = J4,5 = 4.4, Hz,
1H, H-5), 3.90 (dd, 2J6a,6b = 13.2, J5,6b = 11.5 Hz, 1H, H-6b), 3.61 (dd, 2J1a,1b = 13.7,
J1a,2 = 7.1 Hz, 1H, H-1a), 3.44 (dd, 2J1a,1b = 13.7, J1b,2 = 5.4 Hz, 1H, H-1b); 13C NMR:
(125 MHz, 2% DCl in D2O, 20 ◦C) δ 70.2 (C-3), 70.2 (C-4), 62.4 (C-5), 55.8 (C-2), 39.5
(C-6), 36.9 (C-1); HRMS (ESI) m/z calcd. for [C6H1335ClN2O2+H]+: 181.0738, obsd.:
98
181.0741; m/z calcd. for [C6H1337ClN2O2+H]+: 183.0709, obsd.: 183.0713.
General Procedure for Acidic Hydrolysis of Carbamates. Amino carbamate (0.05
mmol) was dissolved in H2SO4 aq.˙ (1 mL, 3M). The solution was refluxed for 12 – 18
h, then cooled and neutralised by the addition of Dowex-OH– ion-exchange resin. The
resin mixture was filtered with H2O and the filtrate concentrated in vacuo to provide the
pure amino-imino-hexitols as the free base. Imino-hexitols were also characterised as
the dihydrochloride salt with the addition of deuterium chloride.
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1-Amino-1,2,5-trideoxy-2,5-imino-D-galactitol (7). By subjecting
amino carbamate 21 (9.7 mg, 0.05 mmol) to the general procedure for the acidic
hydrolysis of carbamates for 18 h, imino-D-galactitol 7 was obtained as a white solid
(8.4 mg, 0.05 mmol, quantitative). Rf = 0.01 (DCM/MeOH/EtOH/30% aq. NH3, 5/2/2/1,
v/v/v/v); (HCl salt) [α]D19.6 = -2.0 (c = 0.47, H2O); IR (film) 3316, 2965, 1644, 1364,
1315, 1081, 1019, 835 cm-1. 1H NMR (500 MHz, D2O, 2HCl salt) δ 4.59 (dd, J2,3 =
7.2, J3,4 = 4.7 Hz, 1H, H-3), 4.42 (t, J4,5 = J3,4 = 4.7 Hz, 1H, H-4), 4.03 (td, J2,3 = J1a,2 =
7.2, J1b,2 = 5.7 Hz, 1H, H-2), 3.97 (dd, 2J6a,6b = 12.5, J5,6a = 4.7 Hz, 1H, H-6a), 3.88 (dd,
2J6a,6b = 12.5, J5,6b = 9.0 Hz, 1H, H-6b), 3.75 (dt, J5,6b = 9.0, J5,6a = J4,5 = 4.7 Hz, 1H,
H-5), 3.57 (dd, 2J1a,1b = 13.9, J1a,2 = 7.2 Hz, 1H, H-1a), 3.42 (dd, 2J1a,1b = 13.9, J1b,2 =
5.7 Hz, 1H, H-1b); 13C NMR (125 MHz, D2O, 2HCl salt) δ 70.1 (C-3), 69.7 (C-4), 62.1
(C-5), 57.3 (C-6), 55.7 (C-2), 36.8 (C-1); HRMS (ESI) m/z calcd. for [C6H14N2O3+H]+:
163.1077, obsd.: 163.1084. 1H NMR: (500 MHz, 2% NaOD in D2O, 20 ◦C) δ 4.21 (dd,
J4,5 = 6.2, J3,4 = 5.1 Hz, 1H, H-4), 4.03 (t, J3,4 = J2,3 = 5.1 Hz, 1H, H-3), 3.63 (dd, 2J6a,6b
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= 11.4, J5,6a = 5.1 Hz, 1H, H-6a), 3.58 (dd, 2J6a,6b = 11.4, J5,6b = 5.1 Hz, 1H, H-6b), 3.07
(dt, J4,5 = 6.2, J5,6a = J5,6b = 5.1 Hz, 1H, H-5), 2.92 (td, J1a,2 = J1b,2 = 6.5, J2,3 = 5.1 Hz,
1H, H-2), 2.76 (dd, 2J1a,1b = 13, J1a,2 = 6.5 Hz, 1H, H-1a), 2.61 (dd, 2J1a,1b = 13, J1b,2 =
6.5 Hz, 1H, H-1b); 13C NMR: (125 MHz, 2% NaOD in D2O, 20 ◦C) δ 73.0 (C-4), 71.6
(C-3), 61.3 (C-2), 60.4 (C-6), 60.3 (C-5), 40.2 (C-1).
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1-Amino-1,2,5-trideoxy-2,5-imino-D-glucitol (14).7 By subjecting
amino carbamate 25 (4.2 mg, 0.02 mmol) to the general procedure for the acidic
hydrolysis of carbamates for 12 h, imino-D-glucitol 14 was obtained as a white solid
(3.6 mg, 0.02 mmol, quantitative). Rf = 0.01 (DCM/MeOH/EtOH/30% aq. NH3, 5/2/2/1,
v/v/v/v); (HCl salt) [α]D20.1 = +8.0 (c = 0.38, H2O); IR (film) 3121, 3050, 2930, 2799,
1633, 1401, 1082, 964, 879 cm-1. 1H NMR (500 MHz, D2O, 2HCl salt) δ 4.38 (t, J4,5
= J3,4 = 3.0 Hz, 1H, H-4), 4.29 (t, J3,4 = J2,3 = 3.0 Hz, 1H, H-3), 4.03 (dd, 2J6a,6b = 9.8,
J5,6a = 3.0 Hz, 1H, H-6a), 3.99 (dt, J5,6b = 7.3, J5,6a = J4,5 = 3.0 Hz, 1H, H-5), 3.96
(dd, 2J6a,6b = 9.8, J5,6b = 7.3 Hz, 1H, H-6b), 3.84 (td, J1,2 = 6.9, J2,3 = 3.0 Hz, 1H, H-2),
3.57 (d, J1,2 = 6.9 Hz, 2H, H-1); 13C NMR (125 MHz, D2O, 2HCl salt) δ 77.5 (C-3),
74.0 (C-4), 64.1 (C-5), 62.5 (C-2), 56.9 (C-6), 39.2 (C-1); HRMS (ESI) m/z calcd. for
[C6H14N2O3+H]+: 163.1077, obsd.: 163.1081. 1H NMR: (500 MHz, 2% NaOD in D2O,
20 ◦C) δ 3.97 (dd, J4,5 = 5.5, J3,4 = 2.7 Hz, 1H, H-4), 3.67 (dd, 2J6a,6b = 11.5, J5,6a = 6.2
Hz, 1H, H-6a), 3.65 (t, J3,4 = J2,3 = 2.7 Hz, 1H, H-3), 3.55 (dd, 2J6a,6b = 11.5, J5,6b = 6.2
Hz, 1H, H-6b), 3.16 (td, J5,6a = J5,6b = 6.2, J4,5 = 5.5 Hz, 1H, H-5), 2.78 (ddd, J1b,2 = 7.0,
J1a,2 = 5.1, J2,3 = 2.7 Hz, 1H, H-2), 2.74 (dd, 2J1a,1b = 12.8, J1a,2 = 5.1 Hz, 1H, H-1a),
2.60 (dd, 2J1a,1b = 12.8, J1b,2 = 7.0 Hz, 1H, H-1b); 13C NMR: (125 MHz, 2% NaOD in
100
D2O, 20 ◦C) δ 80.7 (C-3), 77.6 (C-4), 65.5 (C-2), 60.7 (C-5), 60.3 (C-6), 43.5 (C-1). The
structural characterisation data were consistant with those reported in the literature,7 key
data includes: (free base) [α]D20 = +24.0 (c = 0.7, H2O); 13C NMR (D2O, pH 1) δ 57.8
(C-6), 40.2 (C-1).
General Procedure for Basic Hydrolysis of Carbamates. A solution of NaOH in
EtOH (0.5 ml, 2M) was added to the amino carbamate (0.08 mmol) and stirred under
reflux for 2 h. The resulting reaction mixture was loaded directly on to a Dowex-H+
ion-exchange resin column and washed with H2O to remove excess salt. The amine
product was then eluted with 30% aq.˙ NH3 and concentrated in vacuo to provide the
pure amino-imino-hexitols as a mixture of protonation states, which were characterised
as both the free base by adding sodium deuteroxide and the dihydrochloride salt with
the addition of deuterium chloride.
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1-Amino-1,2,5-trideoxy-2,5-imino-D-talitol (8). By subjecting amino
carbamate 23 (5 mg, 0.03 mmol) to the general procedure for the basic hydrolysis of
carbamates, imino-talitol 8 was obtained as a colourless oil (4.1 mg, 0.03 mmol, 95%).
Rf = 0.01 (DCM/MeOH/EtOH/30% aq. NH3, 5/2/2/1, v/v/v/v); (HCl salt) [α]D27.4 =
+11.1 (c = 0.27 H2O); IR (film) 3322, 2927, 1622, 1497, 1403, 1278, 1127, 1074, 1035,
981 cm-1. 1H NMR: (500 MHz, 2% DCl in D2O, 20 ◦C) δ 4.42 (t, J3,4 = J2,3 = 3.6 Hz,
1H, H-3), 4.31 (dd, J4,5 = 8.6, J3,4 = 3.6 Hz, 1H, H-4), 3.99–3.97 (m, 1H, H-2), 3.97
(dd, 2J6a,6b = 12.7, J5,6a = 3.4 Hz, 1H, H-6a), 3.83 (dd, 2J6a,6b = 12.7, J5,6b = 5.8 Hz, 1H,
H-6b), 3.70 (ddd, J4,5 = 8.6, J5,6b = 5.8, J5,6a = 3.4 Hz, 1H, H-5), 3.60 (dd, 2J1a,1b = 13.9,
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J1a,2 = 7.1 Hz, 1H, H-1a), 3.43 (dd, 2J1a,1b = 13.9, J1b,2 = 6.1 Hz, 1H, H-1b); 13C NMR:
(125 MHz, 2% DCl in D2O, 20 ◦C) δ 71.2 (C-4), 70.0 (C-3), 62.4 (C-5), 57.9 (C-6),
57.6 (C-2), 35.9 (C-1); HRMS (ESI) m/z calcd. for [C6H14N2O3+H]+: 163.1077, obsd.:
163.1084; 1H NMR: (500 MHz, 2% NaOD in D2O, 20 ◦C) δ 4.03 (t, J3,4 = J2,3 = 4.1 Hz,
1H, H-3), 3.89 (dd, J4,5 = 8.3, J3,4 = 4.1 Hz, 1H, H-4), 3.68 (dd, 2J6a,6b = 11.7, J5,6a = 3.9
hz, 1H, H-6a), 3.56 (dd, 2J6a,6b = 11.7, J5,6b = 6.3 Hz, 1H, H-6b), 3.09 (td, J1a,2 = J1b,2 =
7.1, J2,3 = 4.1 Hz, 1H, H-2), 2.99 (ddd, J4,5 = 8.3, J5,6b = 6.3, J5,6a = 3.9 Hz, 1H, H-5),
2.77 (dd, 2J1a,1b = 13.0, J1a,2 = 7.1 Hz, 1H, H-1a), 2.62 (dd, 2J1a,1b = 13.0, J1b,2 = 7.1 Hz,
1H, H-1b); 13C NMR: (125 MHz, 2% NaOD in D2O, 20 ◦C) δ 74.1 (C-4), 72.4 (C-3),
62.4 (C-6), 62.0 (C-5), 60.6 (C-2), 40.4 (C-1).
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1-Amino-1,2,5-trideoxy-2,5-imino-L-altritol (9). By subjecting
amino carbamate 24 (12.3 mg, 0.06 mmol) to the general procedure for the hydrolysis
of carbamates, imino-hexitol 9 was obtained as a colourless oil (10.6 mg, 0.06 mmol,
quantitative). Rf = 0.01 (DCM/MeOH/EtOH/30% aq. NH3, 5/2/2/1, v/v/v/v); (HCl salt)
[α]D27.4 = -20.0 (c = 0.45 H2O); IR (film) 3302, 2928, 1622, 1402, 1342, 1221, 1124,
1039, 1027 cm-1. 1H NMR: (500 MHz, 2% DCl in D2O, 20 ◦C) δ 4.18 (dd, J3,4 = 3.7,
J4,5 = 2.9 Hz, 1H, H-4), 4.14 (dd, J2,3 = 9.7, J2,3 = 3.7 Hz, 1H, H-3), 3.84 (dd, 2J6a,6b =
16.1, J5,6a = 8.7 Hz, 1H, H-6a), 3.75 (dd, 2J6a,6b = 16.1, J5,6b = 8.7 Hz, 1H, H-6b), 3.74
(td, J5,6a = J5,6b = 8.7, J4,5 = 2.9 Hz, 1H, H-5), 3.66 (ddd, J2,3 = 9.7, J1a,2 = 7.9, J1b,2 = 5.9
Hz, 1H, H-2), 3.41 (dd, 2J1a,1b = 14.0, J1a,2 = 7.9 Hz, 1H, H-1a), 3.36 (dd, 2J1a,1b = 14.0,
J1b,2 = 7.9 Hz, 1H, H-1b); 13C NMR: (125 MHz, 2% DCl in D2O, 20 ◦C) δ 74.0 (C-4),
69.3 (C-3), 62.8 (C-5), 57.3 (C-6), 56.9 (C-2), 39.0 (C-1); HRMS (ESI) m/z calcd. for
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[C6H14N2O3+H]+: 163.1077, obsd.: 163.1079. 1H NMR: (500 MHz, 2% NaOD in D2O,
20 ◦C) δ 4.05 (t, J4,5 = J3,4 = 4.1 Hz, 1H, H-4), 3.79 (dd, J2,3 = 8.1, J3,4 = 4.1 Hz, 1H,
H-3), 3.70 (dd, 2J6a,6b = 11.2, J5,6a = 6.3 Hz, 1H, H-6a), 3.58 (dd, 2J6a,6b = 11.2, J5,6b =
6.3 Hz, 1H, H-6b), 3.17 (td, J5,6a = J5,6b = 6.3, J4,5 = 4.1 Hz, 1H, H-5), 2.93 (td, J2,3 =
J1b,2 = 8.1, J1a,2 = 4.4 Hz, 1H, H-2), 2.76 (dd, 2J1a,1b = 13.2, J1a,2 = 4.4 Hz, 1H, H-1a),
2.57 (dd, 2J1a,1b = 13.2, J1b,2 = 8.1 Hz, 1H, H-1b); 13C NMR: (125 MHz, 2% NaOD in
D2O, 20 ◦C) δ 75.6 (C-3), 72.6 (C-4), 62.7 (C-2), 60.6 (C-6), 59.6 (C-5), 43.8 (C-1). The
structural characterisation data were consistant with those reported in the literature13 for
the enantiomer, except for the optical rotation being of similar magnitude but opposite
sign: [α]D20 = +18 (c = 0.1, H2O).
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1-Amino-1,2,5-trideoxy-2,5-imino-D-mannitol (12).7,14 By subject-
ing amino carbamate 26 (4.0 mg, 0.02 mmol) to the general procedure for the basic
hydrolysis of carbamates, imino-mannitol 12 was obtained as a colourless oil (3.2 mg,
0.02 mmol, 91%). Rf = 0.01 (DCM/MeOH/EtOH/30% aq. NH3, 5/2/2/1, v/v/v/v); (HCl
salt) [α]D27.4 = +40.0 (c = 0.10, H2O); IR (film) 3209, 2925, 1603, 1503, 1406, 1123,
1065, 1034, 813 cm-1. 1H NMR: (500 MHz, 2% DCl in D2O, 20 ◦C) δ 4.08 (t, J3,4 = J2,3
= 7.0 Hz, 1H, H-3), 4.04 (t, J4,5 = J3,4 = 7.0 Hz, 1H, H-4), 3.89 (dd, 2J6a,6b = 12.7, J5,6a
= 3.9 Hz, 1H, H-6a), 3.79 (dd, 2J6a,6b = 12.7, J5,6b = 7.0 Hz, 1H, H-6b), 3.73 (td, J1,2 =
7.2, J2,3 = 7.0 Hz, 1H, H-2), 3.61 (td, J4,5 = J5,6b = 7.0, J5,6a = 3.9 Hz, 1H, H-5), 3.36
(d, J1,2 = 7.2 Hz, 2H, H-1); 13C NMR: (125 MHz, 2% DCl in D2O, 20 ◦C) δ 76.4 (C-3),
73.9 (C-4), 63.4 (C-5), 58.4 (C-6), 58.0 (C-2), 38.6 (C-1); HRMS (ESI) m/z calcd. for
[C6H14N2O3+H]+: 163.1077, obsd.: 163.1084. 1H NMR: (500 MHz, 2% NaOD in D2O,
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20 ◦C) δ 3.83 (t, J4,5 = J3,4 = 7.6 Hz, 1H, H-4), 3.75 (t, J3,4 = J2,3 = 7.6 Hz, 1H, H-3),
3.72 (dd, 2J6a,6b = 11.7, J5,6a = 4.4 Hz, 1H, H-6a), 3.64 (dd, 2J6a,6b = 11.7, J5,6b = 6.1
Hz, 1H, H-6b), 2.99 (ddd, J4,5 = 7.6, J5,6b = 6.1, J5,6a = 4.4 Hz, 1H, H-5) 2.95 (td, J2,3 =
J1b,2 = 7.6, J1a,2 = 4.4 Hz, 1H, H-2), 2.83 (dd, 2J1a,1b = 13.2, J1a,2 = 4.4 Hz, 1H, H-1a),
2.67 (dd, 2J1a,1b = 13.2, J1b,2 = 7.6 Hz, 1H, H-1b); 13C NMR: (125 MHz, 2% NaOD in
D2O, 20 ◦C) δ 79.4 (C-3), 77.7 (C-4), 62.0 (C-2), 61.9 (C-6), 61.5 (C-5), 43.5 (C-1). The
structural characterisation data were consistant with those reported in the literature,7,14
key data includes: (free base) [α]D20 = +49.4 (c = 0.9, H2O); 13C NMR (D2O, pH 1) δ
76.4 (C-3), 73.6 (C-4), 38.6 (C-1).
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Chapter 4
Biological Evaluation of
Amino-imino-hexitols
4.1 Introduction
Having developed methodology for the synthesis of amino-imino-hexitols (Chapters 2
and 3) we sought to evaluate their potential glycosidase inhibitory activity.1 Azasugars
have shown great promise for the treatment of lysosomal storage disorders as eluded to
in Chapter 1. In fact, Zavesca,r (1, Fig. 4.1) as a potent inhibitor of glucosylceramide
synthase, is used clinically to treat Gaucher disease in the form of substrate reduction
therapy (SRT).2 Lysosomal storage disorders are a group of over 50 rare metabolic
disorders that result from genetic deficiencies in lysosomal enzymes.3 As a result of
mutations to metabolic enzymes, macromolecules such as glycolipids and glycoproteins
build up in the lysosome, which leads to pathogenesis.3 Gaucher disease, the
most prevalent of the lysosomal storage disorders, is caused by deficiency of β-
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glucocerebrosidase (GCase), the enzyme responsible for glucosylceramide degrada-
tion.2,3 The accumulation of glucosylceramide in the lysosome causes severe symptoms
such as liver or spleen damage, bone pains, and skeletal lesions.2 Treatments for
Gaucher disease include enzyme replacement therapy (ERT), which is costly and does
not treat the neuropathogenic types of the disease due to the inability of proteins
to cross the blood-brain barrier.4 SRT, on the other hand, reduces the amount
of glucosylceremide in the lysosome by inhibiting the enzyme responsible for its
biosynthesis. A downside of this therapy is the requirement for large doses of inhibitor,
which can lead to unwanted side-effects.2 A third strategy is active-site-specific
chaperone (ASSC) therapy.2 An ASSC is a small molecule that can bind specifically
to the active site of a misfolded enzyme to stabilise the structure and prevent it from
being degraded in the cell as a mutant protein.3 Thus, finding specific inhibitors
of β-glucocerebrosidase can lead to treatments of Gaucher disease, as administration
of ASSCs at a sub-inhibitory dose has been shown to be therapeutic.5 An example
of an ASSC is the piperidene deoxygalactonojirimycin (DGJ, 2), an inhibitor of α-
galactosidase,6 which is currently in phase three clinical trials for the treatment of the
lysosomal storage disorder Fabry’s disease.7
N
OH
HO OH
H
N
HO
OH
OH
HO
HO
1 2
Fig. 4.1 Azasugars as clinical drugs
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Deficiencies in β-hexosaminidases are also responsible for a number of lysosomal
storage diseases.8 Absence of enzymes to cleave a terminal N-acetyl-β-D-glucosamine
gives rise to Sanfilippo,9,10 Tay-Sachs and Sandhoff11 diseases. Finding potent inhibitors
of β-hexosaminidases could help elucidate the catalytic mechanism of the enzymes, and
hence lead to the design of ASSCs to treat these debilitating genetic diseases.9 The
inhibition of N-acetyl-β-D-hexosaminidase by the D-manno acetamide (3, Fig. 4.2) first
prepared by Wong and co-workers,12 has also led to potential treatments for osteoarthri-
tis13,14 and bacterial infection15 (discussed in Chapter 1.2). Other amino-imino-hexitols
have proven potent glycosidase inhibitors such as the library of compounds based on the
D-manno scaffold (4) prepared by Wrodnigg and co-workers,16–20 in which coumarin
derivative 5 proved to be a powerful β-glucosidase inhibitor.17
H
N
HO OH
NHAcHO H
N
HO OH
NH2HO
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N
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HNHO
OO NEt2
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3 4 5
Fig. 4.2 Amino-imino-hexitols as glycosidase inhibitors
The work in this chapter outlines the synthesis of N-acylated amino-imino-hexitols from
the previously synthesised hexitols (Chapter 3), along with subsequent evaluation of
the glycosidase kinetics of these amino-hexitols, their precursors, and that of the L-
ido scaffold. To gauge the potential glycosidase inhibitory activity of our synthesised
amino-imino-hexitols we sent samples to the laboratory of Professor Stephen Withers
(University of British Columbia, Canada) for kinetic evaluation. We chose a panel
of glycosidases based on their importance and availability, to determine the inhibition
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dissociation constant (Ki, discussed in Chapter 1.1) for each of the azasugars.
4.2 N-Acylation of Amino-imino-hexitols
Acetylated derivatives of the novel stereoisomers, D-galacto 6, D-talo 7 and L-altro 8,
were prepared as literature precedence suggests that N-acylation improves glycosidase
activity (Scheme 4.1).16,18–26 Subjecting D-galacto hexitol 6 to acetic anhydride in
MeOH20 gave acetamide 9 along with the bis-acetamide 10 in 57% combined yield
in a ratio of 4:1.7 (9:10) and they could be separated by chromatography. Selective
acetylation of D-talo 7 and L-altro 8, however, proceeded smoothly to give the
corresponding acetamides 11 and 12, in 77% and 65% yield, respectively.
H
N
HO OH
NHAcHOH
N
HO OH
NH2HO
N
HO OH
NHAcHO Ac
H
N
HO OH
NHAcHOH
N
HO OH
NH2HO
Ac2O, MeOH
-15 oC, 1 h
(4:1.7,    :     )
57%
Ac2O, MeOH
-15 oC – rt, 4 h
77%
H
N
HO OH
NHAcHOH
N
HO OH
NH2HO Ac2O, MeOH
-15 oC – rt, 5 h
65%
6
9
9
10
10
7 11
8 12
Scheme 4.1 Preparation of acetamides from amino-imino-hexitols 6–8
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4.3 Glycosidase Inhibition
The novel amino-imino-hexitols (6–8), their carbamate precursors (13, 14 and 15) and
acetamides (9–12), and the previously reported L-ido derivative (16)25 and carbamate
precursor (17) were then sent to the laboratory of Professor Stephen Withers for
kinetic studies against three chosen glycosidases. The compounds were tested for
their ability to inhibit human lysosomal β-D-glucocerebrosidase (GCase), N-acetyl-
β-D-hexosaminidase from Streptomyces plicatus (SpHEX) and β-D-glucosidase from
Agrobacterium sp. (ABG) (Table 4.1). ABG is a benchmark enzyme that libraries of
compounds have been tested against, to compare the kinetics of all azasugars evaluated
in the Withers laboratory.17–20
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Table 4.1 Glycosidase inhibition studiesa
Enzyme Amino-imino-hexitols
H
N
HO OH
NH2HO
.2HCl
16
H
N
HO OH
NH2HO
6
H
N
HO OH
NH2HO
.2HCl
7
H
N
HO OH
NH2HO
.2HCl
8
GCase 9 n.i.* n.i. n.i.*
SpHEX n.i. n.i. n.i. n.i.‡
ABG n.i.‡ n.i.‡ 0.006 1.1
N
HO OH
O
O
NH2
.HCl
17
N
HO OH
O
O
NH2
.HCl
13
N
HO OH
O
O
NH2
.HCl
14
N
HO OH
O
O
NH2
.HCl
15
GCase n.i.* n.i. n.i. n.i.
SpHEX n.i. n.i.‡ n.i.‡ n.i.‡
ABG n.i.‡ n.i.‡ 0.06 2.3
H
N
HO OH
NHAcHO
9
N
HO OH
NHAcHO Ac
10
H
N
HO OH
NHAcHO
11
H
N
HO OH
NHAcHO
12
GCase n.i.* n.i.* n.i.* n.i.*
SpHEX 0.5 n.i.‡ n.i.‡ 0.5
ABG 0.8 n.i.‡ 0.07 1.3
aKey: Ki values (mM) of compounds with GCase = β-D-glucocerebrosidase from human lysosome, SpHex = N-acetyl-β-D-hexosaminidase from
Streptomyces plicatus, ABG = β-D-glucosidase from Agrobacterium sp., n.i. = no inhibition was observed up to 10 mM inhibitor concentration, n.i.*
= no inhibition was observed up to 2 mM inhibitor concentration, n.i.‡ = no inhibition was observed up to 1 mM inhibitor concentration.
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Assays were performed in a similar manner for all three glycosidases tested to
determine the inhibition dissociation constant (Ki) for each amino-imino-hexitol.1
Kinetic experiments were run in 96-well plates at 37 ◦C comprising the purified
enzyme, the natural substrate as the p-nitrophenylglycoside27 (18) and the potential
azasugar inhibitor (19) being evaluated (Scheme 4.2). The concentrations of both
the substrate and inhibitor were varied independently for the glycosidase catalysed
reactions. Glycosidase activity rates, or enzyme velocity, were determined by measuring
the amount of p-nitrophenol (20) released by the hydrolysis of substrate 18 to the
hemiacetal product (21), as measured by its absorbance at 405 nm.28 The data gained
from the rate experiments provided information on the Ki value from initial analysis of
a linear plot of the inverse velocity against inhibitor concentration. Subsequent analysis
fit the data directly to the Michaelis-Menton equation, which describes the enzymatic
reaction in the presence of a competitive inhibitor.
O
HO
O
NO2 Glycosidase O
HO
OH
NO2
OH
N
H
H
HO
Substrate
Inhibitor18
19
21 20
Scheme 4.2 Schematic of a general enzymatic kinetic assay
As can be seen in Table 4.1, L-ido amine 16 exhibited weak selective inhibition of GCase
(Ki = 9 mM), the enzyme involved in Gaucher disease, however, this level of inhibition is
likely to be ineffective for any therapeutic effect. Changing the stereochemistry around
the pyrrolidine ring at C-2 and C-3 for D-galacto configured amine 6, resulted in a loss
of any glycosidase inhibitory activity (no inhibition observed up to 1, 2 and 10 mM
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concentrations). However, inverting the stereochemistry at C-5 for D-talo configured
amine 7 provided an azasugar with very good selective glycosidase inhibitory activity
for ABG (Ki = 0.006 mM), this may be due to the D-talo configuration being more
favourable for residing in the glycosidase active-site. With the opposite 2,5-trans-
configuration across the imino-ring for L-altro amine 8, selective inhibition of ABG
was also observed (Ki = 1.1 mM), however, with only moderate inhibition of the
enzyme.
The glycosidase inhibitory activity of the carbamate precursors follows a similar trend
to that observed with the respective amines. Thus, L-ido carbamate 17 and D-galacto
carbamate 13 showed no glycosidase inhibitory activity for any of the enzymes tested.
Furthermore, the D-talo carbamate 14 exhibited good selective inhibition of ABG (Ki =
0.06 mM), although it was an order of magnitude less potent than amine 7. Moderate
selective inhibitory activity was also observed for L-altro carbamate 15 (Ki = 2.3
mM).
Examining the glycosidase inhibitory activity of the N-acyl derivatives, it can be seen
that D-galacto acetamide 9 inhibits both SpHEX and ABG with a Ki of 0.5 mM and 0.8
mM, respectively. However, the addition of a second N-acyl group in bis-acetamide 10
resulted in loss of all glycosidase inhibitory activity. The D-talo acetamide 11 exhibited
good selective inhibitory activity for ABG (Ki = 0.07 mM), with a similar value to D-
talo carbamate 14, however, an order of magnitude less potent than D-talo amine 7. In
the case of L-altro acetamide 12 inhibitory activities were observed for both SpHEX and
ABG (Ki = 0.5 and 1.3 mM), similar to the inhibitory activities observed for acylated
amino-imino-hexitol 9. Given that the D-manno isomer of these compounds (3, refer
Fig. 4.2) has been shown to inhibit Jack bean N-acetyl-β-D-hexosaminidase (Ki = 1.9
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µm),12 it appears as though the functional group pattern around the pyrrolidine scaffold
is more important than stereochemistry for the inhibition of this enzyme.
Of the five compounds found to be selective ABG inhibitors, it is altogether sur-
prising that D-talo amine 7 had the most potent inhibitory activity as generally N-
acylated derivatives of amino-imino-hexitols are better inhibitors than their parent
compounds.16,18–26 Here, it should also be noted that more lipophilic N-substituted
derivatives generally exhibit improved inhibitory activity. For example, D-manno
acetamide 3 and amine 4 both exhibited a Ki of 0.025 mM against ABG,20 whereas N-
functionalised lipophilic D-manno derivatives, such as 5, showed potent inhibition in the
nanomolar range.18 In view of this, the preparation of lipophilic derivatives of the D-talo
scaffold has the potential to produce noteworthy glycosidase inhibitors. Moreover, our
amino-imino-hexitols have only been evaluated against a small range of glycosidases
and may well show inhibitory activity for other glycosyl hydrolytic enzymes, therefore
testing a broader range of glycosidase enzymes may be of interest.
4.4 Conclusion
In summary, we have synthesised four novel N-acylated amino-imino-hexitols in one
step from the amine precursors. A library of amino-imino-hexitols, including the N-acyl
derivatives has been evaluated for glycosidase inhibitory activity against three enzymes:
human lysosomal β-D-glucocerebrosidase (GCase), N-acetyl-β-D-hexosaminidase from
Streptomyces plicatus (SpHex), and β-D-glucosidase from Agrobacterium sp. (ABG).
Unfortunately, no good inhibitors were found for GCase, the glycosidase involved in
Gaucher disease. L-Ido amine 16 is unlikely to have any potential therapeutic effect
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as an active-site-specific chaperone (ASSC) for GCase, with a Ki of only 9 mM. In
the case of SpHEX, two inhibitors were identified with activity in the sub-millimolar
range. Both the D-galacto (9) and L-altro (12) isomers of the acylated amino-imino-
hexitols had inhibitory activities of 0.5 mM and in spite of the varied stereochemistry
around the pyrrolidine ring the acetamido moiety of the azasugar influences inhibitory
activity for SpHEX. Furthermore, several amino-imino-hexitol derivatives have shown
promising selective glycosidase activity against ABG (e.g. 7, 8, 14, and 11), with the D-
talo configuration exhibiting good selective inhibition of β-D-glucosidase. Moreover D-
talo amine 7 was found to be the most potent inhibitor in the micromolar range and may
show inhibitory activity for other types of glycosidases. In light of these findings, further
derivatisation of the D-talo scaffold has the potential to provide powerful glycosidase
inhibitors.
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4.5 Experimental
General Experimental
All chemicals obtained from commercial suppliers were used without further purifica-
tion. All solvents were removed by evaporation under reduced pressure. Reactions were
monitored by TLC analysis on silica gel coated plastic sheets (0.20 mm, Polygram SIL
G/UV254) with detection by coating with 20% H2SO4 in EtOH followed by charring
at ca. 150 ◦C, by coating with a solution of ninhydrin in EtOH followed by charring
at ca. 150 ◦C, or by coating with a solution of 5% KMnO4 and 1% NaIO4 in H2O
followed by heating. Column chromatography was performed on silica gel (40-63 µm).
High-resolution mass spectra were recorded on a Waters Q-TOF PremierTM Tandem
Mass Spectrometer using positive electro-spray ionisation. Nuclear magnetic resonance
spectra were recorded using a Varian Inova operating at 500 MHz for 1H and 125
MHz for 13C or a Varian Direct Drive operating at 600 MHz and 133 MHz. 1H and
13C chemical shifts (δ) were internally referenced to the residual solvent peak (D2O =
4.79 ppm for 1H). NMR peak assignments are based on 2D NMR experiments (COSY,
HSQC, and HMBC).
General Procedure for the Acetylation of Amino-imino-hexitols20 Amino-imino-
hexitol (0.05 mmol) was co-evaporated with dry toluene (0.5 mL) three times, placed
under argon and dissolved in dry MeOH (500 µL). Acetic anhydride (0.05 mmol) was
added to the solution at -15 ◦C. The solution was concentrated in vacuo when TLC
analysis (DCM/MeOH/EtOH/30% aq. NH3, 5/2/2/1, v/v/v/v) revealed the reaction was
complete. Purification was achieved using flash chromatography to provide the pure
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acetamides (DCM/MeOH, 5/1, v/v containing 1% of 30% aq. NH3).
H
N
HO OH
NHAcHO
6 1
2
34
5
1-Acetamido-1,2,5-trideoxy-2,5-imino-D-galactitol (9). By sub-
jecting imino-D-galactitol 6 (8.0 mg, 0.05 mmol) to the general procedure for the
acetylation of amino-imino-hexitols for 1 hour at -15 ◦C, acetamide 9 was obtained
as a colourless oil (4.0 mg, 0.02 mmol, 40%). Rf = 0.29 (DCM/MeOH/EtOH/30% aq.
NH3, 5/2/2/1, v/v/v/v); 1H NMR: (500 MHz, D2O, 20 ◦C) δ 4.48 (dd, J3,4 = 4.7, J2,3 =
6.3 Hz, 1H, H-3), 4.41 (t, J3,4 = J4,5 = 4.7 Hz, 1H, H-4), 3.94 (dd, J6a,6b = 12.2, J5,6a
= 4.5 Hz, 1H, H-6a), 3.87 (dd, J6a,6b = 12.2, J5,6b = 8.6 Hz, 1H, H-6b), 3.77–3.74 (m,
2H, H-2, H-5), 3.64 (dd, J1a,1b = 14.5, J1a,2 = 5.4 Hz, 1H, H-1a), 3.59 (dd, J1a,1b = 14.5,
J1b,2 = 7.8 Hz, 1H, H-1b), 2.00 (s, 3H, COCH3); 13C NMR: (125 MHz D2O, 20 ◦C) δ
175.2 (C=O), 69.9, 69.7 (C-3, C-4), 61.2, 59.4, 57.8 (C-2, C-5, C-6), 36.8 (C-1), 21.6
(COCH3). HRMS (ESI) m/z calcd. for [C8H17N2O4+H]+: 205.1183, obsd.: 205.1185.
N
HO OH
NHAcHO
6 1
2
34
5
Ac
1-Acetamido-1,2,5-trideoxy-2,5-acetimido-D-galactitol (10). By
subjecting imino-D-galactitol 6 (8.0 mg, 0.05 mmol) to the general procedure for the
acetylation of amino-imino-hexitols for 1 hour at -15 ◦C, bis-acetamide 10 was obtained
as a colourless oil and appeared as a 1:1 mixture of rotamers in the NMR spectra (2.0
mg, 0.008 mmol, 17%). Rf = 0.50 (DCM/MeOH/EtOH/30% aq. NH3, 5/2/2/1, v/v/v/v);
1H NMR: (500 MHz, D2O, 20 ◦C) δ 4.38 (dd, J4’,5’ = 6.3, J3’,4’ = 5.6 Hz, 1H, H-4’),
4.34 (dd, J4,5 = 7.6, J3,4 = 5.4 Hz, 1H, H-4), 4.27 (dd, J2,3 = 7.0, J3,4 = 5.4 Hz, 1H,
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H-3), 4.24 (dd, J2’,3’ = 3.0, J3’,4’ = 5.6 Hz, 1H, H-3’), 4.18–4.12 (m, 4H, H-2, H-2’,
H-5, H-5’), 3.89 (dd, J6a,6b = 12.2, J5,6a = 5.0 Hz, 1H, H-6a), 3.87 (dd, J6a’,6b’ = 11.5,
J5’,6a’ = 6.0 Hz, 1H, H-6a’), 3.81 (dd, J6a’,6b’ = 11.5, J5’,6b’ = 4.5 Hz, 1H, H-6b’), 3.79
( dd, J6a,6b = 12.2, J5,6b = 5.5, 1H, H-6b), 3.60 (dd, J1a,1b = 14.1, J1a,2 = 6.3 Hz, 1H,
H-1a), 3.57 (dd, J1a’,1b’ = 13.4, J1a’,2’ = 5.8 Hz, 1H, H-1a’), 3.50 (dd, J1a,1b = 14.1, J1b,2
= 6.3 Hz, 1H, H-1b), 3.48 (dd, J1a’,1b’ = 13.4, J1b’,2’ = 7,7 Hz, 1H, H-1b’), 2.12 (s, 3H,
NCOCH3), 2.11 (s, 3H, NCOCH3’), 1.97 (s, 3H, NHCOCH3), 1.94 (s, 3H, NHCOCH3’);
13C NMR: (125 MHz D2O, 20 ◦C) δ 175.1 (NC=O), 175.0 (NC=O’), 174.3 (NHC=O),
174.1 (NHC=O’), 70.3 (C-3), 70.2 (C-4), 70.1 (C-4’), 69.6 (C-3’), 62.2 (C-5), 61.1
(C-5’), 60.0 (C-2’), 59.3 (C-6), 59.0 (C-6’), 58.7 (C-2), 38.9 (C-1), 38.1 (C-1’), 21.8
(NHCOCH3), 21.8 (NHCOCH3’), 21.7 (NCOCH3), 21.2 (NCOCH3’). HRMS (ESI)
m/z calcd. for [C10H18N2O5+Na]+: 269.1108, obsd.: 269.1115.
H
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HO OH
NHAcHO
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1-Acetamido-1,2,5-trideoxy-2,5-imino-D-talitol (11). By subject-
ing imino-D-talitol dihydrochloride 7 (4.0 mg, 0.017 mmol) to the general procedure
for the acetylation of amino-imino-hexitols for 3 hours at -15 ◦C, then 1 hour at room
temperature, acetamide 11 was obtained as a colourless oil (2.0 mg, 0.009 mmol, 77%).
Rf = 0.30 (DCM/MeOH/EtOH/30% aq. NH3, 5/2/2/1, v/v/v/v); 1H NMR: (500 MHz,
D2O, 20 ◦C) δ 4.17 (t, J2,3 = J3,4 = 3.8 Hz, 1H, H-3), 4.11 (dd, J4,5 = 8.8, J3,4 = 3.8 Hz,
1H, H-4), 3.83 (dd, J6a,6b = 12.2, J5,6a = 3.5 Hz, 1H, H-6a), 3.71 (dd, J6a,6b = 12.2, J5,6b =
5.8 Hz, 1H, H-6b), 3.55–3.49 (m, 1H, H-1a), 3.45–3.36 (m, 3H, H-1b, H-2, H-5), 1.97
(s, 3H, COCH3); 13C NMR: (125 MHz D2O, 20 ◦C) δ 174.7 (C=O), 72.2, 71.0 (C-3,
C-4), 61.7, 59.9, 59.1 (C-2, C-5, C-6), 37.8 (C-1), 21.7 (COCH3). HRMS (ESI) m/z
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calcd. for [C8H17N2O4+H]+: 205.1183, obsd.: 205.1184.
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1-Acetamido-1,2,5-trideoxy-2,5-imino-L-altritol (12). By sub-
jecting imino-L-altritol dihydrochloride 8 (5.0 mg, 0.021 mmol) to the general procedure
for the acetylation of amino-imino-hexitols for 2 hours at -15 ◦C, then 3 hours at room
temperature, acetamide 12 was obtained as a colourless oil (2.6 mg, 0.013 mmol, 65%).
Rf = 0.31 (DCM/MeOH/EtOH/30% aq. NH3, 5/2/2/1, v/v/v/v); 1H NMR: (500 MHz,
D2O, 20 ◦C) δ 4.18 (t, J4,5 = J3,4 = 3.9 Hz, 1H, H-4), 3.98 (dd, J2,3 = 8.5, J3,4 = 3.9 Hz,
1H, H-3), 3.80 (dd, J6a,6b = 11.4, J5,6a = 6.8 Hz, 1H, H-6a), 3.66 (dd, J6a,6b = 11.4, J5,6b
= 6.8 Hz, 1H, H-6b), 3.47 (dd, J1a,1b = 14.1, J1a,2 = 4.4 Hz, 1H, H-1a), 3.41 (td, J5,6a =
J5,6b = 6.8, J4,5 = 3.9 Hz, 1H, H-5), 3.32 (dd, J1a,1b = 14.1, J1b,2 = 7.4 Hz, 1H, H-1b),
3.22–3.25 (m, 1H, H-2), 2.00 (s, 3H, COCH3); 174.9 (C=O), 74.5 (C-3), 71.3 (C-4),
60.0 (C-5), 59.7 (C-2), 59.6 (C-6), 41.1 (C-1), 21.7 (COCH3). HRMS (ESI) m/z calcd.
for [C8H17N2O4+H]+: 205.1183, obsd.: 205.1185.
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Chapter 5
Mechanistic Considerations and
Diastereoselectivity of the I2-mediated
Carbamate Annulation
5.1 Introduction
The I2-mediated carbamate annulation is highly diastereoselective in favour of 3,4-
and 4,5-cis-carbamates, (Scheme 5.1).1–5 Indeed, where R1 = H, only the 3,4-cis
isomer is observed.1–3 However, as illustrated in chapter three of this thesis, a
decrease in diastereoselectivity can be observed when R1 = CN.5 Given that the I2-
mediated carbamate annulation is paramount to our synthesis of amino-imino-hexitols,
we wanted to investigate the mechanism and reasons for the diastereoselectivity of the
reaction.
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3,4-cis, R = H,   R1 = H
4,5-cis, R = Bn, R1 = CN
Scheme 5.1 General scheme for I2-mediated carbamate annulation
5.2 Mechanistic Considerations
As a first step in understanding more about the mechanism of this annulation, it needed
to be determined whether the proposed primary iodide (e.g. 1, Scheme 5.2) was indeed
an intermediate in the reaction. Previous attempts to isolate the suspected iodoazasugar
intermediate in the protecting-group-free carbamate annulation had been unsuccessful1
(Chapter 1.3.3), however, when extending the I2-mediated carbamate annulation to the
synthesis of amino-imino-hexitols, we isolated the iodoamine, which was formed during
reactions to produce carbamate 2 (As highlighted in Chapter 2 and also illustrated in
Scheme 5.2 below).4 Here, alkenylamine syn-3 was treated with either NIS in DCM
or 1.2 equiv. of NaHCO3 and I2 in THF/H2O (1:1) to give iodoamine 1 in good (80%
yield). Subjection of iodide 1 to excess NaHCO3 then led to the smooth transformation
of 1 into carbamate 2, again in good (85%) yield. Having established that iodoamine
1 could be converted to carbamate 2, we then repeated the carbamate annulation and
through careful analysis by TLC, NMR spectroscopy and mass spectrometry, observed
that iodoamine 1 was formed en route to 2. This confirmed the role of iodoamine 1
as an intermediate formed in the I2-mediated carbamate annulation. Furthermore, as
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the formation of iodoamine 1 is irreversible, it is highly likely that this step determines
the diastereoselectivity of the reaction. These findings are also supported by literature
precedent whereby the reactions of alkenylamines with NaHCO3 (ca. 1–3 equiv.) and I2
are found to yield iodoamines.6–8 The diastereoselectivities of these literature iodamine
forming reactions are discussed further in Section 5.3.
BnO OBn
CN
H2N NIS, CH2Cl2
79%; or
I2, NaHCO3 
(1.2 equiv.)
THF:H2O (1:1), 80%
I2
 NaHCO3 (sat.)
THF:H2O (1:1)
85%
H
N CN
OBnBnO
I
N CN
OBnBnO
O
O
3 1 2
Scheme 5.2 Formation of iodoazasugar 1 en route to the synthesis of carbamate 2
Having established that an iodoamine is initially formed in the carbamate annulation,
the next question to address was the mechanism of CO2 addition. As discussed in
the introduction (Section 1.3.2), the source of CO2 has been shown to come from
the dissolution of NaHCO3 in H2O en route to the carbamate. To this end, we have
proposed three reaction pathways from the intermediate iodoamine (Scheme 5.3).9 The
first involves formation of an aziridine, which has been previously reported by Verhelst
et al.6 and also by Diaba and Bonjoch.10 Subsequent ring opening of the aziridine by
CO2 then provides the carbamate. The second pathway involves a carbonate as a key
intermediate, while the third proposed mechanism occurs via the formation of carbamic
acid, which subsequently cyclises with displacement of iodide.
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Scheme 5.3 Possible mechanisms for the carbamate annulation
To gain insight into the potential reaction pathways for the I2-mediated annulation, we
decided to synthesise aziridine 4 to determine if it was an intermediate en route to the
carbamate. To this end, iodoamine 1 was treated with Ag2CO3 (2 equiv.) to provide
aziridine 4 [Rf = 0.19 (hexanes/EtOAc, 1:1, v/v) in good (70%) yield, (Scheme 5.4).9
The structure of 4 was established by 2D (COSY, HSQC and HMBC) and 1D (1H and
13C) NMR in combination with high resolution mass spectrometry ([C20H20N2O2+Na]+
= 343.1416, full characterisation data can be found in the experimental section).
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rt, 20 h, 70%
H
N
BnO OBn
CN
I N
BnO OBn
CNH
1 4
Scheme 5.4 Formation of aziridine 4 from iodoamine 1
Analysis of these data revealed characteristic 1H NMR resonances, (Fig. 5.1) observed
at δ 1.87 (dd) and 1.76 ppm (dd), for the aziridine methylene protons 6A and 6B,
respectively, and δ 2.66 ppm (ddd) for the aziridine methine proton (H-5). The aziridine
methylene protons correlated in the HSQC to the upfield 13C NMR resonance at δ 30.2
ppm (C-6, Fig. 5.2), with the carbon signal for C-5 at δ 39.8. The nitrile carbon chemical
shift, observed at (13C NMR δ) 116.6 ppm, was confirmed by HMBC correlations to H-2
and H-3.
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Fig. 5.1 1H NMR spectrum for aziridine 4, (500 MHz, in CHCl3)
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Fig. 5.2 13C NMR spectrum for aziridine 4, (125 MHz, in CHCl3)
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Having formed aziridine 4, attempts were then made to convert 4 into carbamate 2 using
the previously disclosed carbamate annulation conditions (Scheme 5.5). Thus, aziridine
4 was treated with, a) excess NaHCO3 for seven days, b) for two days with the addition
of I2, and c) for eighteen days with the addition of KI; however in all cases, there was
no trace of the corresponding carbamate 2 by TLC or 1H NMR of the crude reaction
mixture and only starting material was observed. Failure to form the carbamate suggests
that the annulation does not occur via an aziridine intermediate (Pathway I, Scheme 5.3)
and that either the carbonate (Pathway II) or the carbamic acid (Pathway III) is formed
during the annulation. Literature precedent suggests that carbamic acids readily form
upon exposure of amines to CO211–13 and therefore an annulation mechanism involving
a carbamic acid seems most likely. That said, further experiments (such as determining
kinetic isotope effects (KIEs)) would need to be undertaken before any conclusion can
be made.
c) NaHCO3 (30 equiv.), I2 (2 equiv.)
X
KI (2 eq.),THF:H2O (1:1)
rt, 18 d
a) NaHCO3 (30 equiv.)
X
THF:H2O (1:1), rt, 7 d
b) NaHCO3 (30 equiv.), I2 (2 equiv.)
X
THF:H2O (1:1), rt, 2 d
N CN
BnO OBn
O
O
N
BnO OBn
CNH
4 2
Scheme 5.5 Attempted transformation of aziridine 5 into carbamate 6
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5.3 Diastereoselectivity
The high degree of diastereoselectivity observed in the I2-mediated carbamate annu-
lation reaction can be discussed by first considering the previous reactions to produce
3,4-cis-carbamates performed by Stocker, Timmer and co-workers,1–3 along with other
iodocyclisations from the literature, since we now know that an iodoamine is formed
as the key intermediate in the carbamate annulation. As illustrated (Table 5.1), the
stereochemistry at the allylic position exerts stereocontrol on the carbamate annulation
and this appears to be independent of stereochemistry at the homoallylic position (entries
1 and 2)1 or lack thereof (entry 3).3 As already discussed in the introduction (Chapter
1) the observed diastereoselectivities for the protecting-group-free annulations can be
explained by Stocker and Timmer2 via a transition state model originally proposed
by Chamberlin et al.14–16 and in line with theoretical studies by Gouverneur and co-
workers,17 where the cis-isomer is produced via the electronically favoured ‘O-in-plane’
envelope conformation that positions the allylic hydroxyl in plane with the double
bond.2 Similarly, 3,4-cis-diastereoselectivity has been observed for the halocyclisation
or amidomercuration of a number of N-substituted alkenylamines, including N-sulfonyl
(e.g., entry 4),7 N-t-butyloxycarbonyl,18 N-methoxycarbonyl (e.g., entry 5),19 and N-
benzyloxycarbonyl20 derivatives and although slight differences in diastereoselectivity
can be observed when changes to the solvent, reaction temperature, or choice of
iodinating reagent are made, the cis-isomer is the major product. Moreover, the reactions
presented in Table 5.1 show that iodocyclisations on alkenylamines without an α-amine
substituent give predominantly 3,4-cis-products.
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Table 5.1 cis-Diastereoselectivity of previous carbamate annulations from Stocker and
Timmer and other iodocyclisations from the literature
Entry Alkenylamine Cyclic producta dr(cis/trans)
Yield
(%)
1
OH
OH
NH2
N
HO OH
O
O
>95:5 991
2
OH
OH
NH2
N
HO OH
O
O
>95:5 991
3
OH
NH2
N
HO
O
O
>95:5 903
4
OH
NHSO2Tol
N
HO
I SO2Tol
96:4 867
5
OH
NHCO2Me
N
HO
I CO2Me
93:7 8319
aReactions performed via I2-mediated cyclisation in the presence of NaHCO3
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When the carbamate annulation methodology was applied during the synthesis of amino-
imino-hexitols (Chapter 3), however, a decrease in diastereoselectivity was observed in
a couple of instances. As illustrated (Table 5.2), the D-ribose derived major Strecker
product, aminonitrile syn-5, gave a mixture of diastereomers (4:1, cis/trans, entry
1), while the minor Strecker product α-aminonitrile anti-6 led to exclusive formation
of one diastereomer, (entry 2).5 However, for the carbamate annulation of the D-
arabinose derived α-aminonitriles, the major Strecker product syn-3 provided the 4,5-
cis-product exclusively (entry 3),4 whereas a mixture of diastereomers was produced in
the annulation of anti-7 (6:1, cis/trans, entry 4).5 To explain the diastereoselectivities
observed in the carbamate annulation of these alkenylamines, possessing a nitrile
substituent α to the amine, the transition states for the formation of the observed
carbamates need to be considered. Therefore, we propose a transition state model that
builds on Stocker and Timmer’s original model for the protecting-group-free carbamate
annulation2 where attack of the internal-nucleophile on the I2-alkene complex takes
place via a 5-membered ring transition state in which the nitrogen approaches the
double bond in an envelope conformation and follows a Bu¨rgi-Dunitz-like trajectory.21
However, unlike the earlier model, the effect of the α-amine substituent on the transition
states can also be considered. (A computational investigation of iodocyclisation
transition states is presented in Chapter 6).
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Table 5.2 Diastereoselectivity of carbamate annulations presented in this thesis
Entry Alkenylamine Cyclic producta dr(cis/trans)
Yield
(%)
1
OBn
BnO
CN
NH2
syn- 5
N CN
BnO OBn
O
O
N CN
BnO OBn
O
O
+
8 9
4:1 855
2
OBn
BnO
CN
NH2
anti- 6
N CN
BnO OBn
O
O
10
>95:5 535
3
OBn
BnO
CN
NH2
syn-3
N CN
BnO OBn
O
O
2
>95:5 854
4
OBn
BnO
CN
NH2
anti- 7
N CN
BnO OBn
O
O
N CN
BnO OBn
O
O
+
11 12
6:1 955
aReactions performed via I2-mediated cyclisation in the presence of NaHCO3
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In the case of the cyclisation of the D-ribose-derived Strecker product syn-5 (Fig. 5.3),
the benzyloxy substituent on the ring (depicted in blue) can be positioned either in
the plane of the double bond (A, OBn-in-plane), or almost perpendicular to that plane
(B, H-in-plane). Of these two transition states, A, which ultimately leads to the major
carbamate 8, has minimal overlap between the electron-withdrawing σ∗C–O and reacting
piC=C orbitals, thereby resulting in a lower energy transition state. In contrast, transition
state B has overlapping benzyloxy σ∗C–O and double bond piC=C orbitals, which results
in the removal of electron density from the pi-bond and a higher energy transition state.
Similarly, one can view the more favourable transition state (A) as having the C–O
bond in the plane of the olefin to minimise unfavourable electrostatic interactions.22
At this point, however, the influence of the nitrile substituent on the transition state
also needs to be considered. In A, the dihedral angle between the plane of the nitrile
dipole and the lone pair of electrons on the amine is approximately 180◦ (depicted in
green). This results in electron density being withdrawn from the nitrogen nucleophile
thus raising the transition state energy of conformer A. In contrast, the dihedral angle
between the nitrogen dipole and the lone pair of electrons of the amine in transition state
B is approximately 90◦ and thus has less of a negative influence on the nucleophilicity
of the amine. Accordingly, the transition states for A and B become closer in energy and
some of the trans-carbamate product 9 is also formed in the cyclisation.
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C OBn-in-plane
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D H-in-plane
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H
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H
H
H
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Fig. 5.3 Proposed transitions states leading to the formation of carbamate 8 (A, major product) and 9 (B, minor product)
from alkenylamine syn-5 and the formation of carbamate (10) (C) from alkenylamine anti-6
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When considering the formation of carbamate 10 from the anti-α-aminonitrile 6
(Fig. 5.3), similar transition states can be drawn with the benzyloxy substituent in the
plane of the double bond (C, OBn-in-plane, lower energy TS), or almost perpendicular
to that plane (D, H-in-plane, higher energy TS). In addition, the nitrile group in transition
state C does not reduce the nucleophilicity of the amine, while in transition state D the
nitrile dipole leads to electron density being withdrawn from the amine through n–σ∗CCN
overlap. For this reason, there is a large energy difference between the two transition
states and carbamate 10 (from C) is the only product observed.
Similar analyses can also be used when explaining the observed diastereoselectivity of
the carbamate annulation for the D-arabinose derived alkenylamines, syn-3 and anti-7
(Fig. 5.4). Here, as for the ribose derivatives (refer Fig. 5.3), there are two influences on
the transition state energy of the cyclisation. Thus, for the major Strecker product syn-3,
the electronically preferred transition state (E, OBn-in-plane, lower energy TS) leads to
the only carbamate observed (2), as the dihedral angle of the nitrile substituent is also
favourable (90◦), compared with the least preferred conformer (F, 180◦, H-in-plane,
higher energy TS) where the nitrile dipole reduces the nucleophilicity of the amine.
However, in the cyclisation of alkenylamine anti-7 the two transition states are closer
in energy, as the preferred conformation (G, OBn-in-plane → 11) has reduced amine
nucleophilicity due to the dihedral angle of the nitrile dipole (180◦, compared to the
least preferred conformer (H, 90◦, H-in-plane→ 12) where the nitrile dipole has limited
electron withdrawing influence on the nucleophile. Furthermore, we can not rule out
that the trans-products being preferred in the carbamate annulation are not due to the
steric influence of the nitrile group positioned α to the amine, during the iodocyclisation
of both arabinose derived anti-7 and ribose derived syn-5.
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Fig. 5.4 Proposed transitions states leading to the formation of carbamate 2 (E) from alkenylamine syn-3 and the formation
of carbamates (11) (G, major product) and 12 (H, minor product) from alkenylamine anti-7
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The reduced cis-diastereoselectivity observed in the carbamate annulations of α-
aminonitriles can also be rationalised by examining the literature for iodocyclisations
performed on alkenylamines with a substituent at the α-amine position. There are
not many examples, however, Davies et al.8 illustrated (Table 5.3) that the presence
of a CH2CO2tBu group α to the amine influences the stereochemical outcome of
iodoaminocyclisations. Though the 4,5-cis product is the major diastereomer following
concomitant N-debenzylation (entry 1), the relative stereochemistry of the chiral-
auxiliary and α-amine position can reduce, or even reverse, this selectivity. This cis-
selectivity is thought to occur via the rapid equilibriation of the two diastereomeric
iodonium ions and subsequent cyclisation as the rate-determining step. Surpris-
ingly, halocyclisation or amidomercuration of a per-O-benzylated N-benzyloxycarbonyl
protected alkenylamine derived from D-arabinose, however, resulted in preferential
formation of the 4,5-trans-diastereomer (entry 2).23 This trans-selectivity was attributed
to the differential steric requirements in the transition states, and may reflect the
added steric-considerations that need to be taken into account when an alkenylamine
possesses both an α-amine substituent and an N-protecting group.23,24 For example,
O-cyclisation of a similar system (where NHCbz is replaced by OH) gives the cis-
diastereomer preferentially (9:1, cis/trans)25 Moreover, a substituent at the α-amine
position of alkenylamines has been shown to influence the stereochemical outcome
of the carbamate annulation, and may reduce the high cis-diastereoselectivity of the
iodocyclisation.
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Table 5.3 Diastereoselectivity of literature halocyclisations with alkenylamines
possessing an α-amino substituent
Entry Alkenylamine Cyclic producta dr(cis/trans)
Yield
(%)
1
CO2tBuNPh
Ph
OO
N
O O
+
Bn CO2tBuI
N
O O
Bn CO2tBuI
3:1 808
2
CbzHN
OBnBnO
OBn N
BnO OBn
Cbz OBnI
<5:95 5023
aEntry 1 performed via I2-mediated cyclisation in the presence of NaHCO3; entry 2 performed via
NIS-mediated cyclisation in the presence of HMPA
5.4 Conclusion
The mechanism of the I2-mediated carbamate annulation has been investigated. An
aziridine (4) was formed from the intermediate iodoamine (1) isolated en route to the
formation of the carbamate (2). Subsequent attempts to form the carbamate (2) from the
aziridine (4) were unsuccessful, which suggests that an aziridine is not an intermediate
during the annulation. The diastereoselectivity of the I2-mediated carbamate annulations
of α-aminonitriles derived from D-ribose (syn-5 and anti-6) and D-arabinose (syn-3
and anti-7) have been considered. Comparisons to the previous carbamate annulations
from Stocker and Timmer, along with halocyclisations or amidomercurations from
the literature have been drawn, where it was revealed that alkenylamines without
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a substituent at the α-amine position have a high degree of cis-diastereoselectivity.
Furthermore, alkenylamines possessing an α-amino substituent can reduce or even
reverse the 4,5-cis-diastereoselectivity, particularly in the presence of an N-protecting
group. Moreover, transition states for the iodocyclisation of the α-aminonitriles have
been postulated based on a preferred ‘O-in-plane’ conformation, and to reflect the
influence of the nitrile substituent on the diastereoselectivity of the reaction. Here, it
was proposed that D-ribose derived syn-aminonitrile 5 and D-arabinose derived anti-
aminonitrile 7 both had reduced cis-selectivity due to the negative effect of the nitrile
dipole on the nucleophile in the O-in-plane’ conformation. As a result, the ‘H-in-plane’
becomes relatively less disfavoured, thereby lowering the energy of the TS and leading
to some of the trans-product being observed.
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5.5 Experimental
General Experimental
All chemicals obtained from commercial suppliers were used without further purifica-
tion. All solvents were removed by evaporation under reduced pressure. Reactions were
monitored by TLC analysis on silica gel coated plastic sheets (0.20 mm, Polygram SIL
G/UV254) with detection by coating with 20% H2SO4 in EtOH followed by charring
at ca. 150 ◦C, or by coating with a solution of 5% KMnO4 and 1% NaIO4 in H2O
followed by heating. Column chromatography was performed on silica gel (40-63 µm).
High-resolution mass spectra were recorded on a Waters Q-TOF PremierTM Tandem
Mass Spectrometer using positive electro-spray ionisation. Nuclear magnetic resonance
spectra were measured using a Varian Inova operating at 500 MHz for 1H and 125 MHz
for 13C or a Varian Direct Drive operating at 600 MHz and 133 MHz. 1H and 13C
chemical shifts (δ) were internally referenced to the residual solvent peak, (CDCl3 =
7.26 ppm and 77.16 ppm). NMR peak assignments are based on 2D NMR experiments
(COSY, HSQC, and HMBC).
N
BnO OBn
CNH
1
2
3
4
5
6
(2S,3R,4R,5S)-1-Aza-2-cyano-3,4-dibenzyloxybicyclo[3.1.0]hexane (4).
To a solution of iodoamine 1 (113 mg, 0.25 mmol) in THF (2.5 mL), under an argon
atmosphere, was added Ag2CO3 (137 mg, 0.50 mmol). The resulting reaction mixture
was stirred at room temperature for 20 h then filtered through a celite plug and washed
with EtOAc. The filtrate was washed with H2O and brine, dried (MgSO4), filtered and
concentrated in vacuo. Purification was achieved using gradient flash chromatography
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(hexanes/EtOAc, 20/1→ 1/1, v/v) to provide aziridine 4 as a colourless oil (57 mg, 0.17
mmol, 70%). Rf = 0.19 (hexanes/EtOAc, 1/1, v/v); 1H NMR: (500 MHz, CDCl3, 20 ◦C)
δ 7.39–7.31 (m, 10H, H-Ar), 4.64 (s, 2H, CH2 4-O-Bn), 4.62 (d, 2Ja,b = 11.8 Hz, 1H,
CHa 3-O-Bn), 4.59 (d, 2Ja,b = 11.8 Hz, 1H, CHb 3-O-Bn), 4.54 (t, J3,4 = J4,5 = 5.1 Hz,
1H, H-4), 4.02 (d, J2,3 = 6.8 Hz, 1H, H-2), 3.96 (dd, J2,3 = 6.8, J3,4 = 5.1 Hz, 1H, H-3),
2.66 (ddd, J5,6a = 5.4, J4,5 = 5.1, J5,6b = 3.6 Hz, 1H, H-5), 1.87 (dd, J5,6a = 5.5, J6a,6b = 1.5
Hz, 1H, H-6a), 1.76 (dd, J5,6b = 3.6, J6a,6b = 1.5 Hz, 1H, H-6b); 13C NMR: (125 MHz
CDCl3, 20 ◦C) δ 137.7 (C-i 4-O-Bn), 136.9 (C-i 3-O-Bn), 128.73 (C-Ar), 128.72 (C-
Ar), 128.4 (C-Ar), 128.27 (C-Ar), 128.25 (C-Ar), 128.0 (C-Ar), 116.6 (CN), 82.9 (C-4),
81.1 (C-3), 73.2 (CH2 3-O-Bn), 72.8 (CH2 4-O-Bn), 56.9 (C-2), 39.8 (C-5), 30.2 (C-6);
HRMS (ESI) m/z calcd. for [C20H20N2O2+Na]+: 343.1417, obsd.: 343.1416.
Protocol for Attempted Conversion of Aziridine (4) into Carbamate (2). To a
solution of aziridine 4 (6.0 mg, 0.018 mmol) in THF (0.25 mL), was added H2O (0.25
mL) and NaHCO3 (50.0 mg, 0.60 mmol). The reaction mixture was left to stir at
room temperature for seven days, at this point TLC analysis indicated only starting
material present (aziridine 4 Rf = 0.27 [hexanes/EtOAc, 1/2, v/v], carbamate 2 Rf = 0.50
[hexanes/EtOAc, 1/2, v/v]). Upon addition of I2 (10.2 mg, 0.04 mmol) the reaction
mixture was stirred for a further two days, again with only starting material indicated by
TLC analysis. To further attempt reproduction of the I2-mediated carbamate annulation
conditions, KI (6.6 mg, 0.04 mmol) was added. The reaction mixture was stirred at room
temperature for a further 18 days, then quenched with sat. aq. Na2S2O3 and extracted
with EtOAc. The organic layer was washed with H2O and brine, dried (MgSO4), filtered
and concentrated in vacuo to obtain aziridine 4 as the only isolated compound according
to 1H NMR analysis of the crude material.
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Chapter 6
Theoretical Studies of the I2-mediated
Carbamate Annulation
6.1 Introduction
The remarkable diastereoselectivity of the I2-mediated carbamate annulation of alkenyl-
amines makes this an important reaction for the synthesis of azasugars. Gaining further
understanding of the diastereoselectivity could allow the prediction of outcomes for
future carbamate annulations with structurally diverse alkenylamines. This information
could then lead to improved design of synthetic routes for the preparation of azasugars.
As such, we decided to perform a theoretical investigation of the carbamate annulation
using computational modelling to explore the factors governing the diastereoselectivity
of the reaction. Previously we have established that the initial iodocyclisation of
alkenylamines en route to the formation of carbamates is the key stereoselective step in
the I2-mediated carbamate annulation (discussed in Chapter 5). For example, iodoamine
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1 (Scheme 6.1) was isolated from the cyclisation of alkenylamine 2 with I2 and NaHCO3
and then subsequently transformed into carbamate 3 under those same carbamate
annulation conditions.1,2 Therefore, we wanted to use density functional theory (DFT) to
find transition states (TSs) for the possible stereoisomers formed in the iodocyclisation
of a variety of alkenylamines.
I2, NaHCO3 
THF:H2O (1:1) 
80%
I2, NaHCO3 
THF:H2O (1:1)
85%
H
N CN
OBnBnO
I
N CN
OBnBnO
O
O
OBn
BnO
CN
NH2
2 1 3
Scheme 6.1 Isolation of iodoamine 4 en route to the formation of carbamate 3
The analysis of previous experimental halocyclisations to form iodolactones by Cham-
berlin and co-workers,3 showed that they were under kinetic rather than thermodynamic
control to provide the cis-cyclic products. Further work by Chamberlin, Hehre, and co-
workers,4–6 centred on developing reactivity models by assessing the stereoselectivity of
electrophilic cyclisations. They considered the relative affinities of diastereotopic olefin
faces toward a test electrophile (H+) using DFT calculations. The proposed reactivity
models of the electrophilic halocyclisations of acyclic allylic alcohols and ethers suggest
that there are two lowest energy conformations that can lead to the two cis and trans
cyclic products: one conformation where the electrophile attacks syn to H in an ‘O-in-
plane’ conformation (A, Fig. 6.1), and one where the electrophile attacks syn to OH in
an ‘H-in-plane conformation’ (B).6 These models provide an indication of which face of
an allylic pi bond will be attacked by an electrophile in a kinetically controlled addition
reaction.
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H
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H
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H
H
H
A O-in-plane      cis B H-in-plane      trans
E
E
Fig. 6.1 Preferred conformers for electrophilic attack of an olefin
Furthermore, empirical data suggested that electrophilic attack on an acyclic allylic
alcohol or ether with an internal nucleophile preferred the ‘O-in-plane’ conformer, (A)
to give the major cis-cyclic product.5,6 In this conformation the internal nucleophile
was constrained to be in a position for backside attack on the (activated) pi bond.
However, attack on the less abundant ‘H-in-plane’ conformer gave rise to the minor
trans-diastereomer. An example is shown in Scheme 6.2, where iodolactonisation of
hydroxyacid 4 produced the cis-iodolactone 5 in ca. 20:1 selectivity via the ‘O-in-plane’
conformer. These findings were the reverse of the diastereoselectivity observed when
there was an external nucleophile, such as in the reaction of alcohol 6 with I2 and water
to form iodohydrin 7.
O O
HO
HO
O OH
I
H
I2
cis, 95%
`O-in-plane' TS
R
OH I2, H2O
syn, 99%
`H-in-plane' TS
R
OH
I
OH
4 5
6 7
Scheme 6.2 Iodolactonisation compared with iodohydrin formation
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It was believed that for halocyclisations the initially formed, favoured (‘O-in-plane’) I2-
pi complex was trapped by an internal nucleophile before collapse or as it collapsed to an
energetically unfavourable iodonium ion. However, when no internal nucleophile was
present, as for haloadditions, the reaction would proceed through to an iodonium ion TS
and the initial ‘O-in-plane’ conformation would change to that favoured by repositioning
the allylic OH syn to the iodonium ion (D, Fig. 6.2 or ‘H-in-plane’).
R
D Most preferred      transC Least preferred      cis
HO
H
H3C
XR
H
CH3
HO
X
Fig. 6.2 Lowest energy conformers for simple onium ion TSs
Chamberlin argued that the reason for the difference in the observed diastereoselectiv-
ities for the halocyclisation vs. haloaddition of allylic alcohols was due to a change in the
rate determining step (rds) of the reaction, i.e., pi-complex trapping for cyclisations vs.
onium ion formation for additions.6 Thus, the difference in rds would alter the position
of the transition state along the reaction coordinate, presuming an ‘early’ reactant-type
TS for the electrophile-pi complex and ‘late’ product-type TS for onium ion formation.
The change in TS timing would then affect which face of the pi bond preferentially reacts
with the electrophile. These postulations were based on calculations of simple onium ion
TSs, where the lowest energy conformers for the two diastereomers, C and D, positioned
the hydroxyl syn to the halogen. This was presumed to be due to the stabilising effect
of the oxygen electron pair on the developing positive charge in the TSs. Here, the
lowest energy onium ion conformation (D) resembled the ‘H-in-plane’ TS, seen in the
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formation of iodohydrin 7. However, conformation C, which resembled the ‘O-in-
plane’ TS after C2-C3 bond rotation, was higher in energy due to the unfavourable steric
interactions of the methyl group and alkyl chain.
More recently, work by Gouverneur and co-workers investigated the directing abilities
of allylic fluorides on the diastereoselectivity of iodolactone formation (Scheme 6.3).7
Here, they found that a series of allylic fluorides (8a-c) provided the cis iodolactones
(9a-c) as the predominant diastereomers upon iodocyclisation with I2 and NaHCO3.
Furthermore, they investigated this effect using DFT to determine the role of fluorine in
the excellent diastereoselectivities observed.
I2, NaHCO3 
DCM/H2O  
 dr >20:1, 24-95%
O O
R1F
I
R1
F
OH
O
R
R
a R = H, R1 = Bn
b R = H, R1 = H
c R = Me, R1 = Me
a R = H, R1 = Bn
b R = H, R1 = H
c R = Me, R1 = Me8
8
8
9
9
9
Scheme 6.3 Iodocyclisation of allylic fluorides
Calculations were made of an unsubstituted iodonium ion (I, Fig. 6.3) to discover
that the iodonium complex was somewhere between an iodonium ion and iodonium-
pi complex, with bond lengths for C–C of 1.44 A˚, and C–I of 2.29 A˚.8 They then made
calculations of the rotamers of an iodonium ion substituted with a fluoromethyl group
and discovered that the fluorine substituent prefers to sit inside (II) by 12.55 kJ mol-1
with respect to outside, and 20.92 kJ mol-1 with respect to the anti conformer. They
also looked at the TS of I2-pi complexes of 2-fluorobut-3-ene with an external formate
nucleophile. Here, they found that the rotamers where the fluoro group was inside with
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the methyl group either outside (III) or anti were equal in energy. These isomers, with
the fluorine substituent inside, were preferred versus outside by 4.2 kJ mol-1 and anti by
12.6 kJ mol-1. Finally they found TS structures for the iodoetherification of an allylic
fluoride containing an internal alcohol nucleophile. The minimum energy structures
were those with the conformation needed for backside nucleophilic attack of the I2-pi
complex. Here, the structure with fluorine inside (IV) was 8.78 kJ mol-1 more favoured
than the conformer with the fluorine outside (V). In both cases the rest of the molecule
sat anti to the I2-pi complex.
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2.292.29
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δ−δ−
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Fig. 6.3 Preferred TS conformations of fluorine substituted iodonium complexes
Gouverneur proposed that an anti fluorine substituent (F, Fig. 6.4) was energetically
disfavoured as this position aligns the σ*C–F orbital with one of the C–I bonds, having
a destabilising effect on the I2-pi-complex. However, the preferred inside fluorine
substituent position (E) would minimise the σ*C–F orbital and C–I bond interactions.
The fluorine inside would also enable its lone pairs of electrons to have a stabilising
152
effect on the partial positive charge of the I2-pi-complex.
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H
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I
Fig. 6.4 Preferred inside fluorine conformation (E) and disfavoured anti fluorine
conformation (F)
The work presented in this chapter builds on past computational models of the
halocyclisations to form furans from work by Chamberlin et al.3,4,6 and Gouverneur
and co-workers.7 Our aim was to determine the differences in transition state energy
or structure that could account for the high cis-selectivity observed in the I2-mediated
carbamate annulation. We also wanted to refine our previous TS model,9 which
postulated about the effects of the dipole interactions of a nitrile substituent at the α-
amine position on the amine nucleophile of alkenylamines in I2-mediated carbamate
annulations (see Chapter 5).
6.2 Computational Methods
All calculations were performed with the programme package Gaussian09, Rev B.01,10
using density functional theory (DFT) with the B3LYP11 density functional and the
LANL2DZ12 basis set. B3LYP with the LANL2DZ basis set has been shown to
effectively model the geometries and energies of compounds that contain iodine.13,14
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Geometrically optimised structures were confirmed using frequency calculations, where
minima must have no imaginary frequencies and transition states exactly one imaginary
frequency. The found transition states were verified by performing an intrinsic reaction
coordinate calculation (IRC)15 with subsequent optimisation to the preceding and
following minima. The electronic structures of stationary points were also analysed
by the natural bond order (NBO) method.16
6.3 DFT Calculations of Iodocyclisations
To determine what factors govern the transition state energies that lead to the stereo-
selectivity in the iodocyclisations, a number of linear alkenylamine structures possessing
allylic-directing groups were used as starting points in the calculations (Table 6.1). We
wanted to explore the scope of the carbamate annulations with and without protecting
groups and α-amine substituents, and to compare with the previous computational
halocyclisation models.3,4,6,7 Here, we chose to analyse the carbamate annulation of
three alkenylamines with a methylene group α to the amine; the diol derived from D-
ribose (10→ 11),17 the alcohol from 2-deoxy-D-ribose (12→ 13)18 and the methyl ether
from 2-deoxy-D-ribose (14→ 15). To ascertain the influence of the α-amine position on
carbamate annulation diastereoselectivity, we chose to investigate the iodocyclisations
of both the syn- (2 → 3) and anti- (16 → 17 and 18) α-aminonitriles possessing
benzyl ether protecting groups. For all of the alkenylamines in Table 6.1 we used
density functional theory to calculate the optimised geometries corresponding to starting
material, iodine complexes, transitions states and products along the reaction coordinate
of the initial iodocyclisation en route to the formation of carbamates. For ease of
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comparison of all the different structural alkenylamines the atom numbering has been
changed for this Chapter. The numbering starts at 1 for the nitrogen atom and moves
down the carbon chain ending at 6.
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Table 6.1 Diastereoselectivity of iodocyclisations observed experimentally
Alkenylamine Cyclic producta dr
b
(cis/trans)
Yield
(%)
OH
OH
NH2
10
N
HO OH
O
O
11
>95:5 9917
OH
NH2
12
N
HO
O
O
13
>95:5 9018
OMe
NH2
14
N
MeO
O
O
15
>95:5 75
OBn
BnO
CN
NH2
2
N CN
BnO OBn
O
O
3
>95:5 851
OBn
BnO
CN
NH2
16
N CN
BnO OBn
O
O
N CN
BnO OBn
O
O
+
17 18
6:1 959
aReactions performed via I2-mediated cyclisation in the presence of NaHCO3
bAs determined from analysis of the crude reaction mixture by 1H NMR spectroscopy.
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6.3.1 Alkenylamines Possessing an α-Amine Methylene
The iodocyclisation reaction profile of D-ribose derived alkenylamine (10, Scheme 6.4)
plots the electronic energies (∆Eelec) of the optimised geometries relative to the starting
materials, alkenylamine 10 and I2. Here, the reaction proceeds with an exothermic
process upon complexation of I2 to the alkene pi-bond (IC-1 -26.65 kJ mol-1 and
IC-2 -19.41 kJ mol-1). The two iodine complexes, IC-1 and IC-2 exist in a pre-
equilibrium, favouring I2 approach to the Re-face of the alkene over Si-face approach,
before passing through the transition states, cis TS-1 and trans TS-2, which lead
to the diastereomeric iodoamines cis P-1 (experimentally observed) and trans P-2
(experimentally not observed). The activation energy of TS-1 (33.55 kJ mol-1) was
11.16 kJ mol-1 less than that of TS-2 (44.71 kJ mol-1). Interestingly, the cis iodoamine
P-1, (-10.02 kJ mol-1) leading to the observed carbamate, (11) was 9.86 kJ mol-1 less
stable than the trans iodoamine P-2 (-19.88 kJ mol-1). It was also found that the
difference in transition state electronic energy between the cis T-1 (6.89 kJ mol-1)
and trans T-2 (25.30 kJ mol-1) was significant at 18.40 kJ mol-1. We found the
relative Gibb’s free energies from the frequency calculations of TS-1 and TS-2, where
∆G = ∆Eelec + ∆Evib + ∆Erot + ∆Etrans. The value of ∆G was then related to the
equilibrium constant (∆G = −RTlnK) to find the theoretical diastereomeric product
distribution of the iodoamines P-1 and P-2, (cis/trans, Table 6.2). It was found that
the theoretical diastereoselectivity was higher than the detectable experimental value of
>95:5 in favour of the 4,5-cis-carbamate 11.
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Table 6.2 Relative transition-state Gibbs energies (kJ mol-1) and diastereoselectivities
in the iodocyclisation of alkenylamine 10
Transition State ∆Gab (kJ mol-1) dra (%) drc (%)
TS-1 cis 0.00 99.7 >95.0
TS-2 trans 14.05 0.3 <5.0
aB3LYP/LANL2DZ
bRelative to the cis TS
cExperimental results
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Scheme 6.4 Reaction coordinate of the iodocylisation of alkenylamine 10 to form iodoamines cis P-1 and trans P-2.
Energy (kJ mol-1) is shown relative to alkenylamine 10
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The optimised 3D TS structures, cis TS-1 (a) and trans TS-2 (c) depict the calculated
bond lengths of nucleophile approach and I2-pi-complex in Fig. 6.5. Here, Newman
projections of cis (b) and trans (d) TSs show a view down the C5–C4 bond to depict
the calculated dihedral angles of both the allylic hydroxyl (C6C5C4O(H), in red) and
hydrogen (C6C5C4H, in black) to the C5–C6 bond, and the line of nucleophilic approach
to the allylic hydroxyl (N1C5C4O(H), in blue). The transition state structures (TS-1
and TS-2) both possess an I2-pi complex rather than an iodonium ion, as postulated by
Chamberlin6 and found by Gouverneur.7 However, there is a degree of pyramidalisation
in the C5–C6 olefin. The I2–C5–C6 bond lengths have progressed from the initial I2-pi
complexes (IC-1 and IC-2) to a more asymmetric system in which the I–C6 and N1–C5
bonds are forming, and I–I bond lengthening, suggestive of product-like (late) transition
states. Furthermore, the amine nucleophile (N1) approaches C5 of the I2-pi-complex from
either the Si-face to give a cis-TS, or the Re-face to give the trans-TS. The difference in
the calculated distances between TS-1 and TS-2 is small, however, cis-TS-1 is a slightly
earlier TS due to the longer N1–C5 nucleophile approach (1.927 A˚ vs 1.902 A˚), longer
I–C6 distance (2.558 A˚ vs 2.531 A˚) and shorter lengthening C5–C6 bond (1.436 A˚ vs
1.442 A˚), where the uncoordinated alkene is 1.348 A˚. Both of the TSs position the allylic
hydroxyl (C4–OH) in plane with the C5–C6 bond, however, in TS-1 C4-OH is cis with
a small dihedral angle (5.8◦, (b)), whereas in TS-2 the C4-OH is trans with respect to
C5–C6 (176.2◦, (d)). The allylic hydrogen (C4–H) is also positioned out of the plane by
116.8◦, (TS-1) and 55.4◦, (TS-2).
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Fig. 6.5 Calculated transition-state structures for the iodocyclisation of alkenylamine
10 en route to the formation of carbamate 11. Newman projections show dihedral
angles of C6C5C4O(H) (‘O-in-plane’, in red), C6C5C4H (‘H-in-plane’, in black) and
the N1C5C4O(H) (in blue). [Distances in A˚, angles in deg.]
What appears to account for the significant energy difference between the cis and trans
TSs is the position of C4-OH inside (TS-1) vs outside (TS-2) or the ‘inside-alkoxy
effect’.7 Interestingly, both the cis and trans optimised TS structures sit in an envelope
conformation that positions the nucleophile in such a way that the line of attack (N1–C5)
has an approximate 90◦ dihedral angle with the allylic directing C4–OH (N1C5C4O(H)
= 116.7◦ (b) and 66.9◦ (d)). The constraint of this envelope conformation also allows
for backside attack of the amine on C5 of the expanded I2-pi-complex with an attack
angle of ca. 113◦.19 Alternatively the 5-membered TS envelopes could be conformed in
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such a way that the N1C5C4O(H) dihedral angle was approximately 180◦ and still allow
for backside nucleophilic attack. The reason for the approximately 90◦ N1C5C4O(H)
dihedral angle could be due to the need to limit the interaction of the dipoles by
positioning the partial negative lone pair of electrons on the amine perpendicular to
the lone pair of electrons on the allylic oxygen.
A single point calculation with Natural Bond Orbital (NBO) analysis was performed on
both TS structures, TS-1 ((a), Fig. 6.6) and TS-2 (b), to determine the effect the relative
position the allylic-OH has on the electronic nature of the transition states. In the cis
TS-1 the calculated electron withdrawing allylic σ*C4–OH orbital has minimal overlap
with the newly forming N1–C5 bond and lone pair of electrons on C6; the late stages of
the I2-pi-complex. This is also the case for the allylic σ*C4–OH orbital in the trans TS-2.
These electronic interactions illustrate the favourable conformation of the ‘O-in-plane’
model.4–7
(a) TS-1 cis (b) TS-2 trans
Fig. 6.6 Calculated natural bond orbital (NBO) images that show the minimal orbital
interactions of, σ*C4–OH → σN1–C5 and nC6, for cis TS-1 (a) and trans TS-2 (b)
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Next we calculated the iodocyclisation of the more simple 2-deoxy-D-ribose derived
alkenylamine without a homoallylic substituent (12, Scheme 6.5), which proceeds
through similar structural transformations as did alkenylamine 10. Here, it was found
that the ∆Eelec to form the I2-pi-bond-complex with approach from the Re-face (IC-3)
leading to the observed product, was favoured by -25.38 kJ mol-1, compared to -16.66
kJ mol-1 for the Si-face complex (IC-4) which leads to the experimentally unobserved
product. However, a small difference in energy of 0.48 kJ mol-1 was found between
the two transition states in favour of cis TS-3 (5.49 kJ mol-1) vs trans TS-4 (5.97 kJ
mol-1). When calculating the theoretical diastereoselectivity from the TS-3 and TS-
4 ∆G values, it was found that the experimental carbamate annulation gave higher
selectivity for the 4,5-cis-carbamate 13 by around 10%, (Table 6.3). The margin of
error in these type of DFT calculations is±20 kJ mol-1. Here, it is important to note that
the calculated thermodynamic energies of the iodocyclisations presented should all have
a margin of error of a similar magnitude because they are all the same type of electronic
system.20
Table 6.3 Relative transition-state Gibbs energies (kJ mol-1) and diastereoselectivities
in the iodocyclisation of alkenylamine 12
Transition State ∆Gab (kJ mol-1) dra (%) drc (%)
TS-3 cis 0.00 83.5 >95.0
TS-4 trans 3.88 17.5 <5.0
aB3LYP/LANL2DZ
bRelative to the cis TS
cExperimental results
Looking in more detail at the calculated 3D transition state structures for the iodocyc-
lisation of 12 (TS-3 (a) and TS-4 (c), Fig. 6.7) we can see that both I2–C5–C6 complexes
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have progressed along the reaction coordinate towards a more product-like TS, although
the cis TS-3 is a relatively earlier transition state than the trans TS-4. The difference
in reaction coordinate position is illustrated by a much longer nucleophile approach of
N1–C5 for the cis-TS by 0.14 A˚ (1.988 A˚, (a) vs 1.849 A˚, (c)) and 0.03 A˚ shorter C5–C6
bond length (1.426 A˚, (a) vs 1.452 A˚, (c)). The Newman projections of cis TS-3 (b)
and trans TS-4 (d), depict a different picture to those of TS-1 and TS-2 (see Fig. 6.5).
Here, the C4–OH is approximately in-plane cis to C5–C6 in TS-3 (23.8◦), whereas for
TS-4 it is the C4–H that is in-plane (11.8◦), such that the I2 electrophile approaches syn
to the C4-OH.6 Both cis and trans TSs also have a 5-membered envelope conformation
where the nucleophile approach (N1–C5) is approximately 90◦ to the plane of the C4–
OH bond, (N1C5C4O(H) = 96.4◦ (b) and = 130.0◦ (d)) as was the case for the TSs in the
iodocyclisation of 10. NBO analysis shows that there is some energetically unfavourable
σ*C4–OH → σN1–C5 and σC5–I orbital overlap in trans TS-4 ((b) Fig. 6.8) compared to
minimal σ*C4–OH → nN1 and piC5–C6 orbital overlap for cis TS-3 (a).
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Scheme 6.5 Reaction coordinate of the iodocylisation of alkenylamine 12 to form iodoamines cis P-3 and trans P-4.
Energy (kJ mol-1) is shown relative to alkenylamine 12
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(a) TS-3 cis
O
H I
I
N
HH
96.1
96.4
23.8H
(b) Viewed down C5–C4
bond in TS-3
(c) TS-4 trans
O
H
I
I
N
H H
109.7
130.0
11.8
H
(d) Viewed down C5–C4
bond in TS-4
Fig. 6.7 Calculated transition-state structures for the iodocyclisation of alkenylamine
12 en route to the formation of carbamate 13. Newman projections show dihedral
angles of C6C5C4O(H) (‘O-in-plane’, in red), C6C5C4H (‘H-in-plane’, in black) and
the N1C5C4O(H) (in blue). [Distances in A˚, angles in deg.]
(a) TS-3 cis (b) TS-4 trans
Fig. 6.8 Calculated natural bond orbital (NBO) images that show the minimal orbital
interactions of σ*C4–OH → nN1 and piC5–C6 for cis TS-3 (a) and small→ σN1–C5 and σC5–I
orbital overlap for trans TS-4 (b)
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We then wanted to add a methyl group to the deoxy-ribose derived alkenylamine (14,
Scheme 6.6) to ascertain the effects of an ether on the allylic directing properties
in the iodocyclisation. Here, methyl iodoriboside 21, prepared in two steps from
2-deoxy-D-ribose,21 was subjected to a mixture of Ag2O and MeI to produce the
iodoriboside methyl ether 22 in excellent yield (90%). A Vasella reaction with reductive
amination, as pioneered previously in our research group,17,22 was then carried out on
iodomethoxyriboside 22 in the hope of producing the primary methyl ether alkenylamine
14 as the major product. This was the case when the unprotected iodoriboside 21 was
subjected to a Vasella reductive amination and the primary alkenylamine 12 was formed
as the only product and in excellent yield (>95:5, 81%).17 However, using the optimised
conditions for the Vasella reductive amination, with a large excess of NH4OAc and NH3
aq. 30%, a mixture of primary/secondary amines (1:1, 14:23) were obtained and in poor
isolated yield. The primary/secondary amine ratio was established by the 1H NMR and
13C spectra of the crude material.
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Scheme 6.6 Formation of methyl ether alkenylamine 14
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The selectivity in the Vasella reductive amination of iodoriboside 22 is not particularly
surprising as the reductive amination of substrates with benzyl ethers have also produced
approximate 1:1 mixtures of primary/secondary amines.22 The poor yield can be
attributed to the volatility of the methyl ether alkenylamine 14 in that isolation was
difficult with the reaction conditions used, including a DOWEX-H+ column and
subsequent silica chromatography. However, enough material was isolated to perform
the I2-mediated carbamate annulation on the methyl ether alkenylamine, 14, to produce
4,5-cis-carbamate 15 in a diastereoselectivity of >95/5, (refer Table 6.1). Carbamate 15
was proven to have the 4,5-cis configuration by methylating a sample of known 4,5-cis-
hydroxycarbamate 11 with MeI and NaH in DMF, and finding that the NMR spectral
data matched for both methyl ether compounds.
The calculated reaction coordinate of the iodocyclisation of methyl ether alkenylamine
14 follows the reaction mechanism described for the previous alkenylamines discussed
(Scheme 6.7). Here, the relative transition state electronic energies are reversed so that
trans TS-6 is lower in energy than cis TS-5. There is also little energetic preference
for Re-face approach over Si-face approach (IC-5 = -17.47 kJ mol-1 vs IC-6 = -15.87
kJ mol-1), and the trans iodoamine P-6 is 6.2 kJ mol-1 energetically more stable than
the the cis iodoamine P-5. However, the product distribution calculated from TS ∆G’s
(TS-5 vs TS-6) predicts an almost 50:50 ratio of cis/trans products (Table 6.4). This
can not account for the observed experimental diastereoselectivity of >95:5 (cis/trans)
within a reasonable margin of error, compared to the previous two iodocyclisations. The
anomaly exhibited with the iodocyclisation of methyl ether protected alkenylamine 14
can also not be explained by examining the 3D transition state structures and Newman
projections (TS-5 (a), (b) and TS-6 (c), (d), Fig. 6.9).
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Table 6.4 Relative transition-state Gibbs energies (kJ mol-1) and diastereoselectivities
in the iodocyclisation of alkenylamine 14
Transition State ∆Gab (kJ mol-1) dra drc (%)
TS-5 cis 0.00 51.8 >95.0
TS-6 trans 0.19 48.2 <5.0
aB3LYP/LANL2DZ
bRelative to the cis TS
cExperimental results
Here, the trend of later product-like TSs continue with trans (TS-6) later than cis (TS-
5), albeit by a small degree; the nucleophile approach (N1–C5) is shorter by 0.02 A˚
(1.907 A˚, (c) vs 1.931 A˚, (a)) and C5–C6 bond longer by 0.008 A˚ (1.446 A˚, (c) vs
1.438 A˚, (a)). The C6C5C4O(Me) dihedral angle is more acute for cis TS-5 ((b), 43.3◦)
so that OMe is not in the plane of the pyramidalised olefin (C5–C6) as much as for
trans TS-6 ((d), 163.3◦). However, the envelope conformation of both cis and trans
TSs position the nucleophile so that the N1C5C4O(Me) dihedral angle is very close to
90◦, as has been discussed for the previous iodocyclisation TS structures. We can only
speculate as to why the TS energy difference for the cyclisation of methyl ether 14
does not correlate with experimental results, it may be that there is a complexity in
the reaction pathway that we have not proficiently accounted for in our calculations or
model of the reaction.
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Scheme 6.7 Reaction coordinate of the iodocylisation of alkenylamine 14 to form iodoamines cis P-5 and trans P-6.
Energy (kJ mol-1) is shown relative to alkenylamine 14
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(a) TS-5 cis
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I
N
HH
78.8
74.8
43.3Me
(b) Viewed down C5–C4
bond in TS-5
(c) TS-6 trans
OH
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NH H
163.3
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(d) Viewed down C5–C4
bond in TS-6
Fig. 6.9 Calculated transition-state structures for the iodocyclisation of alkenylamine
14 en route to the formation of carbamate 15. Newman projections show dihedral
angles of C6C5C4O(Me) (‘O-in-plane’, in red), C6C5C4H (‘H-in-plane’, in black) and
the N1C5C4O(Me) (in blue). [Distances in A˚, angles in deg.]
6.3.2 Alkenylamines Possessing an α-Amine Nitrile
Next we wanted to determine what adding an α-amine substituent to alkenylamines
while also retaining an ether allylic directing group would do to the structure of
the transition states in the iodocyclisation. Hence, the calculated reaction profile of
arabinose derived benzyl protected syn-α-aminonitrile 2 is shown in Scheme 6.8. Here,
there is virtually no energetic preference in the iodine complex pre-equilibrium for either
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Re- or Si-face approach of I2 to the alkene double bond, (IC-7 Re = -18.31 kJ mol-1
vs IC-8 Si = -18.05 kJ mol-1). However, the two TS geometries found for cis (TS-7
= 18.46 kJ mol-1) and trans (TS-8 = 28.49 kJ mol-1) have a difference in activation
energy of 10.02 kJ mol-1. Interestingly, the trans iodoamine P-8 is 9.74 kJ mol-1 more
energetically favoured than the cis P-7. Taking into account the full thermodynamic
picture of the TSs by relating ∆G (cis/trans) to the equilibrium constant, we found
that the calculated values almost relate to the experimental diastereoselectivity though
predict a lower cis-selectivity by 6% (Table 6.5).
Table 6.5 Relative transition-state Gibbs energies (kJ mol-1) and diastereoselectivities
in the iodocyclisation of alkenylamine 2
Transition State ∆Gab (kJ mol-1) dra drc (%)
TS-7 cis 0.00 89.0 >95.0
TS-8 trans 5.25 11.0 <5.0
aB3LYP/LANL2DZ
bRelative to the cis TS
cExperimental results
The 3D transition state structures cis TS-7 ((a), Fig. 6.10) and trans TS-8 (c) show the
same late TS position on the reaction coordinate, with an asymmetric I2-C6–C5 complex
and pyramidalised C6–C5 olefin bond, as already discussed for the iodocyclisation of
the previous alkenylamines possessing an α-amino methylene. Here, there are two
potential structural influences on the TS energy, the relative position of the C4-OBn
group, and the α-nitrile substituent, which will be discussed shortly in comparison
to the anti-aminonitrile (16) TSs. The position of C4-OBn in the favoured TS-7 (b)
is in-plane, (C6C5C4O(Bn) = 43.2◦) in a similar magnitude to the C4-OBn for TS-8
((d), C6C5C4O(Bn) = 149.9◦), however, situated inside (b) vs outside (d) the I2-C6–C5
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complex. Furthermore, the N1C5C4O(Bn) dihedral angle is very close to 90◦ for both
cis (78.2◦, (b)) and trans (92.2◦, (d)) TSs, following the trend seen in the previous TSs
discussed. It appears that the benzyl ether groups do not impede the preferred ‘O-in-
plane’ conformation or perpendicular positioning of the amine attack to the C4-O(Bn).
(a) TS-7 cis
O
H
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H
H
81.4
78.2
43.2O
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(b) Viewed down C5–C4 bond in
TS-7
(c) TS-8 trans
OH
I
I
N
H
H
149.9
92.2
24.0
Ph
OPh
C
N
(d) Viewed down C5–C4
bond in TS-8
Fig. 6.10 Calculated transition-state structures for the iodocyclisation of alkenylamine
2 en route to the formation of carbamate 3. Newman projections show dihedral angles
of C6C5C4O(Bn) (‘O-in-plane’, in red), C6C5C4H (‘H-in-plane’, in black) and the
N1C5C4O(Bn) (in blue). [Distances in A˚, angles in deg.]
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We then wanted to examine the iodocyclisation of anti-α-aminonitrile 16 to compare
with those iodocyclisations already discussed, as this alkenylamine shows reduced
cis-diastereoselectivity in the experimental I2-mediated carbamate annulation (6:1,
cis/trans, refer Table 6.1). The calculated reaction coordinate of the iodocyclisation
of aminonitrile 16 depicts a similar reaction path as for the rest of the alkenylamines
(Scheme 6.9). Here, there is a small energetic preference of I2-complexation for the
Re diastereotopic olefin face of 3.35 kJ mol-1, (IC-9 = -10.59 kJ mol-1 vs IC-10 =
-7.24 kJ mol-1). Furthermore, the difference in activation energy to form cis TS-9 is
a small degree (1.98 kJ mol-1) more than trans TS-10. However, when calculating
the diastereoselectivity from TS ∆G’s it was found that the theoretical selectivity was
greater for the cis diastereomer by approximately 12% more than the experimentally
observed ratio of dr = 83.3:16.7, (cis/trans, Table 6.6).
Table 6.6 Relative transition-state Gibbs energies (kJ mol-1) and diastereoselectivities
in the iodocyclisation of alkenylamine 16
Transition State ∆Gab (kJ mol-1) dra drc (%)
TS-9 cis 0.00 95.0 83.3
TS-10 trans 7.51 5.0 16.7
aB3LYP/LANL2DZ
bRelative to the cis TS
cExperimental results
Considering the optimised 3D structures of cis TS-9 ((a), Fig. 6.11) and trans TS-10 (c),
we can see that both are late-stage TS structures on the reaction coordinate as previously
discussed in terms of the progression of I2-pi-complex. However, the cis TS is slightly
later than the trans TS indicated by shorter a N1–C5 approach by 0.04 A˚ (1.814 A˚, (a)
vs 1.853 A˚, (c)) and I–C6 bond (2.484 A˚, (a) vs 2.500 A˚, (c)). This is the reverse of the
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trend seen for all the other iodocyclisation TSs. The position of C4-OBn in plane for
TS-9 (b) is calculated to be almost anti the C6–C5 bond (C6C5C4O(Bn) dihedral angle
= 53.3◦), compared to TS-10 (d) where the C6C5C4O(Bn) dihedral angle of 176.2◦ puts
the C4-OBn in the plane, but outside the C6–C5 bond. Interestingly, here, as for all of
the other calculated iodocyclisation TSs, the 5-membered ring envelope conformation
positions the line of nucleophilic attack almost perpendicular to the C4–O(Bn) bond for
both the cis and trans TS (N1C5C4O(Bn) = 66.0 A˚ (b) and 65.6 A˚ (d)).
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Fig. 6.11 Calculated transition-state structures for the iodocyclisation of alkenylamine
16 en route to the formation of carbamates 17 and 18. Newman projections show
dihedral angles of C6C5C4O(Bn) (‘O-in-plane’, in red), C6C5C4H (‘H-in-plane’, in
black) and the N1C5C4O(Bn) (in blue). [Distances in A˚, angles in deg.]
The extent to which the α-amino nitrile affects TS energy for the iodocyclisations of both
syn- (2, TS-7 and TS-8) and anti-aminonitrile (16, TS-9 and TS-10) can be determined
by looking at the influence of the nitrile substituent on the nucleophilicity of the amine
(N1). This can be inferred by measuring the NCN1C5 dihedral angle (Fig. 6.12). Here,
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the measured dihedral angle in cis TS-7 (135.6◦, (a)) shows the nitrile dipole has an
effect on N1 by withdrawing some electron density. In contrast, the NCN1C5 dihedral
angle in trans TS-8 (154.1◦, (b)) related to the nitrile withdrawing electron density from
N1, and to a greater extent than cis TS-7. Whereas, the nitrile dipoles in TS-9 and
TS-10 have a similar electronic influence on the nucleophile, as the NCN1C5 dihedral
angles in TS-9 (131.1◦, (c)) and TS-10 (129.9◦, (d)) show that both have some electron
withdrawing on the amine. Therefore, the sizeable difference in relative energy between
TS-7 and TS-8 could be due to the difference in electronic influence of the α-amino
nitrile substituent. This is compared to TS-9 and TS-10 where the nitrile dipole exerts
a similar effect in both optimised TS structures and the energy gap between the TSs is
significantly smaller. This explanation of nitrile dipole influence on TS energy provides
an update on our previous postulations, (Chapter 5).2,9
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(a) TS-7 cis (b) TS-8 trans
(c) TS-9 cis (d) TS-10 trans
Fig. 6.12 Calculated natural bond orbital (NBO) images that show the difference in
NCN1C5 dihedral angle for cis TS-7 (a) and trans TS-8 (b) and the similar NCN1C5
dihedral angle for cis TS-9 (c) and trans TS-10 (d)
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6.4 Conclusions
We have gained further insight into the factors dictating the diastereoselectivity in the
I2-mediated carbamate annulation of alkenylamines, with and without protecting groups
and α-amine substituents. Iodocyclisations, to produce iodoamine intermediates en
route to the formation of carbamates were investigated using density functional theory
calculations. Stationary points were found on the energy surface of five different iodocy-
clisations corresponding to starting alkenylamines, iodine complexes, transition states
and final products. It was found that the theoretical TS Gibb’s free energies roughly
matched the experimental diastereoselectivities within a theoretical error of ±12% (less
than the error for these calculations of ±20 kJ mol-1) for all of the iodocyclisations
except one. The calculation did not reproduce the experimentally determined cis-
selectivity as there was no theoretical diastereoselectivity for the iodocyclisation of
methyl ether alkenylamine 14. This anomaly could be due to further complexity in
the mechanism not accounted for in the calculated iodocyclisation reactions. Taken as
a whole, both cis and trans TSs were found to be late-stage on the reaction coordinate
with the cis-TSs earlier than the trans-TSs by varying degrees for most of the computed
iodocyclisations. Evidence was found for the cis ‘O-in-plane’ model3–7 by noting
the C5C6C4O(X) dihedral angles and examining the TS molecular orbitals. However,
in the current calculations the trans-TSs were also found to prefer the ‘O-in-plane’
conformation rather than the ’H-in-plane’ conformation, which was not predicted by
earlier models.3–7 There was also a trend in the cis-TSs for the allylic-O(X) group to
prefer to reside inside the C6C5 complex and prefer to reside outside in trans-TSs. The
role of the nitrile on TS energy for the iodocyclisation of α-aminonitriles, (2, and 16)
was found to be important for both sets of TSs. Here, measuring the NCN1C5 dihedral
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angle indicated that the nitrile dipole was more electron withdrawing for the trans TS-8
than cis TS-7 (2), in contrast, the nitrile dipole had the same electronic effect for cis
TS-9 and trans TS-10 (16) so that the two TSs were much closer in energy. It is also
interesting to note that the perpendicular nucleophilic attack relative to the allylic-O(X)
holds true whether the alkenylamine TSs have constraints or not, e.g. bulky benzyl
groups (TS-7–TS-10) through to no other substituents (TS-3 and TS-4). The fact that
all of the TS structures discussed in this chapter exhibit perpendicular nucleophile attack
to the allylic directing group indicates there may be a strong electronic preference for the
5-membered ring envelope that positions the amine in this conformation, which limits
the positioning of the rest of the molecule in the TS. This feature could be useful in
determining the preferred 5-membered ring TS conformation for future iodocyclisations
of alkenylamines.
183
6.5 Experimental
General Experimental
Unless otherwise stated all reactions were performed under air. THF was distilled from
LiAlH4 prior to use. All chemicals obtained from commercial suppliers were used
without further purification. Zn dust was activated by the careful addition of conc.
H2SO4, followed by decantation and washing with EtOH (3 x) and hexanes (3 x), and
storage under dry hexanes. All solvents were removed by evaporation under reduced
pressure. Reactions were monitored by TLC analysis on silica gel coated plastic sheets
(0.20 mm, Polygram SIL G/UV254) with detection by coating with 20% H2SO4 in EtOH
followed by charring at ca. 150 ◦C, by coating with a solution of ninhydrin in EtOH
followed by charring at ca. 150 ◦C, or by coating with a solution of 5% KMnO4 and 1%
NaIO4 in H2O followed by heating. Column chromatography was performed on silica
gel (40-63 µm). Dowex Monosphere M-31 acidic resin was used for ion exchange
chromatography. High-resolution mass spectra were recorded on a Waters Q-TOF
PremierTM Tandem Mass Spectrometer using positive electro-spray ionisation. Optical
rotations were recorded using a Rudolf Research Analytical Autopol II polarimeter at
the sodium D-line. Infrared spectra were recorded as thin films using a Bruker Tensor
27 FTIR spectrometer, equipped with an Attenuated Total Reflectance (ATR) sampling
accessory, and are reported in wave numbers (cm-1). Nuclear magnetic resonance spectra
were measured using a Varian Inova operating at 500 MHz for 1H and 125 MHz for 13C
or a Varian Direct Drive operating at 600 MHz and 133 MHz. 1H and 13C chemical
shifts (δ) were internally referenced to the residual solvent peak, (CDCl3 = 7.26 ppm
and 77.16 ppm). NMR peak assignments are based on 2D NMR experiments (COSY,
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HSQC, and HMBC).
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23
45
O OMe
MeO
I
Methyl 2,5-dideoxy-5-iodo-3-methoxy-α/β-D-ribofuranoside 22.
Methyl riboside 2121 (156 mg, 0.60 mmol) was co-evaporated with dry toluene (0.5
mL) three times, placed under argon and dissolved in dry DMF (1.8 mL). MeI (0.05
mmol) was added to the solution, which was cooled to 0 ◦C for 15 mins. NaH (0.66
mmol) was added and the resulting mixture allowed to warm to room temperature with
stirring. After 1 hour, the reaction was quenched by the careful addition of H2O, diluted
with further H2O, and extracted twice with EtOAc. The organic layer was washed with
brine, dried (MgSO4), filtered and concentrated in vacuo. The residue was purified
using silica gel gradient flash chromatography (hexanes/ EtOAc, 50/1 → 10/1) to give
the methyl methoxyribosides 22 as a colourless oil in a 3:2 ratio of α and β anomers
(147 mg, 0.54 mmol, 90%). Rf α = 0.47, β = 0.38 (hexanes/EtOAc, 2/1). [α]D20.9 = -54
(c = 1.0, CHCl3); IR (film) 2985, 2927, 2829, 1441, 1371, 1203, 1100, 1034, 948, 934
cm-1. α-22: 1H NMR: (500 MHz, CDCl3, 20 ◦C) δ 5.15 (dd, J1,2b = 5.4, J1,2a = 2.2 Hz,
1H, H-1), 4.20 (ddd, J4,5b = 8.4, J4,5a = 6.3, J3,4 = 3.0 Hz, 1H, H-4), 3.99 (ddd, J2a,3 =
6.8, J2b,3 = 5.4 Hz, 1H, H-3), 3.36 (s, 3H, 1-OMe), 3.34 (s, 3H, 3-OMe), 3.29 (dd, 2J5a,5b
= 10.1, J4,5a = 6.3 Hz, 1H, H-5a), 3.22 (dd, 2J5a,5b = 10.1, J4,5b = 8.4 Hz, 1H, H-5b), 2.28
(ddd, 2J2a,2b = 13.8, J2a,3 = 6.8, J1,2a = 2.2 Hz, 1H, H-2a), 2.12 (dt, 2J2a,2b = 13.8, J3,2b
= J1,2b = 5.4 Hz, 1H, H-2b); 13C NMR: (125 MHz CDCl3, 20 ◦C) δ 106.0 (C-1), 84.0
(C-4), 83.8 (C-3), 57.3 (3-OMe), 55.5 (1-OMe), 39.6 (C-2), 8.1 (C-5); β-22: 1H NMR:
(500 MHz, CDCl3, 20 ◦C) δ 5.10 (J1,2a = 5.4, J1,2b = 1 Hz, 1H, H-1), 3.97 (dd, J4,5a =
8.5, J4,5b = J3,4 = 4.5 Hz, 1H, H-4), 3.68 (ddd, J2a,3 = 8.0, J3,4 = 4.5, J2b,3 = 2.2 Hz, 1H,
185
H-3), 3.39 (s, 3H, 1-OMe), 3.36 (s, 3H, 3-OMe), 3.35 (dd, 2J5a,5b = 10.8, J4,5a = 8.5 Hz,
1H, H-5a), 3.33 (dd, 2J5a,5b = 10.8, J4,5a = 4.5 Hz, 1H, H-5b), 2.25 (ddd, 2J2a,2b = 13.9,
J2a,3 = 8.0, J1,2a = 5.4 Hz, 1H, H-2a), 2.02 (ddd, 2J2a,2b = 13.9, J2b,3 = 2.2, J1,2b = 1 Hz,
1H, H-2b); 13C NMR: (125 MHz CDCl3, 20 ◦C) δ 105.6 (C-1), 84.9 (C-3), 81.6 (C-4),
57.8 (3-OMe), 55.4 (1-OMe), 38.6 (C-2), 8.6 (C-5); α/β-22: HRMS (ESI) m/z calcd.
for [C7H13IO3+Na]+: 294.9802, obsd.: 294.9814.
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NH2 (3S)-1-Amino-3-methoxy-pent-5-ene 14. To a solution of iodo-
riboside 22 (1.55 g, 5.7 mmol) in a saturated solution of NH4OAc in EtOH (114
mL) were added activated Zn (1.86 g, 28.5 mmol), NaCNBH3 (1.07 g, 17.1 mmol),
and 30% aqueous NH3 (46 mL). The mixture was stirred at reflux for 18 h, cooled
to room temperature, and concentrated under reduced pressure. The residue was
redissolved in H2O, loaded onto a Dowex-H+ ion-exchange resin, and washed several
times with H2O to remove excess salt. The amine product was then eluted with 30%
aqueous NH3, and further purification was achieved using gradient flash chromatog-
raphy (DCM/EtOH/MeOH/30% aq NH3, 100/2/2/1 → 25/2/2/1, v/v/v/v), to provide
methoxyalkenylamine 14 as a colourless liquid (10 mg, 0.09 mmol, <5% yield). Rf =
0.11 (DCM/EtOH/MeOH/30% aq NH3, 50/2/2/1, v/v/v/v). IR (film) 3294, 3077, 2928,
2853, 2823, 1661, 1451, 1423, 1377, 1105, 993, 927 cm-1. 1H NMR: (500 MHz, CDCl3,
20 ◦C) δ 5.67 (ddd, J3,4 = 13.5, J4,5b = 10.1, J4,5b = 8.4 Hz, 1H, H-4), 5.24–5.19 (m, 2H,
H-5), 3.65 (dt, J3,4 = 13.5, J2a,3 = J2b,3 = 7.1 Hz, 1H, H-3), 3.27 (s, 3H, OMe), 2.78 (t,
J1,2a = J1,2b = 7.1 Hz, 1H, H-1), 1.74 (dt, 2J2a,2b = 13.8, J1,2a = J2a,3 = 7.1 Hz, 1H, H-2a),
1.63 (dt, 2J2a,2b = 13.8, J1,2b = J2b,3 = 7.1 Hz, 1H, H-2b), 1.39 (br-s, 2H, NH2); 13C NMR:
(125 MHz CDCl3, 20 ◦C) δ 138.7 (C-4), 117.4 (C-5), 81.4 (C-3), 56.3 (OMe), 39.4 (C-
186
2), 38.8 (C-1); HRMS (ESI) m/z calcd. for [C6H13NO+H]+: 116.1070, obsd.: 116.1074.
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(7S,7aS)-7-Methoxy-tetrahydro-pyrrolo[1,2-c]oxazol-3-one 15. To a
solution of methoxyalkenylamine 14 (10 mg, 0.09 mmol) in THF (0.9 mL), were added
I2 (68.5 mg, 0.27 mmol), H2O (0.9 mL) and NaHCO3 (226.8 g, 2.7 mmol). The reaction
mixture was stirred at room temperature for 20 h, quenched with sat. aq. Na2S2O3
and extracted with EtOAc. The organic layer was washed with H2O and brine, dried
(MgSO4), filtered and concentrated in vacuo. Purification was achieved using gradient
flash chromatography (hexanes/EtOAc, 20/1→ 1/2, v/v) to provide methoxycarbamate
15 as a colourless viscous liquid (10 mg, 0.07 mmol, 75% yield). IR (film) 2954, 2923,
2853, 1741, 1467, 1397, 1244, 1206, 1089, 1073, 1000, 777 cm-1. 4.52 (dd, 2J5a,5b =
8.5, J4,5a = 3.6 Hz, 1H, H-5a), 4.39 (t, 2J5a,5b = J4,5b = 8.5 Hz, 1H, H-5b), 3.90 (dt, J4,5b
= 8.5, J4,5a = J3,4 = 3.6 Hz, 1H, H-4), 3.70 (t, J3,4 = J2b,3 = 3.6 Hz, 1H, H-3), 3.60 (dd,
2J1a,1b = 10.4, J1a,2a = 8.6 Hz, 1H, H-1a), 3.31 (s, 3H, OMe), 3.25, (t, 2J1a,1b = J1b,2b =
10.4 Hz, 1H, H-1b), 2.31 (dd, 2J2a,2b = 13.4, J1a,2a = 8.6 Hz, 1H, H-2a), 3.85 (ddd, 2J2a,2b
= 13.4, J1b,2b = 10.4, J2b,3 = 3.6 Hz, 1H, H-2b); 13C NMR: (125 MHz CDCl3, 20 ◦C) δ
79.0 (C-3), 63.6 (C-4), 63.0 (C-5), 56.3 (OMe), 44.0 (C-1), 30.1 (C-2); HRMS (ESI)
m/z calcd. for [C7H11NO3+H]+: 158.0812, obsd.: 158.0822.
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Cartesian coordinates for stationary points
I2
2
I -1.974045 0.544267 0.000000
I -4.836898 0.544267 0.000000
HI
2
I -2.014284 0.166909 0.000000
H -3.650548 0.166909 0.000000
10
19
C 0.680764 0.068401 0.531186
H 0.533802 0.046938 1.625220
C -0.576168 -0.550948 -0.107080
H -0.426671 -0.600714 -1.198009
C -1.863351 0.249584 0.202251
H -1.846859 1.203886 -0.339217
H -1.894529 0.471313 1.276575
C 1.927604 -0.726919 0.202036
H 1.935520 -1.730855 0.623708
C 2.954616 -0.289088 -0.553762
H 2.952273 0.693235 -1.021895
H 3.818599 -0.919758 -0.746899
N -3.031804 -0.610251 -0.115886
H -3.849670 -0.450431 0.465590
H -3.273434 -0.642452 -1.104392
O 0.731861 1.454117 0.061777
H 1.552886 1.884329 0.380456
O -0.710131 -1.893129 0.440895
H -1.678184 -2.098069 0.372465
IC-1
21
C -0.669634 0.080115 -0.741894
H -0.359047 -0.121369 -1.780369
C 0.555687 -0.172266 0.160905
H 0.261717 0.006443 1.207881
C 1.758615 0.733103 -0.200274
H 1.552519 1.766013 0.106797
H 1.896543 0.725121 -1.288800
C -1.794551 -0.868983 -0.389016
H -1.583084 -1.916496 -0.596322
C -2.969749 -0.498101 0.196729
H -3.154384 0.533841 0.482855
H -3.710501 -1.239070 0.483284
N 2.975085 0.147540 0.414956
H 3.827647 0.268257 -0.124200
H 3.111329 0.386028 1.395039
O -1.023268 1.484679 -0.570558
H -1.706258 1.748738 -1.223870
O 0.932613 -1.564092 -0.023554
H 1.902650 -1.592733 0.185639
I -3.998775 -0.155725 -2.586116
I -5.382216 0.470832 -5.104612
IC-2
21
C -0.610222 0.094770 -0.021975
H -0.458894 0.125038 -1.116438
C 0.719620 -0.382533 0.593782
H 0.588653 -0.481500 1.682360
C 1.899310 0.573482 0.299223
H 1.783414 1.497754 0.879271
H 1.889843 0.838491 -0.765857
C -1.734514 -0.881701 0.244853
H -1.539907 -1.888420 -0.122425
C -2.914215 -0.581193 0.854072
H -3.130253 0.415339 1.231095
H -3.706655 -1.319710 0.932065
N 3.159317 -0.161685 0.571929
H 3.944733 0.104108 -0.015255
H 3.420077 -0.200831 1.555300
O -0.857133 1.435390 0.497402
H -1.635797 1.840541 0.061611
O 0.998099 -1.681351 0.000995
H 1.983771 -1.780057 0.059409
I -1.896963 -1.614481 3.517670
I -1.484885 -2.483214 6.280527
TS-1
21
C -2.870638 0.748952 0.380515
H -2.329753 1.192724 1.227093
C -4.394349 1.041700 0.518456
H -4.571305 2.006377 1.008314
C -5.014069 -0.133703 1.275768
H -6.106955 -0.095474 1.222391
H -4.697976 -0.160055 2.323859
C -2.606736 -0.781001 0.395585
H -2.336840 -1.153168 1.387334
C -1.916321 -1.407336 -0.696274
H -2.117907 -1.050516 -1.702980
H -1.697976 -2.469296 -0.612630
N -4.450997 -1.313470 0.560517
H -4.532717 -2.214632 1.032972
H -4.792568 -1.349250 -0.404098
O -2.482706 1.397096 -0.856971
H -1.509423 1.343659 -0.997666
O -5.016715 1.010271 -0.797657
H -4.395356 1.431910 -1.436508
I 0.469099 -0.531084 -0.401553
I 3.377542 0.561842 -0.176963
TS-2
21
C -3.266603 -0.689457 -0.659787
H -2.593145 -0.206162 0.056508
C -4.495452 -1.325973 0.025265
H -4.187508 -1.902435 0.905641
C -5.155970 -2.233472 -1.051418
H -6.096740 -1.776082 -1.368179
H -5.360489 -3.234226 -0.664783
C -2.548008 -1.792444 -1.422611
H -2.050783 -1.431511 -2.324959
C -1.882190 -2.862543 -0.721937
H -2.356570 -3.284721 0.162723
H -1.351130 -3.590406 -1.331538
N -4.196098 -2.337592 -2.199904
H -4.085709 -3.273045 -2.590490
H -4.364706 -1.622975 -2.912430
O -3.741614 0.263693 -1.662015
H -4.381416 0.877822 -1.239088
O -5.463624 -0.296251 0.399655
H -5.360144 -0.023035 1.334130
I 0.112704 -1.788204 0.406140
I 2.515911 -0.561695 1.968047
P-1
19
C -0.859765 -0.139688 -0.870315
C -2.118435 1.786478 0.033480
C -2.984467 0.524288 0.194111
C -2.377282 -0.500973 -0.803668
H -0.439644 -0.398924 -1.851557
H -1.885439 2.178281 1.032885
H -2.647012 2.565829 -0.531830
H -4.044829 0.705922 -0.020664
H -2.807541 -0.346321 -1.801969
N -0.928467 1.318115 -0.713572
H -0.070437 1.854986 -0.676734
O -2.725194 -1.820292 -0.305158
H -2.141168 -2.521999 -0.662655
C 0.018790 -0.775841 0.234389
H -0.478511 -0.811766 1.204015
H 0.982597 -0.267328 0.301532
I 0.614640 -2.883552 -0.232298
O -2.840411 0.035944 1.562069
H -3.064497 -0.923360 1.555022
P-2
19
C 0.890962 0.596552 -0.405394
C 3.130604 1.102512 0.428967
C 2.921887 -0.414356 0.520115
C 1.382697 -0.547921 0.534261
H 4.083082 1.327588 -0.060916
H 3.140599 1.550873 1.432033
H 3.383809 -0.865672 1.408234
H 0.998993 -0.394027 1.553979
N 1.978685 1.609001 -0.370033
H 2.234261 1.967704 -1.285536
O 1.054803 -1.884888 0.064102
H 0.082165 -2.006866 0.020952
O 3.457777 -1.019419 -0.691640
H 2.955114 -1.846825 -0.867887
C -0.394754 1.293456 0.063052
H -0.708297 2.084378 -0.619286
H -0.303542 1.679792 1.079757
I -2.145726 -0.095969 0.114320
188
H 0.749083 0.183443 -1.414356
12
18
C -2.075050 0.328354 0.077818
H -1.677132 -0.664532 0.361987
C -1.563861 1.369208 1.092404
H -1.894730 2.366137 0.779992
H -2.022997 1.161747 2.071701
C -0.028894 1.362569 1.225087
H 0.403594 1.641695 0.258827
H 0.307912 0.327795 1.442725
C -3.589939 0.240646 0.060756
H -4.031209 -0.235666 0.938944
C -4.388592 0.697376 -0.925039
H -3.983243 1.196917 -1.801954
H -5.469971 0.602573 -0.865606
N 0.407234 2.342650 2.233894
H 0.119090 2.139516 3.187214
H 1.378075 2.632804 2.169749
O -1.515948 0.711444 -1.222068
H -1.835771 0.098337 -1.917869
IC-3
20
C 3.428672 -0.543045 -0.058761
H 2.661239 -0.862910 0.668844
C 3.953692 -1.792883 -0.799589
H 4.669896 -1.483603 -1.569201
H 4.492467 -2.432901 -0.084444
C 2.816575 -2.596385 -1.464478
H 2.338688 -1.959736 -2.215574
H 2.046913 -2.827906 -0.700506
C 4.546630 0.145563 0.697210
H 4.907105 -0.380207 1.583146
C 5.134813 1.318050 0.321595
H 4.825814 1.827985 -0.586730
H 5.981803 1.724417 0.867068
N 3.351630 -3.790561 -2.132493
H 3.688933 -4.526940 -1.520145
H 2.814170 -4.138447 -2.919039
O 2.822619 0.319427 -1.069652
H 2.345229 1.065261 -0.645024
I 3.098378 2.604420 2.118811
I 1.237083 4.289754 3.645678
IC-4
20
C 1.995970 0.181289 0.501664
H 2.455742 0.032607 1.498477
C 0.497965 -0.171363 0.608447
H 0.003069 0.065759 -0.339219
H 0.397395 -1.255456 0.768971
C -0.201049 0.592850 1.750793
H -0.143471 1.664951 1.536026
H 0.359337 0.421576 2.693626
C 2.746978 -0.709054 -0.466708
H 2.855039 -1.748121 -0.149722
C 3.314657 -0.303465 -1.635236
H 3.228272 0.723970 -1.978482
H 3.916864 -0.980826 -2.233555
N -1.615850 0.208869 1.835372
H -1.800709 -0.747100 2.122715
H -2.238737 0.886202 2.261239
O 2.067574 1.596321 0.139561
H 2.995701 1.913416 0.162055
I 1.000589 -1.521004 -3.230717
I -0.848687 -2.593573 -5.219245
TS-3
20
C 2.802262 0.999344 -0.033866
H 2.086866 1.496731 -0.703854
C 4.232723 1.564472 -0.244013
H 4.242090 2.398328 -0.952945
H 4.555363 1.956248 0.726961
C 5.178967 0.438477 -0.713763
H 6.222922 0.649622 -0.450128
H 5.125117 0.292876 -1.798704
C 2.724408 -0.504984 -0.354152
H 2.781006 -0.716947 -1.425987
C 1.906199 -1.383634 0.415304
H 1.859573 -1.236683 1.490950
H 1.803781 -2.412123 0.079100
N 4.670096 -0.802643 -0.074721
H 4.967679 -1.685063 -0.491457
H 4.762649 -0.817779 0.942888
O 2.454107 1.274788 1.354400
H 1.484937 1.170203 1.487258
I -0.474758 -0.566432 -0.136195
I -3.377713 0.410986 -0.621522
TS-4
20
C 3.063513 0.549676 -1.117873
H 3.007744 -0.009952 -2.062723
C 4.468428 1.146193 -0.920281
H 4.886178 1.513244 -1.862270
H 4.385485 2.002324 -0.238256
C 5.326274 0.032265 -0.306822
H 6.273058 0.389902 0.111594
H 5.541782 -0.755419 -1.036501
C 2.746011 -0.431972 0.041077
H 2.261818 0.072088 0.882487
C 2.200787 -1.737672 -0.288086
H 2.623718 -2.256245 -1.148862
H 1.920808 -2.389205 0.538551
N 4.444797 -0.564639 0.759432
H 4.610049 -1.556595 0.946979
H 4.468860 -0.028451 1.632284
O 2.133112 1.663060 -1.125561
H 1.230288 1.347143 -1.362228
I -0.093795 -1.233826 -1.182862
I -2.957599 -0.708735 -2.344748
P-3
18
C 1.084445 -0.102369 0.479544
C 2.355297 1.851723 -0.180106
C 3.260657 0.639972 -0.470769
C 2.575263 -0.556179 0.229417
H 0.898573 -0.072524 1.568064
H 2.414440 2.613206 -0.965915
H 2.636460 2.327604 0.779058
H 3.271479 0.421642 -1.543447
H 4.292153 0.785946 -0.135480
H 3.039423 -0.780987 1.199910
N 1.009688 1.238294 -0.141932
H 0.251163 1.833266 0.184050
O 2.727112 -1.705204 -0.656737
H 2.405228 -2.524955 -0.221703
C 0.021636 -0.985504 -0.188887
H 0.304286 -1.264289 -1.203127
H -0.965710 -0.522547 -0.162675
I -0.268631 -2.908748 0.900425
P-4
18
C -1.164787 -0.216300 -0.180056
C -2.790203 1.616414 -0.251538
C -3.351776 0.529363 0.687020
C -2.564490 -0.735435 0.296353
H -2.901322 2.622791 0.169831
H -3.310656 1.600683 -1.227756
H -3.116754 0.766769 1.730117
H -4.433415 0.392034 0.591820
N -1.367301 1.236247 -0.334259
H -0.728907 1.773706 -0.909731
C -0.709280 -0.828954 -1.517908
H 0.260566 -0.446334 -1.845679
H -1.455506 -0.711580 -2.308043
H -0.418272 -0.435978 0.596036
H -3.057491 -1.253737 -0.541922
O -2.496996 -1.617554 1.450307
H -2.062925 -2.462676 1.202845
I -0.367064 -3.032409 -1.369923
14
21
C -0.901014 -0.741681 -0.148505
H -0.972677 -0.887694 -1.233623
H -0.870656 -1.739347 0.315585
C -2.151799 0.020417 0.329316
H -2.042809 0.248317 1.409846
H -2.196328 0.979274 -0.196927
C 0.411411 -0.012384 0.186903
H 0.471881 0.170992 1.276186
C 1.627497 -0.801035 -0.255415
H 1.680233 -1.001557 -1.327830
C 2.598400 -1.244085 0.568548
H 3.443057 -1.821631 0.199660
H 2.571524 -1.049727 1.640454
N -3.371398 -0.744425 0.014800
H -3.454042 -1.636581 0.495356
H -4.235053 -0.210201 0.030865
O 0.343759 1.282497 -0.511444
C 1.382036 2.230605 -0.133405
H 2.385583 1.863178 -0.391415
189
H 1.172430 3.146881 -0.692591
H 1.349583 2.445538 0.947520
IC-5
23
C -1.069794 -0.453526 -0.326577
H -1.142212 -0.365993 -1.417874
H -1.276821 -1.501628 -0.065798
C -2.132891 0.461857 0.311505
H -2.015559 0.434445 1.414493
H -1.943061 1.492334 -0.006346
C 0.358776 -0.108371 0.121677
H 0.429632 -0.124462 1.224261
C 1.398012 -1.038622 -0.471153
H 1.354893 -1.149679 -1.556309
C 2.386122 -1.654920 0.234580
H 3.159105 -2.237942 -0.259202
H 2.481664 -1.527784 1.311508
N -3.477341 0.073095 -0.142450
H -3.783790 -0.850306 0.151428
H -4.197253 0.780608 -0.034436
O 0.618022 1.261331 -0.359303
C 1.776254 1.917566 0.236217
H 2.716261 1.411132 -0.025622
H 1.785039 2.932423 -0.170074
H 1.685146 1.962185 1.333329
I 0.745388 -4.201091 0.448975
I -0.389499 -6.840484 0.978465
IC-6
23
C -0.909601 -0.627220 -0.170139
H -1.169538 -0.684481 -1.233883
H -0.904433 -1.653559 0.224623
C -1.981436 0.210897 0.558138
H -1.672533 0.348024 1.614427
H -2.011699 1.205467 0.102678
C 0.508869 -0.031007 -0.011089
H 0.754855 0.040977 1.064296
C 1.530339 -0.899458 -0.718324
H 1.658056 -0.680561 -1.780458
C 2.199542 -1.942565 -0.150912
H 2.807661 -2.616037 -0.748736
H 2.059228 -2.209203 0.895116
N -3.304569 -0.412027 0.413767
H -3.435615 -1.289910 0.907094
H -4.099852 0.212884 0.490686
O 0.453247 1.305806 -0.598146
C 1.575896 2.179196 -0.272532
H 2.520883 1.803883 -0.688867
H 1.339700 3.148680 -0.718871
H 1.687101 2.292556 0.817022
I 4.721321 -0.431125 0.404356
I 7.357766 0.576151 1.188727
TS-5
23
C 4.379664 0.721103 -1.284187
H 4.245153 0.323291 -2.298645
C 5.286545 -0.204770 -0.436562
H 6.061829 -0.693669 -1.034569
H 5.763234 0.366187 0.363347
C 3.027352 0.755163 -0.554811
H 2.262457 1.268927 -1.152081
C 2.592685 -0.697547 -0.327045
H 2.546145 -1.276559 -1.254287
C 1.613777 -1.050957 0.665721
H 1.355043 -2.103752 0.761015
H 1.625199 -0.493871 1.599952
N 4.376949 -1.230687 0.183263
H 4.534577 -2.194506 -0.113058
H 4.322742 -1.162270 1.200420
O 3.226571 1.416722 0.731555
C 2.269150 2.478899 1.060403
H 1.241773 2.096172 1.086971
H 2.559113 2.844535 2.048717
H 2.334113 3.300077 0.332235
I -0.559213 -0.264531 -0.352178
I -3.292388 0.761998 -1.483217
H 4.805769 1.725296 -1.363785
TS-6
23
C -4.409711 -0.067156 1.139809
H -4.116745 -0.869673 1.827380
H -4.858188 0.741697 1.723529
C -5.379090 -0.580017 0.055801
H -6.122483 -1.283076 0.445500
H -5.891048 0.263172 -0.411745
C -3.182526 0.437808 0.367021
H -2.357602 0.703300 1.040338
C -2.737265 -0.679757 -0.589790
H -2.482354 -0.328949 -1.592011
C -1.931898 -1.777413 -0.101476
H -1.672839 -2.561652 -0.810984
H -2.101962 -2.130580 0.915068
N -4.515870 -1.238955 -0.989983
H -4.467222 -2.256622 -0.911611
H -4.751423 -0.959440 -1.944765
O -3.625340 1.604163 -0.391839
C -2.548782 2.512746 -0.795864
H -1.813981 2.013485 -1.442806
H -3.031785 3.326084 -1.342574
H -2.028946 2.913815 0.084979
I 0.358894 -0.754477 0.105284
I 3.220617 0.475954 0.424333
P-5
21
C -0.150561 -2.579151 0.061188
C 1.655268 -0.960494 -0.289223
C 0.447222 -0.186501 0.276661
C -0.736110 -1.126421 -0.061895
H -0.503765 -3.174210 -0.796538
H 2.596589 -0.666878 0.191163
H 1.756807 -0.767527 -1.374886
H 0.533516 -0.093960 1.366126
H 0.345347 0.812867 -0.159978
H -1.047049 -0.961499 -1.108496
C -0.613929 -3.281593 1.347669
H -1.698645 -3.350566 1.418457
H -0.187394 -2.819454 2.237344
N 1.308004 -2.356441 0.034520
H 1.884712 -3.099680 -0.343560
O -1.897550 -0.989118 0.801126
I 0.097824 -5.383939 1.411016
C -2.629323 0.256675 0.629747
H -3.517300 0.178482 1.262494
H -2.032704 1.124849 0.946302
H -2.938275 0.395208 -0.419245
P-6
21
C -1.000308 0.153071 -0.092865
C -2.066184 2.320848 -0.283918
C -3.153376 1.354731 0.243204
C -2.511078 -0.058174 0.252158
H -2.101690 3.294158 0.219131
H -2.189095 2.500725 -1.368463
H -3.403522 1.590503 1.281808
H -4.071290 1.391960 -0.352367
N -0.821045 1.607490 0.060849
H 0.067036 2.014039 -0.219614
H -0.365904 -0.393910 0.614420
H -2.973592 -0.736560 -0.481661
O -2.719656 -0.598132 1.592409
C -2.501545 -2.031652 1.727725
H -1.456954 -2.312174 1.528069
H -2.751968 -2.275636 2.763865
H -3.153801 -2.599369 1.046070
C -0.633095 -0.255614 -1.540769
H 0.398220 0.014244 -1.780712
H -1.313910 0.170046 -2.282964
I -0.677557 -2.453214 -1.922083
2
46
C -0.996385 1.676375 -2.050712
H -1.980349 1.910358 -2.457094
H -0.333676 1.094754 -2.687471
C -0.609686 2.101096 -0.831693
H 0.383312 1.884253 -0.444704
C -1.505542 2.902649 0.086127
H -2.469208 3.081403 -0.421550
C -0.966661 4.281402 0.537030
H -1.766615 4.749937 1.128807
C 0.301526 4.191895 1.439310
H 0.120753 3.380783 2.155160
C 0.443875 5.459336 2.228886
N 0.598818 6.453641 2.848770
N 1.484124 3.887410 0.633015
H 1.552878 4.456481 -0.207092
H 2.352058 3.791722 1.150712
O -1.753434 2.202275 1.358838
O -0.678924 5.069798 -0.652786
C -2.556890 0.985998 1.241952
H -3.475028 1.223833 0.674867
H -2.006189 0.220978 0.677111
C -1.214889 6.436031 -0.663840
190
H -2.297931 6.390533 -0.457307
H -0.743094 7.036069 0.127151
C -0.962380 7.056271 -2.024802
C -0.984121 8.461208 -2.158192
C -0.739642 6.257481 -3.165109
C -0.800305 9.061652 -3.416978
H -1.139119 9.087433 -1.280632
C -0.549637 6.859564 -4.423714
H -0.702049 5.178678 -3.052963
C -0.583207 8.261107 -4.555592
H -0.818363 10.145239 -3.507586
H -0.374117 6.236569 -5.297994
H -0.436270 8.723569 -5.528867
C -2.905963 0.479945 2.627996
C -3.110037 -0.900766 2.834920
C -3.071943 1.368252 3.710969
C -3.486771 -1.387279 4.100751
H -2.971377 -1.598291 2.010084
C -3.441183 0.882136 4.978949
H -2.896488 2.428387 3.556670
C -3.654006 -0.496015 5.178027
H -3.640616 -2.453971 4.246999
H -3.561076 1.575112 5.808726
H -3.939960 -0.870250 6.158244
IC-7
48
C -0.448888 0.572005 2.388373
H -0.970923 1.501619 2.186775
H -0.666113 0.051426 3.316533
C 0.573313 0.158802 1.581241
H 1.141340 -0.736758 1.820997
C 0.977372 0.850877 0.302351
H 0.683106 0.200257 -0.540264
C 2.511584 1.081357 0.167801
H 2.678138 1.618904 -0.779489
C 3.081295 1.932082 1.328776
H 2.384193 2.764445 1.488245
C 4.398755 2.512678 0.916760
N 5.453326 2.956855 0.623836
N 3.159438 1.129261 2.545379
H 3.727626 0.292050 2.456230
H 3.283112 1.643443 3.410584
O 0.310744 2.143418 0.198099
O 3.241407 -0.177445 0.170628
C -0.253424 2.454552 -1.137815
H 0.560286 2.477622 -1.878960
H -0.958419 1.655319 -1.408598
C 3.453582 -0.807699 -1.148655
H 2.512186 -1.248298 -1.507344
H 3.767800 -0.023140 -1.855898
C 4.521700 -1.867356 -1.009186
C 5.828474 -1.503286 -0.614294
C 4.236150 -3.219551 -1.284405
C 6.831900 -2.479873 -0.496417
H 6.052562 -0.461815 -0.394406
C 5.242417 -4.199193 -1.172645
H 3.230484 -3.510886 -1.581981
C 6.541801 -3.830845 -0.778047
H 7.834932 -2.191750 -0.191288
H 5.012574 -5.239681 -1.388383
H 7.319780 -4.585483 -0.690193
C -0.948815 3.791395 -1.058159
C -2.293639 3.870273 -0.636636
C -0.263175 4.978380 -1.392396
C -2.940676 5.115923 -0.544169
H -2.831155 2.959581 -0.380245
C -0.907254 6.226060 -1.301824
H 0.773498 4.928789 -1.721019
C -2.248199 6.296910 -0.876898
H -3.977168 5.165804 -0.219883
H -0.370252 7.134683 -1.562762
H -2.748688 7.259942 -0.809660
I -2.264618 -1.105963 0.837973
I -4.424270 -2.622106 -0.504121
IC-8
48
C 0.572761 2.327328 -1.476874
H -0.055247 2.752858 -2.254745
H 1.587719 2.057446 -1.754003
C 0.181463 2.323320 -0.168491
H 0.856267 1.971381 0.609357
C -1.157850 2.834305 0.320336
H -1.930992 2.623510 -0.437485
C -1.205350 4.365656 0.584274
H -2.234591 4.596860 0.893282
C -0.240273 4.798330 1.720602
H -0.421441 4.126844 2.568558
C -0.581118 6.190295 2.157073
N -0.807852 7.299289 2.495736
N 1.144606 4.658083 1.276369
H 1.335725 5.112747 0.387292
H 1.853911 4.801174 1.988091
O -1.531310 2.246199 1.602975
O -0.856286 5.063786 -0.645588
C -2.001161 0.855489 1.547636
H -2.796443 0.787756 0.785457
H -1.183491 0.191565 1.236101
C -1.842029 6.080257 -1.101056
H -2.789794 5.567452 -1.322363
H -2.006416 6.802868 -0.291105
C -1.285328 6.755954 -2.329638
C -0.460061 7.894014 -2.202240
C -1.570915 6.254987 -3.617460
C 0.077231 8.517055 -3.343345
H -0.241549 8.290856 -1.212708
C -1.035810 6.875841 -4.761144
H -2.211026 5.381105 -3.725764
C -0.209259 8.008250 -4.625538
H 0.710048 9.394599 -3.235444
H -1.263349 6.483570 -5.749350
H 0.202645 8.491300 -5.508476
C -2.525212 0.457074 2.911810
C -2.359008 -0.868053 3.365558
C -3.217481 1.380451 3.723702
C -2.886537 -1.270087 4.607332
H -1.817735 -1.586934 2.752783
C -3.737568 0.981956 4.968476
H -3.331526 2.405496 3.383547
C -3.577373 -0.345407 5.413202
H -2.752785 -2.294942 4.945349
H -4.265597 1.702142 5.589394
H -3.981239 -0.652895 6.374895
I -0.245744 -0.439425 -1.943625
I -0.951995 -3.136471 -2.907355
TS-7
48
C 0.861939 -0.863806 -2.301127
H 1.255932 -1.736737 -1.783111
H 0.757731 -0.987957 -3.378873
C 1.354354 0.434355 -1.845807
H 0.900181 1.294236 -2.343592
C 1.537324 0.703283 -0.344397
H 0.578246 0.968717 0.107258
C 2.544252 1.874623 -0.253679
H 2.839543 2.083792 0.780620
C 3.735701 1.327381 -1.084571
H 4.168780 0.492177 -0.524796
C 4.767948 2.315916 -1.415522
N 5.609138 3.102344 -1.669629
N 3.068937 0.747607 -2.317963
H 3.055438 1.407867 -3.101214
H 3.466027 -0.151379 -2.604045
O 2.157771 -0.444934 0.299837
O 2.043545 3.045788 -0.941203
C 1.360018 -1.095947 1.381885
H 1.338072 -0.411978 2.241891
H 0.338204 -1.247812 1.015346
C 1.469725 4.129291 -0.092591
H 2.275071 4.537856 0.533526
H 1.183404 4.878204 -0.836602
C 0.296011 3.680367 0.752449
C -0.905218 3.247303 0.144415
C 0.396015 3.667835 2.160090
C -1.978167 2.784612 0.925926
H -0.995726 3.254041 -0.939904
C -0.684249 3.223049 2.948791
H 1.310326 4.012931 2.641225
C -1.867334 2.773417 2.332512
H -2.882573 2.415517 0.449663
H -0.600801 3.223488 4.032970
H -2.696782 2.412236 2.934752
C 2.024763 -2.404775 1.725446
C 1.559139 -3.609995 1.157056
C 3.123587 -2.442099 2.611364
C 2.186374 -4.832173 1.463131
H 0.702043 -3.593266 0.486711
C 3.754514 -3.661438 2.917042
H 3.481165 -1.518869 3.064119
C 3.286748 -4.859827 2.341830
H 1.815026 -5.755897 1.026404
H 4.597627 -3.680823 3.603477
H 3.768677 -5.804418 2.582648
I -1.501739 -0.792953 -1.640370
I -4.505941 -0.520941 -0.609170
TS-8
48
C 1.022704 -0.474557 1.763861
H 1.886026 -0.857035 1.219777
191
H 1.004743 -0.768890 2.814056
C 0.664239 0.928681 1.497748
H -0.201751 1.277154 2.067740
C 0.599230 1.441545 0.032574
H 0.421249 0.606807 -0.653888
C 1.935396 2.159709 -0.263445
H 1.883505 2.749820 -1.185691
C 2.107008 3.042870 0.992486
H 1.273502 3.752023 1.033604
C 3.391109 3.745467 1.100504
N 4.411527 4.329510 1.188765
N 1.908240 2.019138 2.091821
H 2.739381 1.419586 2.170869
H 1.655835 2.421574 2.999558
O -0.417620 2.473858 -0.099962
O 3.048434 1.233360 -0.237036
C -1.775238 1.987115 -0.456209
H -1.693795 1.439981 -1.407783
H -2.130916 1.282572 0.306224
C 3.347583 0.548226 -1.527327
H 2.410977 0.158131 -1.948243
H 3.764189 1.301486 -2.210118
C 4.323087 -0.567192 -1.252613
C 5.709879 -0.307926 -1.206009
C 3.856651 -1.880175 -1.024172
C 6.618240 -1.345521 -0.929169
H 6.076729 0.701382 -1.382517
C 4.763898 -2.919569 -0.748886
H 2.789976 -2.094869 -1.066695
C 6.146215 -2.653280 -0.700110
H 7.685082 -1.138967 -0.896946
H 4.395389 -3.927788 -0.579042
H 6.848234 -3.456860 -0.491197
C -2.693997 3.180773 -0.574941
C -2.311064 4.314981 -1.324340
C -3.965849 3.154685 0.032806
C -3.187272 5.405792 -1.460742
H -1.329571 4.341192 -1.790927
C -4.848093 4.243149 -0.110525
H -4.272815 2.284088 0.609051
C -4.460261 5.371962 -0.855907
H -2.884799 6.275528 -2.039471
H -5.829149 4.208754 0.356625
H -5.140107 6.213292 -0.966855
I -0.825173 -1.799158 0.874406
I -3.215171 -3.457136 -0.408493
P-6
46
C -1.588439 -1.172301 -0.848849
C -0.005324 0.051088 0.556206
C -1.106419 1.015561 0.053725
C -2.299990 0.066434 -0.197269
H -1.359359 1.789617 0.787783
H -3.039641 0.500256 -0.884064
N -0.257211 -1.210396 -0.205755
H 0.499026 -1.537674 -0.800446
H -1.518717 -0.987188 -1.933285
C -2.340700 -2.430089 -0.651359
N -2.941524 -3.435337 -0.506679
H -0.175839 -0.130111 1.624018
C 1.429206 0.530226 0.323190
H 2.157536 -0.234735 0.601720
H 1.575966 0.876857 -0.699820
I 1.944150 2.260286 1.597428
O -0.666387 1.594570 -1.211883
O -2.887175 -0.240748 1.091687
C -4.355215 -0.455623 1.087342
H -4.844745 0.501959 0.852268
H -4.607766 -1.187155 0.308075
C -1.315169 2.868211 -1.570676
H -2.376221 2.697129 -1.808747
H -1.257693 3.540442 -0.699874
C -0.591033 3.456486 -2.759521
C 0.741291 3.906030 -2.622811
C -1.229686 3.571210 -4.010565
C 1.422009 4.457541 -3.721722
H 1.239745 3.818723 -1.659536
C -0.551411 4.127705 -5.112713
H -2.255172 3.224800 -4.127333
C 0.776406 4.571300 -4.970222
H 2.447386 4.801115 -3.607470
H -1.054213 4.212807 -6.073117
H 1.302335 5.001212 -5.819456
C -4.766123 -0.957100 2.450145
C -4.561081 -2.311048 2.796328
C -5.352629 -0.085950 3.391055
C -4.933615 -2.781934 4.067572
H -4.107262 -2.986068 2.074398
C -5.728530 -0.556052 4.663844
H -5.510947 0.959560 3.131978
C -5.518813 -1.905906 5.004261
H -4.771462 -3.825434 4.326689
H -6.180297 0.123289 5.382921
H -5.808661 -2.271825 5.986660
P-7
46
C 0.151594 -0.360239 1.880811
C 0.449201 1.186642 0.002181
C 0.944581 -0.219051 -0.398512
C 0.180076 -1.180030 0.545046
H 0.754868 -0.460961 -1.450898
H 0.714586 -2.129617 0.682288
N 0.078569 1.042187 1.432156
H 0.430546 1.741625 2.076205
H 1.085884 -0.574940 2.426520
C -0.978973 -0.732678 2.758778
N -1.871853 -1.035258 3.468263
O 2.371855 -0.269321 -0.089277
O -1.143237 -1.396301 -0.008172
C -1.719379 -2.744164 0.232803
H -1.130799 -3.474916 -0.342511
H -1.639488 -2.980661 1.301860
C 3.116025 -1.308010 -0.805299
H 2.756371 -2.310104 -0.521050
H 2.938720 -1.180504 -1.887107
C 4.591550 -1.173547 -0.485782
C 5.167670 0.091405 -0.245326
C 5.414173 -2.319193 -0.469172
C 6.547682 0.206284 0.003081
H 4.530129 0.969978 -0.240959
C 6.796269 -2.204154 -0.227970
H 4.979516 -3.302743 -0.642541
C 7.367491 -0.939435 0.009261
H 6.982553 1.185348 0.190872
H 7.420279 -3.094742 -0.218659
H 8.434170 -0.848500 0.200094
C -3.161483 -2.731951 -0.210641
C -4.166867 -2.257837 0.660669
C -3.520964 -3.184640 -1.497224
C -5.510666 -2.234305 0.246742
H -3.895072 -1.904787 1.652984
C -4.865381 -3.162421 -1.913147
H -2.750513 -3.548439 -2.174830
C -5.863066 -2.686721 -1.040684
H -6.278757 -1.867505 0.923318
H -5.132893 -3.512621 -2.907263
H -6.902817 -2.669506 -1.359299
C -0.797450 1.656200 -0.772743
H -1.562071 0.880890 -0.822611
H -1.198798 2.572606 -0.339524
H 1.269109 1.902504 -0.128295
I -0.325546 2.194414 -2.873926
17
46
C 0.139909 -3.112206 0.188019
H 0.168489 -3.289102 -0.887563
H 0.379077 -3.960231 0.824882
C -0.162131 -1.904963 0.705352
H -0.181817 -1.762956 1.783514
C -0.512423 -0.706041 -0.151657
H -0.378874 -0.989155 -1.210698
C 0.320869 0.580607 0.113279
H 0.158876 1.266675 -0.732893
C -0.085229 1.396083 1.363510
H -1.162069 1.575032 1.285559
O -1.902736 -0.263174 0.036632
O 1.742734 0.309116 0.262166
C -2.921314 -1.207506 -0.432366
H -2.642029 -1.547459 -1.445766
H -2.948214 -2.089220 0.221727
C 2.449620 -0.058487 -0.962358
H 2.087210 -1.038797 -1.312173
H 2.240370 0.685920 -1.748407
C 3.937578 -0.127361 -0.676240
C 4.858170 0.014640 -1.736243
C 4.417498 -0.370776 0.627166
C 6.241200 -0.093454 -1.500675
H 4.498970 0.213844 -2.745236
C 5.801616 -0.472851 0.863243
H 3.707622 -0.467372 1.442192
C 6.717612 -0.337930 -0.197971
H 6.941449 0.019127 -2.325226
H 6.162833 -0.657444 1.872398
H 7.786269 -0.417906 -0.012816
C -4.265950 -0.510159 -0.453368
C -5.425141 -1.196980 -0.037857
C -4.384272 0.815669 -0.923389
C -6.687343 -0.575607 -0.101514
H -5.344142 -2.214256 0.341480
C -5.642816 1.440319 -0.980665
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H -3.489444 1.353425 -1.224098
C -6.799623 0.745542 -0.573782
H -7.573808 -1.115499 0.223045
H -5.723314 2.463886 -1.339746
H -7.772597 1.229224 -0.618960
N 0.628850 2.677848 1.325262
H 0.309778 3.366551 2.000369
H 1.640066 2.569922 1.298355
C 0.144981 0.652499 2.641262
N 0.321525 0.139818 3.690517
IC-9
48
C -0.772201 -0.652483 2.257253
H -1.462955 -1.442110 1.976985
H -0.274096 -0.733191 3.219258
C -0.664269 0.485335 1.509720
H -0.027383 1.305622 1.833097
C -1.370463 0.695073 0.186262
H -0.735957 0.275684 -0.613952
C -1.595565 2.202997 -0.143753
H -1.848815 2.295582 -1.213276
C -2.740713 2.844461 0.700567
H -2.457244 3.898097 0.809997
O -2.642782 -0.024044 0.209533
O -0.401180 2.990731 0.129884
C -3.119617 -0.533258 -1.103168
H -3.377398 0.317479 -1.748577
H -2.299848 -1.102656 -1.566538
C 0.703722 2.807963 -0.830480
H 1.173247 1.823912 -0.690406
H 0.282038 2.848857 -1.849964
C 1.719877 3.908615 -0.619421
C 3.090281 3.597918 -0.509132
C 1.312341 5.259064 -0.561473
C 4.045200 4.621815 -0.354787
H 3.414902 2.559425 -0.539381
C 2.263151 6.281557 -0.400499
H 0.254597 5.500624 -0.626855
C 3.633731 5.966204 -0.300549
H 5.099645 4.370137 -0.271530
H 1.940617 7.319123 -0.353628
H 4.368851 6.758102 -0.178123
C -4.325419 -1.407444 -0.860803
C -4.166470 -2.788021 -0.612369
C -5.623490 -0.852013 -0.869880
C -5.286853 -3.603616 -0.370934
H -3.168536 -3.223010 -0.608544
C -6.745121 -1.666943 -0.629080
H -5.755367 0.211278 -1.057412
C -6.579591 -3.043298 -0.379114
H -5.155180 -4.666475 -0.182856
H -7.741259 -1.231352 -0.638707
H -7.447369 -3.672932 -0.196382
N -2.868992 2.257130 2.027940
H -3.160705 2.881972 2.770021
H -3.278810 1.328466 2.050604
C -4.017350 2.805287 -0.079297
N -5.038033 2.742337 -0.670191
I 1.595155 -1.669276 0.843548
I 3.851786 -3.096715 -0.423870
IC-10
48
C 0.071733 -0.627251 -1.779592
H 1.102763 -0.376785 -1.542583
H -0.290707 -0.361210 -2.768755
C -0.687550 -1.396117 -0.943161
H -1.684352 -1.713177 -1.239149
C -0.197425 -1.911643 0.396608
H 0.209742 -1.073794 0.986612
C 0.950739 -2.961135 0.287424
H 0.968229 -3.480527 1.257571
C 0.766299 -3.985394 -0.865649
H 1.131341 -3.494248 -1.777549
O -1.235223 -2.586036 1.175535
O 2.223459 -2.311548 0.022061
C -2.338593 -1.750714 1.710829
H -2.445016 -2.081858 2.750465
H -2.041252 -0.693784 1.707705
C 3.002844 -1.932051 1.217259
H 2.492600 -1.122745 1.760893
H 3.063585 -2.812353 1.876921
C 4.376825 -1.489896 0.769216
C 5.198081 -2.373384 0.034293
C 4.860924 -0.206822 1.093639
C 6.484197 -1.975585 -0.368504
H 4.823301 -3.360128 -0.226819
C 6.152587 0.191262 0.696141
H 4.231917 0.484092 1.652440
C 6.966319 -0.692624 -0.036158
H 7.109775 -2.660494 -0.935899
H 6.517099 1.183180 0.952108
H 7.962858 -0.387004 -0.346233
C -3.634867 -1.957009 0.950381
C -4.228090 -0.905603 0.221401
C -4.276228 -3.216071 0.982501
C -5.439097 -1.107828 -0.469794
H -3.748305 0.070484 0.192621
C -5.480931 -3.422789 0.288640
H -3.829607 -4.030774 1.549708
C -6.066497 -2.367095 -0.440165
H -5.887688 -0.287909 -1.025349
H -5.965956 -4.395639 0.320134
H -7.001296 -2.524595 -0.972904
N -0.633361 -4.354379 -1.041272
H -0.840340 -5.025215 -1.771063
H -1.198647 -4.414272 -0.200960
C 1.675867 -5.148638 -0.616356
N 2.372386 -6.086728 -0.443153
I -0.974951 1.862879 -0.612111
I -1.651455 4.569896 0.327707
TS-9
48
C -0.566397 0.003964 1.476536
H -1.153606 0.866940 1.169393
H -0.974041 -0.546715 2.322929
C 0.879242 0.138661 1.425959
H 1.438251 -0.748723 1.735233
C 1.551542 0.851104 0.249018
H 1.451235 0.256576 -0.664910
C 3.029632 1.046404 0.659748
H 3.542633 1.757414 -0.001177
C 2.973087 1.567320 2.139982
H 3.637502 0.921994 2.723722
O 0.923251 2.160633 0.123522
O 3.728843 -0.223078 0.740473
C 0.706323 2.661893 -1.261643
H 1.679737 2.942312 -1.688700
H 0.271988 1.845460 -1.853537
C 4.224610 -0.764277 -0.557927
H 3.417047 -0.718235 -1.300968
H 5.054894 -0.124120 -0.889274
C 4.665078 -2.188556 -0.335525
C 3.754398 -3.250732 -0.525014
C 5.985347 -2.473750 0.073606
C 4.157130 -4.579908 -0.301548
H 2.735797 -3.046018 -0.849269
C 6.389623 -3.802188 0.298751
H 6.694198 -1.659876 0.215945
C 5.474947 -4.857468 0.111823
H 3.449604 -5.390290 -0.455589
H 7.409105 -4.014653 0.611327
H 5.787207 -5.885349 0.280303
C -0.225072 3.845289 -1.190712
C -1.621596 3.654322 -1.272745
C 0.284506 5.151102 -1.026888
C -2.496144 4.752803 -1.187263
H -2.021913 2.651316 -1.407794
C -0.588181 6.251241 -0.940107
H 1.359972 5.307864 -0.964993
C -1.980565 6.053351 -1.019946
H -3.569749 4.597371 -1.257250
H -0.187051 7.254013 -0.815809
H -2.655940 6.903348 -0.958490
N 1.552739 1.344205 2.601867
H 1.463644 1.020595 3.567244
H 0.956718 2.158854 2.413841
C 3.383219 2.970002 2.299557
N 3.721359 4.092543 2.429468
I -1.013924 -1.613360 -0.354095
I -1.501540 -3.598480 -2.764759
TS-10
48
C -0.263662 -0.931140 1.751358
H -1.343865 -1.007924 1.654243
H 0.099191 -0.755227 2.762803
C 0.559854 -1.778620 0.910125
H 1.635583 -1.649105 1.035782
C 0.132976 -2.077851 -0.535582
H -0.083553 -1.151886 -1.079792
C -1.102809 -3.015882 -0.489013
H -1.139049 -3.585419 -1.426929
C -0.881742 -3.947704 0.753183
H -1.654429 -3.674014 1.479783
O 1.152092 -2.873223 -1.219459
O -2.351384 -2.332805 -0.229961
C 2.246140 -2.136691 -1.912512
H 2.521315 -2.814834 -2.726283
H 1.833557 -1.213778 -2.340487
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C -2.967971 -1.674630 -1.414243
H -2.252503 -0.953967 -1.833764
H -3.177522 -2.452285 -2.163448
C -4.227746 -0.980632 -0.962309
C -5.473765 -1.638779 -1.035383
C -4.168495 0.335082 -0.453559
C -6.646602 -0.993414 -0.602250
H -5.526574 -2.652594 -1.428446
C -5.339731 0.981525 -0.019440
H -3.212816 0.852318 -0.393490
C -6.580783 0.318684 -0.093720
H -7.603551 -1.505868 -0.664345
H -5.284215 1.995704 0.367371
H -7.486956 0.820822 0.236835
C 3.432004 -1.845780 -1.015180
C 3.704926 -0.533181 -0.574261
C 4.284649 -2.899593 -0.611156
C 4.806389 -0.277432 0.265954
H 3.061716 0.290200 -0.877188
C 5.382334 -2.646987 0.230580
H 4.094973 -3.911201 -0.967080
C 5.644609 -1.333141 0.671800
H 5.004289 0.738149 0.597907
H 6.037165 -3.461902 0.530097
H 6.496961 -1.135101 1.317121
N 0.453311 -3.579399 1.335765
H 0.526968 -3.725430 2.344243
H 1.231960 -4.000269 0.815157
C -0.974354 -5.385485 0.457647
N -1.052314 -6.539130 0.224187
I 0.109075 1.345485 0.788961
I 0.491961 4.191668 -0.500748
P-9
46
C -1.042493 -1.647776 2.062285
C 0.131655 0.399622 2.032724
C 0.173181 -0.101725 0.566491
C -0.904825 -1.212311 0.534627
H -0.048012 0.678462 -0.171639
H -0.592959 -2.054683 -0.098751
N -0.042756 -0.852538 2.836969
H 0.845459 -1.357563 2.908748
H -0.774578 1.005214 2.161029
C 1.354364 1.175314 2.513858
H 1.283012 1.404929 3.577755
H 2.282311 0.655494 2.274985
I 1.529833 3.134142 1.515161
O 1.498429 -0.676262 0.364849
O -2.135192 -0.628421 0.038980
C -3.171364 -1.597260 -0.312294
H -2.754086 -2.316312 -1.038836
H -3.477532 -2.166912 0.580475
C 1.897272 -0.837991 -1.047226
H 1.219088 -1.549836 -1.542291
H 1.803723 0.138544 -1.546408
C 3.321613 -1.338086 -1.081790
C 4.397243 -0.428462 -0.989698
C 3.596391 -2.717652 -1.186550
C 5.725685 -0.890564 -0.997803
H 4.193317 0.637299 -0.906711
C 4.924266 -3.183878 -1.195703
H 2.773896 -3.427415 -1.254375
C 5.991858 -2.270420 -1.101306
H 6.547414 -0.182009 -0.926635
H 5.125086 -4.249454 -1.275753
H 7.018581 -2.628771 -1.109851
C -4.368128 -0.875872 -0.905352
C -4.322640 0.495132 -1.224628
C -5.551266 -1.605352 -1.154363
C -5.447676 1.127442 -1.789875
H -3.415697 1.054429 -1.022946
C -6.672503 -0.974364 -1.721076
H -5.599926 -2.664850 -0.905079
C -6.623925 0.397040 -2.041536
H -5.404624 2.187217 -2.030773
H -7.578335 -1.546288 -1.908098
H -7.491058 0.887425 -2.477511
C -0.894765 -3.093513 2.277400
N -0.783495 -4.258900 2.427072
H -2.047904 -1.343760 2.385037
P-10
46
C 0.008978 -0.327487 1.797949
C 0.195864 1.213744 -0.113843
C 0.715638 -0.177245 -0.537449
C 0.085095 -1.163884 0.476627
H 0.430674 -0.444930 -1.561931
H 0.697638 -2.066858 0.603294
N -0.159965 1.053359 1.319275
H 0.092022 1.802700 1.954436
O 2.163604 -0.153269 -0.374627
O -1.240898 -1.501216 -0.006209
C -1.820806 -2.715688 0.586334
H -1.216684 -3.587576 0.292409
H -1.787686 -2.633147 1.686046
C 2.882868 -1.182126 -1.136187
H 2.470288 -2.175640 -0.887469
H 2.729373 -1.011349 -2.212519
C 4.354592 -1.119045 -0.786394
C 5.325322 -1.252066 -1.800330
C 4.771318 -0.969771 0.554457
C 6.697211 -1.248805 -1.482357
H 5.013911 -1.352367 -2.838903
C 6.141518 -0.959435 0.870730
H 4.030674 -0.844480 1.338503
C 7.108746 -1.103117 -0.144333
H 7.437012 -1.351305 -2.272932
H 6.452785 -0.839329 1.905736
H 8.167568 -1.095807 0.104144
C -3.248446 -2.863129 0.108007
C -4.129273 -1.760287 0.135228
C -3.725005 -4.113836 -0.333521
C -5.466479 -1.909632 -0.271508
H -3.760021 -0.790560 0.458658
C -5.066802 -4.266961 -0.733465
H -3.051824 -4.968656 -0.370256
C -5.940956 -3.164678 -0.703662
H -6.136662 -1.053431 -0.252844
H -5.423664 -5.236756 -1.071893
H -6.975888 -3.279395 -1.016904
C 1.220728 -0.524312 2.638775
N 2.167932 -0.666757 3.329245
H -0.856032 -0.652402 2.392471
C -1.074688 1.659826 -0.863927
H -1.818651 0.863618 -0.906635
H -1.495519 2.560583 -0.415758
I -0.664452 2.227562 -2.967231
H 1.000665 1.944150 -0.255158
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Chapter 7
Future Prospects
The biological activity of azasugars has been largely attributed to their ability to mimic
the oxocarbenium ion-like transition state formed during a glycosidase reaction. This
ability has led to functional and stereochemical modifications of the azasugar scaffold in
the development of specific and potent glycosidase inhibitors.1–8 The work presented in
this thesis has described the development of synthetic methodology to prepare a series of
amino-imino-hexitols as azasugar scaffolds. The amino-imino-hexitols were evaluated
for their biological activity against a panel of glycosidases with the D-talo configuration
exhibiting good selective inhibition of β-D-glucosidase. The key transformation in
the synthetic route to produce amino-imino-hexitols was an I2-mediated carbamate
annulation of alkenylamines possessing an α-aminonitrile moiety. As eluded to in
Chapter 5, we have proposed three potential pathways for the mechanism of addition
of CO2 to the intermediate iodoamine in the carbamate annulation, which could proceed
via an aziridine (Pathway A, Scheme 7.1), carbonate (Pathway B) or carbamic acid
(Pathway C) intermediate. We suggested that an aziridine is not an intermediate in
197
the carbonylation as it was not transformed to the carbamate when subjected to the
annulation conditions. To determine whether carbonylation proceeds via pathway B
(carbonate) or C (carbamic acid), we can utilise the measurement of kinetic isotope
effects (KIEs). The measurement of KIEs is a powerful tool for probing reaction
mechanisms that has been used to elucidate events taking place in the rate determining
step (rds) of a wide range of reactions.9–15
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Scheme 7.1 Proposed pathways for carbonlyation of iodoamine
Isotope effects have generally been measured by kinetic competition reactions using
isotopically labeled and unlabelled reactants.16 However, the synthesis of isotopically
labeled reactants can be tedious, and a new synthesis and competition reaction is
required for each KIE determination. Seminal work by Singleton revealed that carbon
KIEs could be measured at natural abundance using 13C NMR analysis,16 to provide
information on the fundamental bonding changes of carbon atoms occurring in the rds of
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a reaction. With Singleton’s technique, KIEs can be derived from the ratio of 12C/13C in
the carbons of the reacting starting material (SM). The carbons involved in the rds of the
reaction will have an isotopic enhancement or diminishment of 13C over 12C, which can
be determined by recovering a sample (R) of SM from a reaction taken to a high degree
of conversion and comparing the measured 13C NMR spectrum with that of a standard
(R0) of SM. Any difference in the isotopic ratio of R/R0 will be apparent by examining
the comparative integrations of the carbon signals in the 13C NMR spectrum of the SM.
The integrations are referenced to the chemical shift of an internal carbon known not to
be involved in the transformation. However, the observed difference in R/R0 is small
due to the low natural abundance of 13C (1.1%). Thus, high precision NMR data is
necessary to accurately determine the difference in the integrations of carbon signals
within experimental error and this requires a large amount of material to be measured
in the 13C NMR (ca. 2 mmol at 125 MHz). For successful KIE analysis of a reaction;
the unreacted SM must be recovered in sufficient quantity for NMR measurements; the
reaction must be irreversible and the mechanism not change as the reaction proceeds and
the reaction must be clean with no side product formation. Therefore, we believe the I2-
mediated carbamate annulation is an ideal reaction to study using the 12C/13C natural
abundance KIE technique.
Iodoamine 1 was considered as a starting material to investigate KIEs for the mechanism
of CO2 addition to produce carbamate 2, since a route to gram quantities of 1 had
previously been established via the halocyclisation of alkenylamine 3 (Scheme 7.2).
However, with a molecular weight of 448 gmol-1 iodoamine 1 was not ideal to use as
a starting material for natural abundance 12C/13C KIE analysis, due to the difficultly of
dissolving enough material (2 mmol, 896 mg) in deuterated solvent in a 5 mm i.d. NMR
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tube.
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Scheme 7.2 Formation of iodoazasugar 1 en route to the synthesis of carbamate 2
An ideal molecule to study KIEs for the I2-mediated carbamate annulation would have
a low molecular weight for the dissolution of ca. 2 mmol in an NMR tube, while
also possessing the necessary functionality to undergo an annulation, and a carbon
to act as an internal NMR standard. Thus alkoxy alkenylamine (4, Scheme 7.3)
derived from 2-deoxy-D-ribose fits these criteria, with a molecular weight of 115
gmol-1 when R = Me, and 191 gmol-1 when R = Bn. KIEs could be determined for
the cyclisation of alkenylamine 4 to iodoamine 5, for the annulation of alkenylamine
4 to carbamate 6, and for the CO2 addition of iodoamine 5 to carbamate 6. The
combined results from these KIE experiments could then be compared to theoretical
KIEs derived using density functional theory (DFT). This comparison would indicate
whether the initial iodocyclisation or subsequent CO2 addition was the rds of the
carbamate annulation and whether the addition of CO2 proceeded via a carbonate or
carbamic acid intermediate.
We produced the simplified alkenylamine 4 (R = Me, as discussed in Chapter 6),
utilising the Vasella reductive amination17–19 on methyl 2,5-dideoxy-5-iodo-3-methoxy-
α/β-D-ribofuranoside. However, this route was not high yielding due to the formation
of a major byproduct and difficulties in isolating the alkenylamine. As we needed
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annulation
large quantities of material to run the KIE experiments protected amines were used
in the reductive amination. Thus, a Vasella reductive amination in the presence of
diphenylmethylamine was performed, however, all attempts to remove the diphenyl-
methyl group were unsuccessful whilst also keeping the methyl ether intact. When
p-methoxybenzylamine was used as an amine source in the Vasella reductive amination
a secondary amine byproduct was formed along with the desired primary amine and
problems were also encountered removing the p-methoxybenzyl moiety.
In light of the difficulties with the Vasella reductive amination protocol other ways to
make an alkoxy alkenylamine framework have been explored, thus a concise racemic
route was anticipated involving a [2+3] dipolar cycloaddition as the key step based on
the procedure by Torssell and Das (Scheme 7.4).20 It is important to note that a racemic
alkenylamine will not be detrimental to obtaining KIEs, as the carbamate annulation
of (3S)-1-amino-3-methoxy-pent-4-ene is known to produce the cis-diastereomer as the
only observable product (Chapter 6), therefore, both enantiomers should cyclise via the
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same mechanistic pathway. Furthermore, as enantiomers have identical spectral data,
measurement of the racemic alkenylamine (4) will not affect the determination of R/R0
in the 13C NMR spectra. Here, the [2+3] dipolar cycloaddition of butadiene (7) and
nitromethane (8) produced the cyclic oxime 9 in 20% yield and, although this reaction
was low yielding, further optimisation could be achieved. Ring opening of oxime 9
under basic conditions gave hydroxy nitrile 10 in good (89%) yield. At this point
alkylation of nitrile 10 in the presence of Ag2O could be carried out with either MeI
or BnBr to produce the alkoxy nitrile 11, which could be subsequently reduced to the
alkenylamine 4 with treatment by LiAlH4.
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Scheme 7.4 Preparation of a racemic alkoxy alkenylamine for KIE analysis
Methoxy alkenylamine (4, R = Me) was prepared using the racemic route shown in
Scheme 7.4, however, this compound is highly volatile which makes it difficult to
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reliably recover in a quantitative amount from KIE experiments. Although carbamate
annulation of alkenylamine 4 (R = Me) successfully produced the cis-carbamate 6,
attempts to isolate the iodoamine 5 were yet unsuccessful. However, it is anticipated
that the benzyloxy alkenylamine (4, R = Bn) will not be volatile, and can be prepared
through the use of BnBr and Ag2O (10 → 11) followed by reduction of the nitrile
via treatment with LiAlH4. A benzyl ether increases the weight of the alkenylamine
compared to a methyl ether, however, we anticipate the trade-off in molecular weight
should facilitate the smooth re-isolation of the SM in the KIE experiments. We also
believe the iodoamine (5, R = Bn) can be synthesised from alkenylamine 4 (R = Bn)
using NIS in DCM. With this racemic route, gram quantities of benzyloxy alkenylamine
(4, R = Bn) can be prepared and utilised as the SM for the KIE experiments. Moreover,
analysis of the experimental KIE data will enable further elucidation of the I2-mediated
carbamate annulation mechanism.
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